Hadassah Medical Center: Lerer Bernard

1) Wolf G, Singh S, Blakolmer K, Lerer L, Lifschytz T, Heresco-Levy U, et al. Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation. Mol Psychiatry 2023;28(1):44-58.

(2) Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Lotan A, et al. Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications. Int J Mol Sci 2022;23(22).

(3) Donen A, Lifschytz T, Wolf G, Ben-Ari H, Lotan A, Lerer L, et al. Evaluation of the Therapeutic Potential of Oral Phycocyanin-Rich Spiruli-na Extracts in Neuropsychiatric Disorders. Nat Prod J 2022;12(6):76-81.

(4) Similon MVM, Paasche C, Krol F, Lerer B, Goodwin GM, Berk M, et al. Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs. Eur Neuropsychopharmacol 2022;60:91-99.

(5) Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature 2022;604(7906):502-508.

(6) Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L. Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes (Front. Psychiatry., (2022), 12, 780696, 10.3389/fpsyt.2021.780696). Front Psychiatry 2022;13.

(7) Alkelai A, Greenbaum L, Docherty AR, Shabalin AA, Povysil G, Malakar A, et al. The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders. Mol Psychiatry 2022;27(3):1435-1447.

(8) Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L. Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes. Front Psychiatry 2022;12.

(9) Blokland GAM, Grove J, Chen C-, Cotsapas C, Tobet S, Handa R, et al. Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders. Biol Psychiatry 2022;91(1):102-117.

(10) Moskovich D, Finkelshtein Y, Alfandari A, Rosemarin A, Lifschytz T, Weisz A, et al. Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment. Oncogene 2021;40(44):6248-6257.

(11) Ni G, Zeng J, Revez JA, Wang Y, Zheng Z, Ge T, et al. A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts. Biol Psychiatry 2021;90(9):611-620.

(12) Taliaz D, Spinrad A, Barzilay R, Barnett-Itzhaki Z, Averbuch D, Teltsh O, et al. Optimizing prediction of response to antidepressant medications using machine learning and integrated genetic, clinical, and demographic data. Transl Psychiatry 2021;11(1).

(13) Moskovich D, Alfandari A, Finkelshtein Y, Weisz A, Katzav A, Kidron D, et al. DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer. Cancer Lett 2021;501:224-233.

(14) Hess JL, Tylee DS, Mattheisen M, Adolfsson R, Agartz I, Agerbo E, et al. A polygenic resilience score moderates the genetic risk for schizophrenia. Mol Psychiatry 2021;26(3):800-815.

(15) Kamitaki N, Sekar A, Handsaker RE, de Rivera H, Tooley K, Morris DL, et al. Complement genes contribute sex-biased vulnerability in diverse disorders. Nature 2020;582(7813):577-581.

(16) Krol FJ, Hagin M, Vieta E, Harazi R, Lotan A, Strous RD, et al. Placebo—To be or not to be? Are there really alternatives to placebo-controlled trials? Eur Neuropsychopharmacol 2020;32:1-11.

(17) Lee PH, Anttila V, Won H, Feng Y-A, Rosenthal J, Zhu Z, et al. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders. Cell 2019;179(7):1469-1482.e11.

(18) Alkelai A, Greenbaum L, Heinzen EL, Baugh EH, Teitelbaum A, Zhu X, et al. New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approach. Prog Neuro-Psychopharmacol Biol Psychiatry 2019;94.

(19) Huckins LM, Dobbyn A, Ruderfer DM, Hoffman G, Wang W, Pardiñas AF, et al. Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (Nature Genetics, (2019), 51, 4, (659-674), 10.1038/s41588-019-0364-4). Nat Genet 2019;51(6):1068.

(20) Ben-Ari H, Lifschytz T, Wolf G, Rigbi A, Blumenfeld-Katzir T, Merzel TK, et al. White matter lesions, cerebral inflammation and cognitive function in a mouse model of cerebral hypoperfusion. Brain Res 2019;1711:193-201.

(21) Huckins LM, Dobbyn A, Ruderfer DM, Hoffman G, Wang W, Pardiñas AF, et al. Gene expression imputation across multiple brain regions provides insights into schizophrenia risk. Nat Genet 2019;51(4):659-674.

(22) Harold D, Connolly S, Riley BP, Kendler KS, McCarthy SE, McCombie WR, et al. Population-based identity-by-descent mapping combined with exome sequencing to detect rare risk variants for schizophrenia. Am J Med Genet Part B Neuropsychiatr Genet 2019;180(3):223-231.

(23) Ni G, Gratten J, Wray NR, Lee SH, Ripke S, Neale BM, et al. Age at first birth in women is genetically associated with increased risk of schizophrenia. Sci Rep 2018;8(1).

(24) Wolf G, Lifschytz T, Ben-Ari H, Tatarskyy P, Merzel TK, Lotan A, et al. Effect of chronic unpredictable stress on mice with developmental under-expression of the Ahi1 gene: Behavioral manifestations and neurobiological correlates. Transl Psychiatry 2018;8(1).

(25) Zai CC, Lee FH, Tiwari AK, Lu JY, De Luca V, Maes MS, et al. Investigation of the HSPG2Gene in tardive dyskinesia-new data and meta-analysis. Front Pharmacol 2018;9(SEP).

(26) LeBlanc M, Zuber V, Thompson WK, Andreassen OA, Frigessi A, Andreassen BK, et al. A correction for sample overlap in genome-wide association studies in a polygenic pleiotropy-informed framework. BMC Genomics 2018;19(1).

(27) Ruderfer DM, Ripke S, McQuillin A, Boocock J, Stahl EA, Pavlides JMW, et al. Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. Cell 2018;173(7):1705-1715.e16.

(28) Ni G, Moser G, Ripke S, Neale BM, Corvin A, Walters JTR, et al. Estimation of Genetic Correlation via Linkage Disequilibrium Score Regression and Genomic Restricted Maximum Likelihood. Am J Hum Genet 2018;102(6):1185-1194.

(29) Lotan A, Lifschytz T, Wolf G, Keller S, Ben-Ari H, Tatarsky P, et al. Differential effects of chronic stress in young-adult and old female mice: Cognitive-behavioral manifestations and neurobiological correlates. Mol Psychiatry 2018;23(6):1432-1445.

(30) Lerer B. From freud to biology, from genes to medicines: A 40 year perspective. Isr J Psychiatry 2018;55(3):65-71.

(31) Sarner-Levin K, Canetti L, Latzer Y, Bonne O, Lerer B, Bachar E. Anorexia nervosa, selflessness, and gender-role identity: A study of daughters and parents. Isr J Psychiatry 2018;55(1):25-34.

(32) Eitan R, Fontaine D, Benoît M, Giordana C, Darmon N, Israel Z, et al. One year double blind study of high vs low frequency subcallosal cingulate stimulation for depression. J Psychiatr Res 2018;96:124-134.

(33) Wolf G, Lotan A, Lifschytz T, Ben-Ari H, Merzel TK, Tatarskyy P, et al. Differentially severe cognitive effects of compromised cerebral blood flow in aged mice: Association with myelin degradation and microglia activation. Front Aging Neurosci 2017;9(JUN).

(34) Lotan A, Lifschytz T, Mernick B, Lory O, Levi E, Ben-Shimol E, et al. Alterations in the expression of a neurodevelopmental gene exert long-lasting effects on cognitive-emotional phenotypes and functional brain networks: Translational evidence from the stress-resilient Ahi1 knockout mouse. Mol Psychiatry 2017;22(6):884-899.

(35) McLaughlin RL, Schijven D, Van Rheenen W, Van Eijk KR, O'Brien M, Kahn RS, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nat Commun 2017;8.

(36) Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat Genet 2017;49(1):27-35.

(37) Li M, Huang L, Grigoroiu-Serbanescu M, Bergen SE, Landén M, Hultman CM, et al. Convergent Lines of Evidence Support LRP8 as a Susceptibility Gene for Psychosis. Mol Neurobiol 2016;53(10):6608-6619.

(38) Johnson EC, Bjelland DW, Howrigan DP, Abdellaoui A, Breen G, Borglum A, et al. No Reliable Association between Runs of Homozygosity and Schizophrenia in a Well-Powered Replication Study. PLoS Genet 2016;12(10).

(39) Hagelkruys D, Böhm C, Motschnig R, Kertzman S, Sirota A, Lerer B, et al. Adapting a stand-alone computerized cognitive test battery for online use - A case-study in the context of users with special needs. Comput Hum Behav 2016;63:757-768.

(40) Franke B, van Hulzen KJE, Arias-Vasquez A, Bralten J, Hoogman M, Klein M, et al. Genetic influences on schizophrenia and subcortical brain volumes: Large-scale proof of concept. Nat Neurosci 2016;19(3):420-431.

(41) Li X, Zhang W, Lencz T, Darvasi A, Alkelai A, Lerer B, et al. Common variants of IRF3 conferring risk of schizophrenia. J Psychiatr Res 2015;64:67-73.

(42) Bulik-Sullivan B, Loh P-, Finucane HK, Ripke S, Yang J, Patterson N, et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet 2015;47(3):291-295.

(43) Vilhjálmsson BJ, Yang J, Finucane HK, Gusev A, Lindström S, Ripke S, et al. Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores. Am J Hum Genet 2015;97(4):576-592.

(44) Greenbaum L, Lerer B. Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes. Front Neurol 2015;6(FEB).

(45) Lotan A, Lifschytz T, Slonimsky A, Broner EC, Greenbaum L, Abedat S, et al. Neural mechanisms underlying stress resilience in Ahi1 knockout mice: Relevance to neuropsychiatric disorders. Mol Psychiatry 2014;19(2):243-252.

(46) Lotan A, Lifschytz T, Lory O, Goelman G, Lerer B. Amygdalar disconnectivity could underlie stress resilience in the Ahi1 knockout mouse: Conclusions from a resting-state functional MRI study. Mol Psychiatry 2014;19(2):144.

(47) Gusev A, Lee SH, Trynka G, Finucane H, Vilhjálmsson BJ, Xu H, et al. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. Am J Hum Genet 2014;95(5):535-552.

(48) Luo X-, Li M, Huang L, Steinberg S, Mattheisen M, Liang G, et al. Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene. Mol Psychiatry 2014;19(7):774-783.

(49) Ripke S, Neale BM, Corvin A, Walters JTR, Farh K-, Holmans PA, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014;511(7510):421-427.

(50) Baldinger P, Lotan A, Frey R, Kasper S, Lerer B, Lanzenberger R. Neurotransmitters and electroconvulsive therapy. J ECT 2014;30(2):116-121.

(51) Greenbaum L, Goldwurm S, Zozulinsky P, Lifschytz T, Cohen OS, Yahalom G, et al. Do tardive dyskinesia and l-dopa induced dyskinesia share common genetic risk factors? An exploratory study. J Mol Neurosci 2013;51(2):380-388.

(52) Gesundheit B, Rosenzweig JP, Naor D, Lerer B, Zachor DA, Procházka V, et al. Immunological and autoimmune considerations of Autism Spectrum Disorders. J Autoimmun 2013;44:1-7.

(53) Greenbaum L, Lorberboym M, Melamed E, Rigbi A, Barhum Y, Kohn Y, et al. Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson's disease. Front Neurosci 2013(7 APR).

(54) Teltsh O, Kanyas-Sarner K, Rigbi A, Greenbaum L, Lerer B, Kohn Y. Erratum: Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree (International Journal of Neuropsychopharmacology (2011) DOI:10.1017/S1461145711001374). Int J Neuropsychopharmacol 2013;16(5):1183.

(55) Greenbaum L, Rigbi A, Lipshtat N, Cilia R, Tesei S, Asselta R, et al. Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson's disease age at onset: Gene and smoking status interaction. Parkinsonism Relat Disord 2013;19(1):72-76.

(56) Greenbaum L, Alkelai A, Zozulinsky P, Kohn Y, Lerer B. Support for association of HSPG2 with tardive dyskinesia in Caucasian populations. Pharmacogenomics J 2012;12(6):513-520.

(57) Lifschytz T, Broner EC, Zozulinsky P, Slonimsky A, Eitan R, Greenbaum L, et al. Relationship between Rgs2 gene expression level and anxiety and depression-like behaviour in a mutant mouse model: Serotonergic involvement. Int J Neuropsychopharmacol 2012;15(9):1307-1318.

(58) Levinson DF, Shi J, Wang K, Oh S, Riley B, Pulver AE, et al. Genome-wide association study of multiplex schizophrenia pedigrees. Am J Psychiatry 2012;169(9):963-973.

(59) Pelov I, Teltsh O, Greenbaum L, Rigbi A, Kanyas-Sarner K, Lerer B, et al. Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition. Psychiatr Genet 2012;22(4):168-176.

(60) Alkelai A, Lupoli S, Greenbaum L, Kohn Y, Kanyas-Sarner K, Ben-Asher E, et al. Erratum: DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population (International Journal of Neuropsychopharmacology (2011) DOI: 10.1017/S1461145711000903). Int J Neuropsychopharmacol 2012;15(4):541.

(61) Greenbaum L, Lifschytz T, Zozulinsky P, Broner EC, Slonimsky A, Kohn Y, et al. Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse model. Eur Neuropsychopharmacol 2012;22(5):379-386.

(62) Greenbaum L, Smith RC, Lorberboym M, Alkelai A, Zozulinsky P, Lifschytz T, et al. Erratum: Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients (Psychopharmacology DOI:10.1007/s00213- 011-2499-6). Psychopharmacology 2012;220(3):643.

(63) Greenbaum L, Smith RC, Lorberboym M, Alkelai A, Zozulinsky P, Lifshytz T, et al. Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients. Psychopharmacology 2012;220(3):519-528.

(64) Alkelai A, Greenbaum L, Lupoli S, Kohn Y, Sarner-Kanyas K, Ben-Asher E, et al. Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample. PLoS ONE 2012;7(1).

(65) Stein DJ, Lerer B, Stahl S. Preface. Essent Evidence-Based Psychopharmacology, Second Edition 2012:viii.

(66) Stein DJ, Lerer B, Stahl S. Essential evidence-based psychopharmacology, second edition. Essential Evidence-Based Psychopharmacology, Second Edition; 2012. p. 1-325.

(67) Lerer B, Belmaker RH. Conference scene in global personalized medicine: CINP Thematic Meeting on Pharmacogenomics and Personalised Medicine in Psychiatry, Jerusalem, Israel (April 21-23, 2013). Curr Pharmacogenomics Per Med 2012;10(4):264.

(68) Alkelai A, Lupoli S, Greenbaum L, Kohn Y, Kanyas-Sarner K, Ben-Asher E, et al. DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population. Int J Neuropsychopharmacol 2012;15(4):459-469.

(69) Teltsh O, Kanyas-Sarner K, Rigbi A, Greenbaum L, Lerer B, Kohn Y. Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree. Int J Neuropsychopharmacol 2012;15(3):309-319.

(70) Alkelai A, Lupoli S, Greenbaum L, Giegling I, Kohn Y, Sarner-Kanyas K, et al. Identification of new schizophrenia susceptibility loci in an ethnically homogeneous, family-based, Arab-Israeli sample. FASEB J 2011;25(11):4011-4023.

(71) Vardi N, Freedman N, Lester H, Gomori JM, Chisin R, Lerer B, et al. Hyperintensities on T2-weighted images in the basal ganglia of patients with major depression: Cerebral perfusion and clinical implications. Psychiatry Res Neuroimaging 2011;192(2):125-130.

(72) Lifschytz T, Zozulinsky P, Eitan R, Landshut G, Ohayon S, Lerer B. Effect of triiodothyronine on antidepressant screening tests in mice and on presynaptic 5-HT 1A receptors: Mediation by thyroid hormone α receptors. J Pharmacol Exp Ther 2011;337(2):494-502.

(73) Greenbaum L, Levin R, Lerer E, Alkelai A, Kohn Y, Heresco-Levy U, et al. Association of Reelin (RELN) single nucleotide polymorphism rs7341475 with prepulse inhibition in the Jewish Israeli population. Biol Psychiatry 2011;69(5):e17-e18.

(74) Rigbi A, Yakir A, Sarner-Kanyas K, Pollak Y, Lerer B. Why do young women smoke VI. A controlled study of nicotine effects on attention: Pharmacogenetic interactions. Pharmacogenomics J 2011;11(1):45-52.

(75) Isserles M, Rosenberg O, Dannon P, Levkovitz Y, Kotler M, Deutsch F, et al. Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome. J Affective Disord 2011;128(3):235-242.

(76) Cooper-Kazaz R, Rigbi A, Lerer B. Targeting remission by 8 weeks: When should supplementation be considered in patients with major depression treated with a specific serotonin reuptake inhibitor? Compr Psychiatry 2011;52(1):9-16.

(77) Greenbaum L, Alkelai A, Rigbi A, Kohn Y, Lerer B. Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia. Mov Disord 2010;25(16):2809-2817.

(78) Greenbaum L, Kanyas KS, Rigbi A, Alkelai A, Kohn Y, Lerer B. Why do young women smoke? VII COMT as a risk modifying gene for Nicotine dependence - Role of gene-gene interaction, personality, and environmental factors. Hum Psychopharmacol 2010;25(7-8):536-542.

(79) Cooper R, Lerer B. [The use of thyroid hormones in the treatment of depression]. Harefuah 2010;149(8):529-534, 550, 549.

(80) Torri F, Akelai A, Lupoli S, Sironi M, Amann-Zalcenstein D, Fumagalli M, et al. Fine mapping of AHI1 as a schizophrenia susceptibility gene: From association to evolutionary evidence. FASEB J 2010;24(8):3066-3082.

(81) Slonimsky A, Levy I, Kohn Y, Rigbi A, Ben-Asher E, Lancet D, et al. Lymphoblast and brain expression of AHI1 and the novel primate-specific gene, C6orf217, in schizophrenia and bipolar disorder. Schizophr Res 2010;120(1-3):159-166.

(82) Eitan R, Landshut G, Lifschytz T, Einstein O, Ben-Hur T, Lerer B. The thyroid hormone, triiodothyronine, enhances fluoxetine-induced neurogenesis in rats: Possible role in antidepressant-augmenting properties. Int J Neuropsychopharmacol 2010;13(5):553-561.

(83) Lifschytz T, Goltser-Dubner T, Landshut G, Lerer B. Effect of triiodothyronine on 5-HT1A and 5-HT1B receptor expression in rat forebrain and on latency to feed in the novelty suppressed feeding test. Prog Neuro-Psychopharmacol Biol Psychiatry 2010;34(4):632-638.

(84) Cooper-Kazaz R, Cohen A, Lerer B. Noradrenergic adverse effects due to combined treatment with reboxetine and triiodothyronine. J Clin Psychopharmacol 2010;30(2):211-212.

(85) Greenbaum L, Pelov I, Teltsh O, Lerer B, Kohn Y. No association between regulator of G-protein signaling 9 (RGS9) and schizophrenia in a Jewish population. Psychiatr Genet 2010;20(1):47-48.

(86) Ingason A, Giegling I, Cichon S, Hansen T, Rasmussen HB, Nielsen J, et al. A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Hum Mol Genet 2010;19(7):1379-1386.

(87) Alkelai A, Kohn Y, Olender T, Sarner-Kanyas K, Rigbi A, Hamdan A, et al. Evidence for an interaction of schizophrenia susceptibility loci on chromosome 6q23.3 and 10q24.33-q26.13 in Arab Israeli families. Am J Med Genet Part B Neuropsychiatr Genet 2009;150(7):914-925.

(88) Greenbaum L, Rigbi A, Teltsh O, Lerer B. Role of genetic variants in the CHRNA5-CHRNA3-CHRNB4 cluster in nicotine dependence risk: Importance of gene-environment interplay. Mol Psychiatry 2009;14(9):828-830.

(89) Alkelai A, Greenbaum L, Rigbi A, Kanyas K, Lerer B. Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients. Psychopharmacology 2009;206(3):491-499.

(90) Ng MYM, Levinson DF, Faraone SV, Suarez BK, Delisi LE, Arinami T, et al. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry 2009;14(8):774-785.

(91) Greenbaum L, Lerer B. Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: Recent progress and emerging open questions. Mol Psychiatry 2009;14(10):912-945.

(92) Cooper-Kazaz R, van der Deure WM, Medici M, Visser TJ, Alkelai A, Glaser B, et al. Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronine. J Affective Disord 2009;116(1-2):113-116.

(93) Rigbi A, Yakir A, Kanyas K, Pollak Y, Lerer B. Further support for a role of the His452Tyr variant in 5-HT2A receptor gene in memory functions in humans. Int J Neuropsychopharmacol 2009;12(5):723-725.

(94) Greenbaum L, Smith RC, Rigbi A, Strous R, Teltsh O, Kanyas K, et al. Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: Protective role of a functional polymorphism in the 3′-untranslated region. Pharmacogenomics J 2009;9(2):103-110.

(95) Teltsh O, Kanyas K, Karni O, Levi A, Korner M, Hamdan A, et al. P.3.18 Mutation screening in a candidate region for schizophrenia on chromosome 20p13. Eur Neuropsychopharmacol 2009;19:S77.

(96) Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: Leads for future research and new drug developments in depression. Metab Brain Dis 2009;24(1):27-53.

(97) Eitan R, Landshut G, Lerer B. Neurochemical effects of electrically induced seizures: Relevance to the antidepressant mechanism of electroconvulsive therapy. Electroconvulsive and Neuromodulation Therapies; 2009. p. 45-74.

(98) Papakostas GI, Cooper-Kazaz R, Appelhof BC, Posternak MA, Johnson DP, Klibanski A, et al. Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: A quantitative synthesis of double-blind studies. Int Clin Psychopharmacol 2009;24(1):19-25.

(99) Thomas P, Srivastava V, Singh A, Mathur P, Nimgaonkar VL, Lerer B, et al. Correlates of response to Olanzapine in a North Indian Schizophrenia sample. Psychiatry Res 2008;161(3):275-283.

(100) Lerer B. IJNP: A decade in perspective. Int J Neuropsychopharmacol 2008;11(8):1035-1036.

(101) Gesundheit B, Lerer B, Budowski E, Neuman T, Gomori JM, Or R. Sudden psychotic symptoms in a 28-year-old male with thymoma. J Clin Oncol 2008;26(26):4353-4355.

(102) Kohn Y, Freedman N, Lester H, Krausz Y, Chisin R, Lerer B, et al. Cerebral perfusion after a 2-year remission in major depression. Int J Neuropsychopharmacol 2008;11(6):837-843.

(103) Ludewick HP, Schwab SG, Albus M, Lerer B, Maier W, Trixler M, et al. No support for an association with TAAR6 and schizophrenia in a linked population of European ancestry. Psychiatr Genet 2008;18(4):208-210.

(104) Cooper-Kazaz R, Lerer B. Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors. Int J Neuropsychopharmacol 2008;11(5):685-699.

(105) Canetti L, Kanyas K, Lerer B, Latzer Y, Bachar E. Anorexia nervosa and parental bonding: The contribution of parent-grandparent relationships to eating disorder psychopathology. J Clin Psychol 2008;64(6):703-716.

(106) Smith RC, Segman RH, Golcer-Dubner T, Pavlov V, Lerer B. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia. Pharmacogenomics J 2008;8(3):228-236.

(107) Bachar E, Kanyas K, Latzer Y, Canetti L, Bonne O, Lerer B. Depressive tendencies and lower levels of self-sacrifice in mothers, and selflessness in their anorexic daughters. Eur Eating Disord Rev 2008;16(3):184-190.

(108) Teltsh O, Kanyas K, Karni O, Levi A, Korner M, Ben-Asher E, et al. Genome-wide linkage scan, fine mapping, and haplotype analysis in a large, inbred, arab israeli pedigree suggest a schizophrenia susceptibility locus on chromosome 20p13. Am J Med Genet Part B Neuropsychiatr Genet 2008;147(2):209-215.

(109) Rigbi A, Kanyas K, Yakir A, Greenbaum L, Pollak Y, Ben-Asher E, et al. Why do young women smoke? V. Role of direct and interactive effects of nicotinic cholinergic receptor gene variation on neurocognitive function. Genes Brain Behav 2008;7(2):164-172.

(110) Schwab SG, Plummer C, Albus M, Borrmann-Hassenbach M, Lerer B, Trixler M, et al. DNA sequence variants in the metabotropic glutamate receptor 3 and risk to schizophrenia: An association study. Psychiatr Genet 2008;18(1):25-30.

(111) Srivastava V, Deshpande SN, Nimgaonkar VL, Lerer B, Thelma BK. Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: Role of metabolic pathway genes. Pharmacogenomics 2008;9(8):1055-1068.

(112) Lerer B, Isserles M. From Meduna to ultrabrief: New directions for the oldest brain stimulation therapy. Brain Stimul 2008;1(2):84-85.

(113) Pae C-, Yu H-, Amann D, Kim J-, Lee C-, Lee S-, et al. Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample. J Psychiatr Res 2008;42(1):35-40.

(114) Tiwari AK, Deshpande SN, Lerer B, Nimgaonkar VL, Thelma BK. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C > T polymorphism. Pharmacogenomics J 2007;7(5):305-311.

(115) Massat I, Lerer B, Souery D, Blackwood D, Muir W, Kaneva R, et al. HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter association study [3]. Mol Psychiatry 2007;12(9):797-798.

(116) Kohn Y, Freedman N, Lester H, Krausz Y, Chisin R, Lerer B, et al. 99mTc-HMPAO SPECT study of cerebral perfusion after treatment with medication and electroconvulsive therapy in major depression. J Nucl Med 2007;48(8):1273-1278.

(117) Greenbaum L, Strous RD, Kanyas K, Merbl Y, Horowitz A, Karni O, et al. Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication. Pharmacogenet Genomics 2007;17(7):519-528.

(118) Segman RH, Kanyas K, Karni O, Lerer E, Goltser-Dubner T, Pavlov V, et al. Why do young women smoke? IV. Role of genetic variation in the dopamine transporter and lifetime traumatic experience. Am J Med Genet Part B Neuropsychiatr Genet 2007;144(4):533-540.

(119) Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, et al. Combined treatment with sertraline and liothyronine in major depression: A randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2007;64(6):679-688.

(120) Strous RD, Greenbaum L, Kanyas K, Merbl Y, Horowitz A, Karni O, et al. Association of the dopamine receptor interacting protein gene, NEF3, with early response to antipsychotic medication. Int J Neuropsychopharmacol 2007;10(3):321-333.

(121) Thelma BK, Tiwari AK, Deshpande SN, Lerer B, Nimgaonkar VL. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: Role of oxidative stress pathway genes. Schizophr Res 2007;92(1-3):278-279.

(122) Morar B, Schwab SG, Albus M, Maier W, Lerer B, Wildenauer DB. Evaluation of association of SNPs in the TNF alpha gene region with schizophrenia. Am J Med Genet Part B Neuropsychiatr Genet 2007;144(3):318-324.

(123) Yakir A, Rigbi A, Kanyas K, Pollak Y, Kahana G, Karni O, et al. Why do young women smoke? III. Attention and impulsivity as neurocognitive predisposing factors. Eur Neuropsychopharmacol 2007;17(5):339-351.

(124) Amann-Zalcenstein D, Avidan N, Kanyas K, Ebstein RP, Kohn Y, Hamdan A, et al. Erratum: AHI1, a pivotal neurodevelopment gene, and C6orf217 are associated with susceptibility to schizophrenia (European Journal of Human Genetics (2006) vol. 14 (1111-1119) 10.1038/sj.ejhg.5201675). Eur J Hum Genet 2007;15(3):387.

(125) Lerer B. IJNP Editorial Board: Meeting new challenges. Int J Neuropsychopharmacol 2007;10(1):1-2.

(126) Krausz Y, Freedman N, Lester H, Barkai G, Levin T, Bocher M, et al. Brain SPECT study of common ground between hypothyroidism and depression. Int J Neuropsychopharmacol 2007;10(1):99-106.

(127) Schwab SG, Knapp M, Sklar P, Eckstein GN, Sewekow C, Borrmann-Hassenbach M, et al. Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIα gene (PIP5K2A) with schizophrenia. Mol Psychiatry 2006;11(9):837-846.

(128) Lerer E, Kanyas K, Karni O, Ebstein RP, Lerer B. Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes. Mol Psychiatry 2006;11(8):771-781.

(129) Eitan R, Lerer B. Nonpharmacological, somatic treatments of depression: Electroconvulsive therapy and novel brain stimulation modalities. Dialogues Clin Neurosci 2006;8(2):241-258.

(130) Lerer B, Segman RH. Pharmacogenetics of antipsychotic therapy: Pivotal research issues and the prospects for clinical implementation. Dialogues Clin Neurosci 2006;8(1):85-94.

(131) Greenbaum L, Kanyas K, Karni O, Merbl Y, Olender T, Horowitz A, et al. Localization of SNPs in the CHRNB2 gene. Mol Psychiatry 2006;11(3):223.

(132) Cheng R, Juo SH, Loth JE, Nee J, Iossifov I, Blumenthal R, et al. Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol Psychiatry 2006;11(3):252-260.

(133) Greenbaum L, Kanyas K, Karni O, Merbl Y, Olender T, Horowitz A, et al. Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Mol Psychiatry 2006;11(3):312-322.

(134) Lerer B. Recent strategies for potentiation and facilitation of antidepressant treatment: Introduction. Curr Drug Targets 2006;7(2):137.

(135) Lifschytz T, Segman R, Shalom G, Lerer B, Gur E, Golzer T, et al. Basic mechanisms of augmentation of antidepressant effects with thyroid hormone. Curr Drug Targets 2006;7(2):203-210.

(136) Amann D, Avidan N, Kanyas K, Kohn Y, Hamdan A, Ben-Asher E, et al. The trace amine receptor 4 gene is not associated with schizophrenia in a sample linked to chromosome 6q23 [3]. Mol Psychiatry 2006;11(2):119-121.

(137) Lifschytz T, Shalom G, Lerer B, Newman ME. Sex-dependent effects of fluoxetine and triiodothyronine in the forced swim test in rats. Eur Neuropsychopharmacol 2006;16(2):115-121.

(138) Amann-Zalcenstein D, Avidan N, Kanyas K, Ebstein RP, Kohn Y, Hamdan A, et al. AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia. Eur J Hum Genet 2006;14(10):1111-1119.

(139) Srivastava V, Varma PG, Prasad S, Semwal P, Nimgaonkar VL, Lerer B, et al. Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms. Pharmacogenet Genomics 2006;16(2):111-117.

(140) Kohn Y, Lerer B. Excitement and confusion on chromosome 6q: The challenges of neuropsychiatric genetics in microcosm. Mol Psychiatry 2005;10(12):1062-1073.

(141) Schwab SG, Hoefgen B, Hanses C, Hassenbach MB, Albus M, Lerer B, et al. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of european sib-pair families. Biol Psychiatry 2005;58(6):446-450.

(142) Deshpande SN, Varma PG, Semwal P, Rao AR, Bhatia T, Nimgaonkar VL, et al. II. Serotonin receptor gene polymorphisms and their association with tardive dyskinesia among schizophrenia patients from North India. Psychiatr Genet 2005;15(3):157-158.

(143) Lerer B, Segman RH, Tan E-, Basile VS, Cavallaro R, Aschauer HN, et al. Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype. Int J Neuropsychopharmacol 2005;8(3):411-425.

(144) Levi A, Kohn Y, Kanyas K, Amann D, Pae C-, Hamdan A, et al. Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: Increased evidence for linkage and reduced linkage interval. Eur J Hum Genet 2005;13(6):763-771.

(145) Tiwari AK, Deshpande SN, Rao AR, Bhatia T, Lerer B, Nimgaonkar VL, et al. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphisms. Schizophr Res 2005;75(1):21-26.

(146) Tiwari AK, Deshpande SN, Rao AR, Bhatia T, Mukit SR, Shriharsh V, et al. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism. Pharmacogenomics J 2005;5(1):60-69.

(147) Lifschytz T, Gur E, Lerer B, Newman ME. Erratum: Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: Regional differences (Journal of Neuroscience Methods (2004) 140 (133-139) PII: S0165-0270(04)00290-0 and DOI: 10.1016/j.jneumeth.2004.03.028). J Neurosci Methods 2005;141(2):335.

(148) Ozdemir V, Lerer B. Pharmacogenomics and the promise of personalized medicine. Pharmacogenomics, Second Edition; 2005. p. 13-50.

(149) McQueen MB, Devlin B, Faraone SV, Nimgaonkar VL, Sklar P, Smoller JW, et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. Am J Hum Genet 2005;77(4):582-595.

(150) Weiser M, Kanyas K, Malaspina D, Harvey PD, Glick I, Goetz D, et al. Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. Compr Psychiatry 2005;46(1):38-42.

(151) Lifschytz T, Gur E, Lerer B, Newman ME. Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: Regional differences. J Neurosci Methods 2004;140(1-2 SPEC. ISS.):133-139.

(152) Park N, Juo SH, Cheng R, Liu J, Loth JE, Lilliston B, et al. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schipzoprenia. Mol Psychiatry 2004;9(12):1091-1099.

(153) Gur E, Lifschytz T, Van De Kar LD, Lerer B, Newman ME. Effects of triiodothyronine on 5-HT1A and 5-HT1B autoreceptor activity, and postsynaptic 5-HT1A receptor activity, in rat hypothalamus: Lack of interaction with imipramine. Psychoneuroendocrinology 2004;29(9):1172-1183.

(154) Gur E, Lerer B, Van De Kar LD, Newman ME. Chronic rTMS induces subsensitivity of post-synaptic 5-HT1A receptors in rat hypothalamus. Int J Neuropsychopharmacol 2004;7(3):335-340.

(155) Bah J, Quach H, Ebstein RP, Segman RH, Melke J, Jamain S, et al. Maternal transmission disequilibrium of the glutamate receptor GRIK2 in schizophrenia. Neuroreport 2004;15(12):1987-1991.

(156) Kohn Y, Danilovich E, Filon D, Oppenheim A, Karni O, Kanyas K, et al. Linkage disequlibrium in the DTNBP1 (dysbindin) gene region and on chromosome 1p36 among psychotic patients from a genetic isolate in Israel: Findings from identity by descent haplotype sharing analysis. Am J Med Genet Neuropsychiatr Genet 2004;128 B(1):65-70.

(157) Mendlewicz J, Massat I, Souery D, Del-Favero J, Oruč L, Nöthen MM, et al. Serotonin transporter 5HTTLPR polymorphism and affective disorders: No evidence of association in a large European multicentre study. Eur J Hum Genet 2004;12(5):377-382.

(158) Blairy S, Linotte S, Souery D, Papadimitriou GN, Dikeos D, Lerer B, et al. Social adjustment and self-esteem of bipolar patients: A multicentric study. J Affective Disord 2004;79(1-3):97-103.

(159) Siegfried Z, Kanyas K, Latzer Y, Karni O, Bloch M, Lerer B, et al. Association Study of Cannabinoid Receptor Gene (CNR1) Alleles and Anorexia Nervosa: Differences between Restricting and Bingeing/Purging Subtypes. Am J Med Genet Neuropsychiatr Genet 2004;125 B(1):126-130.

(160) Kanyas K, Karni O, Hamdan A, Turetsky N, Kaadan M, Lerer B. Illness Recognition and Disruptiveness in Psychotic Illness. Compr Psychiatry 2004;45(2):109-113.

(161) Schwab SG, Mondabon S, Knapp M, Albus M, Hallmayer J, Borrmann-Hassenbach M, et al. Association of tumor necrosis factor alpha gene -G308A polymorphism with schizophrenia. Schizophr Res 2003;65(1):19-25.

(162) Bonne O, Gilboa A, Louzoun Y, Kempf-Sherf O, Katz M, Fishman Y, et al. Cerebral blood flow in chronic symptomatic mild traumatic brain injury. Psychiatry Res Neuroimaging 2003;124(3):141-152.

(163) Segman RH, Goltser T, Heresco-Levy U, Finkel B, Shalem R, Schlafman M, et al. Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia. Pharmacogenomics J 2003;3(5):277-283.

(164) Lerer B. Evidence-based psychopharmacology series. Int J Neuropsychopharmacol 2003;6(3):301.

(165) Lerer B, Segman RH, Hamdan A, Kanyas K, Karni O, Kohn Y, et al. Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Mol Psychiatry 2003;8(5):488-498.

(166) Liu J, Juo SH, Dewan A, Grunn A, Tong X, Brito M, et al. Evidence for a putative bipolar disorder locus on 2p13-16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21-24, 13q32, 14q21 and 17q11-12. Mol Psychiatry 2003;8(3):333-342.

(167) Agid O, Lerer B. Algorithm-based treatment of major depression in an outpatient clinic: Clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation. Int J Neuropsychopharmacol 2003;6(1):41-49.

(168) Lichtigfeld FJ, Gillman MA, Lerer B, Macciardi F. Another marker for different types of depression [3] (multiple letters). Int J Neuropsychopharmacol 2003;6(1):91-93.

(169) Bonne O, Louzoun Y, Aharon I, Krausz Y, Karger H, Lerer B, et al. Cerebral blood flow in depressed patients: A methodological comparison of statistical parametric mapping and region of interest analyses. Psychiatry Res Neuroimaging 2003;122(1):49-57.

(170) Lerer B, Macciardi F. Reply to Lichtigfeld and Gillman. Int J Neuropsychopharmacol 2003;6(1):93.

(171) Kohn Y, Lerer B. Methodological Advances in Psychiatric Genetics. Handbook of Medical Psychiatry; 2003. p. 13-24.

(172) Rigbi A, Shalev-Mevorach L, Taller A, Taller Y, Lerer B. Relationship of clinical and demographic characteristics of schizophrenia patients to rehabilitation status. Isr J Psychiatry Relat Sci 2003;40(4):258-267.

(173) Agid R, Levin T, Gomori JM, Lerer B, Bonne O. T2-weighted image hyperintensities in major depression: Focus on the basal ganglia. Int J Neuropsychopharmacol 2003;6(3):215-224.

(174) Dremencov E, Gur E, Lerer B, Newman ME. Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus. Prog Neuro-Psychopharmacol Biol Psychiatry 2003;27(5):729-739.

(175) Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003;72(1):185-190.

(176) Gur E, Lifschytz T, Lerer B, Newman ME. Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT1 autoreceptor activity in rat cortex. Eur J Pharmacol 2002;457(1):37-43.

(177) Gur E, Dremencov E, Garcia F, Van de Kar LD, Lerer B, Newman ME. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT1A and 5-HT1B receptor activity in rat hippocampus and hypothalamus. Brain Res 2002;952(1):52-60.

(178) Dremencov E, Gur E, Lerer B, Newman ME. Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hypothalamus. Prog Neuro-Psychopharmacol Biol Psychiatry 2002;26(6):1029-1034.

(179) Lerer B, Macciardi F. Pharmacogenetics of antidepressant and mood-stabilizing drugs: A review of candidate-gene studies and future research directions. Int J Neuropsychopharmacol 2002;5(3):255-275.

(180) Cichon S, Schumacher J, Müller DJ, Hürter M, Windemuth C, Strauch K, et al. Erratum: A genome screen for genes predisposing to bipolar affecting disorder detects a new susceptibility locus on 8q (Human Molecular Genetics (2001) vol. 10 (2933-2944)). Hum Mol Genet 2002;11(14):1685.

(181) Lerer B, Segman RH, Fangerau H, Daly AK, Basile VS, Cavallaro R, et al. Pharmacogenetics of tardive dyskinesia: Combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology 2002;27(1):105-119.

(182) Levinson DF, Holmans PA, Laurent C, Riley B, Pulver AE, Gejman PV, et al. No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science 2002;296(5568):739-741.

(183) Segman RH, Shapira Y, Modai I, Hamdan A, Zislin J, Heresco-Levy U, et al. Angiotensin converting enzyme gene insertion/deletion polymorphism: Case-control association studies in schizophrenia, major affective disorder, and tardive dyskinesia and a family-based association study in schizophrenia. Am J Med Genet Neuropsychiatr Genet 2002;114(3):310-314.

(184) Schwab SG, Hallmayer J, Freimann J, Lerer B, Albus M, Borrmann-Hassenbach M, et al. Investigation of linkage and association/linkage disequilibrium of HLA A-, DQA1-, DQB 1-, AND DRB1-alleles in 69 sib-pair- and 89 trio-families with schizophrenia. Am J Med Genet Neuropsychiatr Genet 2002;114(3):315-320.

(185) Massat I, Souery D, Del-Favero J, Van Gestel S, Serretti A, Macciardi F, et al. Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association study of affective disorders. Am J Med Genet Neuropsychiatr Genet 2002;114(2):177-185.

(186) Segman RH, Heresco-Levy U, Yakir A, Goltser T, Strous R, Greenberg DA, et al. Interactive effect of cytochrome P450 17α-hydroxylase and dopamine D3 receptor gene polymorphisms on abnormal involuntary movements in chronic schizophrenia. Biol Psychiatry 2002;51(3):261-263.

(187) Gur E, Dremencov E, Van De Kar LD, Lerer B, Newman ME. Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus. Eur J Pharmacol 2002;436(1-2):57-65.

(188) Kohn Y, Lerer B. Genetics of Schizophrenia: A review of linkage findings. Isr J Psychiatry Relat Sci 2002;39(4):240-251.

(189) Segman RH, Lerer B. Age and the relationship of dopamine D3, serotonin 2C and serotonin 2A receptor genes to abnormal involuntary movements in chronic schizophrenia [2]. Mol Psychiatry 2002;7(2):137-139.

(190) Cichon S, Schumacher J, Müller DJ, Hürter M, Windemuth C, Strauch K, et al. A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Hum Mol Genet 2001;10(25):2933-2944.

(191) Schumacher J, Cichon S, Richter C, Aboujamra R, Albus M, Borrmann-Hassenbach M, et al. Fine-mapping of chromosomal region 8q24 in bipolar affective disorder. Am J Med Genet Neuropsychiatr Genet 2001;105(7):610.

(192) Schwab SG, Sklar P, Hallmayer J, Albus M, Rietschel M, Lerer B, et al. Association of SNPs with schizophrenia on chromosome 10p, a region with previously detected linkage. Am J Med Genet Neuropsychiatr Genet 2001;105(7):562.

(193) Lerer B, Shapira B. Time-dependent sensitization and ECT [1]. Mol Psychiatry 2001;6(5):500.

(194) Lerer B, Macciardi F, Segman RH, Adolfsson R, Blackwood D, Blairy S, et al. Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Mol Psychiatry 2001;6(5):579-585.

(195) Sklar P, Schwab SG, Williams NM, Daly M, Schaffner S, Maier W, et al. Association analysis of NOTCH4 loci in schizophrenia using family and population-based controls. Nat Genet 2001;28(2):126-128.

(196) Cichon S, Schmidt-Wolf G, Schumacher J, Müller DJ, Hürter M, Schulze TG, et al. A possible susceptibility locus for bipolar affective disorder in chromosomal region 10q25-q26. Mol Psychiatry 2001;6(3):342-349.

(197) Segman RH, Heresco-Levy U, Finkel B, Goltser T, Shalem R, Schlafman M, et al. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Mol Psychiatry 2001;6(2):225-229.

(198) Liu J, Juo SH, Terwilliger JD, Grunn A, Tong X, Brito M, et al. A follow-up linkage study supports evidence for a bipolar affective disorder locus on chromosome 21q22. Am J Med Genet Neuropsychiatr Genet 2001;105(2):189-194.

(199) Nimgaonkar VL, Faraone SV, Lerer B, Mallet J, Sherrington R, Maier W. Impact of overlapping recruitment on psychiatric genetic studies. Am J Med Genet Neuropsychiatr Genet 2001;105(2):139-140.

(200) Souery D, Van Gestel S, Massat I, Blairy S, Adolfsson R, Blackwood D, et al. Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: A Multicenter Association Study. Biol Psychiatry 2001;49(5):405-409.

(201) Gur E, Dremencov E, Lerer B, Newman ME. Functional effects of corticosterone on 5-HT1A and 5-HT1B receptor activity in rat brain: In vivo microdialysis studies. Eur J Pharmacol 2001;411(1-2):115-122.

(202) Kohn Y, Zislin J, Agid O, Hanin B, Troudart T, Shapira B, et al. Increased prevalence of negative life events in subtypes of major depressive disorder. Compr Psychiatry 2001;42(1):57-63.

(203) Agid O, Shalev AY, Lerer B. Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorder. J Clin Psychiatry 2001;62(3):169-173.

(204) Parasol N, Cohen N, Zemishlany Z, Lerer B, Kosower NS. Duffy antigen/receptor for chemokines (DARC): Genotypes in Ashkenazi and non-Ashkenazi Jews in Israel. Hum Biol 2001;73(2):307-313.

(205) Newman ME, Gur E, Dremencov E, Garcia F, Lerer B, Van De Kar LD. Chronic clomipramine alters presynaptic 5-HT(1B) and postsynaptic 5-HT(1A) receptor sensitivity in rat hypothalamus and hippocampus, respectively. Neuropharmacology 2000;39(12):2309-2317.

(206) Gur E, Lerer B, Dremencov E, Newman ME. Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain. Neuroreport 2000;11(13):2925-2929.

(207) Segman RH, Levy UH, Finkel B, Greenberg D, Yakir A, Shlaffman M, et al. 5-HT2A receptor polymorphism and susceptibility to tardive dyskinesia in patients with chronic schizophrenia. Am J Med Genet Neuropsychiatr Genet 2000;96(4):526.

(208) Segman RH, Levy U, Finkel B, Greenberg D, Lerner A, Yakir A, et al. Additive contribution of DRD3gly and HT2CRser alleles to susceptibility to tardive dyskinesia in patients with chronic schizophrenia. Am J Med Genet Neuropsychiatr Genet 2000;96(4):529-530.

(209) Cichon S, Schumacher J, Muller DJ, Hürter M, Albus M, Borrmann-Hassenbach M, et al. Systematic search for susceptibility genes in bipolar affective disorder. Am J Med Genet Neuropsychiatr Genet 2000;96(4):467-468.

(210) Eckstein GN, Schwab SG, Hallmayer J, Albus M, Lerer B, Maier W, et al. A genome-wide survey for transmission disequilibrium in schizophrenia. Am J Med Genet Neuropsychiatr Genet 2000;96(4):552-553.

(211) Liu J, Juo SH, Terwilliger JD, Grunn A, Tong X, Brito M, et al. Further analysis of chromosome 21q22 augments prior evidence for linkage to bipolar affective disorder. Am J Med Genet Neuropsychiatr Genet 2000;96(4):483.

(212) Schumacher J, Cichon S, Albus M, Borrmann-Hassenbach M, Franzek E, Fritze J, et al. No evidence for an X-chromosomal locus for bipolar affective disorder in 64 German and 4 Israeli families. Am J Med Genet Neuropsychiatr Genet 2000;96(4):548.

(213) Kanyas K, Segman RH, Agid O, Lerer B. The molecular genetics of cigarette smoking: Demographic and environmental complexities. Am J Med Genet Neuropsychiatr Genet 2000;96(4):505.

(214) Karni O, Yakir A, Kanyas K, Turetsky N, Lerer B. Age at onset in sibling pairs with schizophrenia and schizoaffective disorder. Am J Med Genet Neuropsychiatr Genet 2000;96(4):505.

(215) Lerer B, Mendlewicz J. Vaeiability of 5-HT2C receptor CYS23SER polymorphism in European populations and vulnerability to affective disorder. Am J Med Genet Neuropsychiatr Genet 2000;96(4):484.

(216) Schwab SG, Eckstein GN, Gabel S, Hallmayer J, Lerer B, Albus M, et al. Susceptibility locus for schizophrenia on 10p: Searching for a candidate. Am J Med Genet Neuropsychiatr Genet 2000;96(4):461.

(217) Shapira B, Newman ME, Gelfin Y, Lerer B. Blunted temperature and cortisol responses to ipsapirone in major depression: Lack of enhancement by electroconvulsive therapy. Psychoneuroendocrinology 2000;25(5):421-438.

(218) Newman ME, Agid O, Gur E, Lerer B. Pharmacological mechanisms of T3 augmentation of antidepressant action. Int J Neuropsychopharmacol 2000;3(2):187-191.

(219) Shapira B, Tubi N, Lerer B. Balancing speed of response to ECT in major depression and adverse cognitive effects: Role of treatment schedule. J ECT 2000;16(2):97-109.

(220) Agid O, Kohn Y, Lerer B. Environmental stress and psychiatric illness. Biomed Pharmacother 2000;54(3):135-141.

(221) Dremencov E, Gur E, Lerer B, Newman ME. Subchronic fluoxetine administration to rats: Effects on 5-HT autoreceptor activity as measured by in vivo microdialysis. Eur Neuropsychopharmacol 2000;10(4):229-236.

(222) Frisch A, Michaelovsky E, Rockah R, Amir I, Hermesh H, Laor N, et al. Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur Neuropsychopharmacol 2000;10(3):205-209.

(223) Hranilovic D, Schwab SG, Jernej B, Knapp M, Lerer B, Albus M, et al. Serotonin transporter gene and schizophrenia: Evidence for association/linkage disequilibrium in families with affected siblings. Mol Psychiatry 2000;5(1):91-95.

(224) Levinson DF, Holmans P, Straub RE, Owen MJ, Wildenauer DB, Gejman PV, et al. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: Schizophrenia linkage collaborative group III. Am J Hum Genet 2000;67(3):652-663.

(225) Canetti L, Bachar E, Bonne O, Agid O, Lerer B, De-Nour AK, et al. The impact of parental death versus separation from parents on the mental health of Israeli adolescents. Compr Psychiatry 2000;41(5):360-368.

(226) Segman RH, Heresco-Levy U, Finkel B, Inbar R, Neeman T, Schlafman M, et al. Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: Additive contribution of 5-HT2C(ser) and DRD3(gly) alleles to susceptibility. Psychopharmacology 2000;152(4):408-413.

(227) Schwab SG, Hallmayer J, Albus M, Lerer B, Eckstein GN, Borrmann M, et al. A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: Support for loci on chromosome 10p and 6. Mol Psychiatry 2000;5(6):638-649.

(228) Shapira B, Lerer B. Speed of response to bilateral ECT: An examination of possible predictors in two controlled trials. J ECT 1999;15(3):202-206.

(229) Souery D, Lipp O, Rivelli SK, Massat I, Serretti A, Cavallini C, et al. Tyrosine hydroxylase polymorphism and phenotypic heterogeneity in bipolar affective disorder: A multicenter association study. Am J Med Genet Neuropsychiatr Genet 1999;88(5):527-532.

(230) Newman ME, Li Q, Gelfin Y, Van de Kar LD, Lerer B. Low doses of ipsapirone increase growth hormone but not oxytocin secretion in normal male and female subjects. Psychopharmacology 1999;145(1):99-104.

1.

Singh S, Botvinnik A, Shahar O, Wolf G, Yakobi C, Saban M, et al. Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder. Translational Psychiatry [Internet]. 2023;13(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85158895976&doi=10.1038%252fs41398-023-02456-9&partnerID=40&md5=52ea2aaa9a1d5aafe210a16f18bd818f

2.

Moskovich D, Alfandari A, Finkelshtein Y, Weisz A, Katzav A, Kidron D, et al. Corrigendum to “DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer” [Canc. Lett. 501 224–233] (Cancer Letters (2021) 501 (224–233), (S0304383520306030), (10.1016/j.canlet.2020.11.011)). Cancer Letters [Internet]. 2023;563. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85153290915&doi=10.1016%252fj.canlet.2023.216196&partnerID=40&md5=afdc44c51c3f7f34d8d4124030761eb8

3.

Hsu YHH, Pintacuda G, Liu R, Nacu E, Kim A, Tsafou K, et al. Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophrenia. iScience [Internet]. 2023;26(5). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85158169608&doi=10.1016%252fj.isci.2023.106701&partnerID=40&md5=09c0b82b69727411548ca6cbaad2f885

4.

Moskovich D, Finkelshtein Y, Alfandari A, Rosemarin A, Lifschytz T, Weisz A, et al. Correction: Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment (Oncogene, (2021), 40, 44, (6248-6257), 10.1038/s41388-021-02020-z). Oncogene [Internet]. 2023;42(18):1508. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85149989994&doi=10.1038%252fs41388-023-02629-2&partnerID=40&md5=f8b2eafae2252d5f30d4a27f99413172

5.

Wolf G, Singh S, Blakolmer K, Lerer L, Lifschytz T, Heresco-Levy U, et al. Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation. Molecular Psychiatry [Internet]. 2023;28(1):44–58. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85140396359&doi=10.1038%252fs41380-022-01832-z&partnerID=40&md5=95ed2f3ad82530384e51763753243a11

6.

Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Lotan A, et al. Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications. International Journal of Molecular Sciences [Internet]. 2022;23(22). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85142631049&doi=10.3390%252fijms232214148&partnerID=40&md5=98e5b67b5fa11dbecd9a9dc984e3e4f1

7.

Donen A, Lifschytz T, Wolf G, Ben-Ari H, Lotan A, Lerer L, et al. Evaluation of the Therapeutic Potential of Oral Phycocyanin-Rich Spiruli-na Extracts in Neuropsychiatric Disorders. Natural Products Journal [Internet]. 2022;12(6):76–81. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134020567&doi=10.2174%252f2210315512666211224102922&partnerID=40&md5=5e4df1ab2d4f325cab348928bfd35ba8

8.

Similon MVM, Paasche C, Krol F, Lerer B, Goodwin GM, Berk M, et al. Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs. European Neuropsychopharmacology [Internet]. 2022;60:91–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85132424534&doi=10.1016%252fj.euroneuro.2022.05.002&partnerID=40&md5=1259064f492081b220e1da2306143410

9.

Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature [Internet]. 2022;604(7906):502–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85127650703&doi=10.1038%252fs41586-022-04434-5&partnerID=40&md5=52b472574a9e21941e58222b114186d4

10.

Alkelai A, Greenbaum L, Docherty AR, Shabalin AA, Povysil G, Malakar A, et al. The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders. Molecular Psychiatry [Internet]. 2022;27(3):1435–47. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119470435&doi=10.1038%252fs41380-021-01383-9&partnerID=40&md5=146a3d321df0861f98624559a9cc71c3

11.

Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L. Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes. Frontiers in Psychiatry [Internet]. 2022;12. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123303086&doi=10.3389%252ffpsyt.2021.780696&partnerID=40&md5=3cd253839977bd009fe13d3059de8b42

12.

Blokland GAM, Grove J, Chen CY, Cotsapas C, Tobet S, Handa R, et al. Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders. Biological Psychiatry [Internet]. 2022;91(1):102–17. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108284544&doi=10.1016%252fj.biopsych.2021.02.972&partnerID=40&md5=ce1d80b8c642baf31f8d1bfa5ee9f57e

13.

Moskovich D, Finkelshtein Y, Alfandari A, Rosemarin A, Lifschytz T, Weisz A, et al. Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatment. Oncogene [Internet]. 2021;40(44):6248–57. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85115395328&doi=10.1038%252fs41388-021-02020-z&partnerID=40&md5=242bb45432e9eb4580f7f28faf4787b4

14.

Ni G, Zeng J, Revez JA, Wang Y, Zheng Z, Ge T, et al. A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts. Biological Psychiatry [Internet]. 2021;90(9):611–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107783986&doi=10.1016%252fj.biopsych.2021.04.018&partnerID=40&md5=a55a5be04549c828fa305b6e3d8aa763

15.

Taliaz D, Spinrad A, Barzilay R, Barnett-Itzhaki Z, Averbuch D, Teltsh O, et al. Optimizing prediction of response to antidepressant medications using machine learning and integrated genetic, clinical, and demographic data. Translational Psychiatry [Internet]. 2021;11(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85109693820&doi=10.1038%252fs41398-021-01488-3&partnerID=40&md5=3955ebbb34bedf143fa23d7485d4cf03

16.

Moskovich D, Alfandari A, Finkelshtein Y, Weisz A, Katzav A, Kidron D, et al. DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer. Cancer Letters [Internet]. 2021;501:224–33. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097477246&doi=10.1016%252fj.canlet.2020.11.011&partnerID=40&md5=5d986fda23165e43b908d64001c8c441

17.

Hess JL, Tylee DS, Mattheisen M, Adolfsson R, Agartz I, Agerbo E, et al. A polygenic resilience score moderates the genetic risk for schizophrenia. Molecular Psychiatry [Internet]. 2021;26(3):800–15. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073941184&doi=10.1038%252fs41380-019-0463-8&partnerID=40&md5=3a6a18c3da6d89dddf0246ad937e2939

18.

Kamitaki N, Sekar A, Handsaker RE, de Rivera H, Tooley K, Morris DL, et al. Complement genes contribute sex-biased vulnerability in diverse disorders. Nature [Internet]. 2020;582(7813):577–81. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086580754&doi=10.1038%252fs41586-020-2277-x&partnerID=40&md5=ef6da8b6bd6699bc074141eb28559923

19.

Krol FJ, Hagin M, Vieta E, Harazi R, Lotan A, Strous RD, et al. Placebo—To be or not to be? Are there really alternatives to placebo-controlled trials? European Neuropsychopharmacology [Internet]. 2020;32:1–11. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078044448&doi=10.1016%252fj.euroneuro.2019.12.117&partnerID=40&md5=47d7fbe3a6bd09eace3ff96f2db6cc8b

20.

Lee PH, Anttila V, Won H, Feng YCA, Rosenthal J, Zhu Z, et al. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders. Cell [Internet]. 2019;179(7):1469-1482.e11. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076270049&doi=10.1016%252fj.cell.2019.11.020&partnerID=40&md5=4674d45977a665aca731460bf896ab7a

21.

Alkelai A, Greenbaum L, Heinzen EL, Baugh EH, Teitelbaum A, Zhu X, et al. New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approach. Progress in Neuro-Psychopharmacology and Biological Psychiatry [Internet]. 2019;94. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066476751&doi=10.1016%252fj.pnpbp.2019.109659&partnerID=40&md5=988f826379add66d82cfe78a239bb387

22.

Huckins LM, Dobbyn A, Ruderfer DM, Hoffman G, Wang W, Pardiñas AF, et al. Publisher Correction: Gene expression imputation across multiple brain regions provides insights into schizophrenia risk (Nature Genetics, (2019), 51, 4, (659-674), 10.1038/s41588-019-0364-4). Nature Genetics [Internet]. 2019;51(6):1068. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065757972&doi=10.1038%252fs41588-019-0435-6&partnerID=40&md5=d9d1a90c7c52e2bd06ed57a401cb02a6

23.

Ben-Ari H, Lifschytz T, Wolf G, Rigbi A, Blumenfeld-Katzir T, Merzel TK, et al. White matter lesions, cerebral inflammation and cognitive function in a mouse model of cerebral hypoperfusion. Brain Research [Internet]. 2019;1711:193–201. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060843770&doi=10.1016%252fj.brainres.2019.01.017&partnerID=40&md5=d13e320f2a29be6120e1bb8ec91d13a8

24.

Huckins LM, Dobbyn A, Ruderfer DM, Hoffman G, Wang W, Pardiñas AF, et al. Gene expression imputation across multiple brain regions provides insights into schizophrenia risk. Nature Genetics [Internet]. 2019;51(4):659–74. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063585118&doi=10.1038%252fs41588-019-0364-4&partnerID=40&md5=0a82e49a083e8a1ac1389abc4d08ae9f

25.

Harold D, Connolly S, Riley BP, Kendler KS, McCarthy SE, McCombie WR, et al. Population-based identity-by-descent mapping combined with exome sequencing to detect rare risk variants for schizophrenia. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics [Internet]. 2019;180(3):223–31. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061993948&doi=10.1002%252fajmg.b.32716&partnerID=40&md5=eafb8499df56a73594cd4873b3ca6fe7

26.

Ni G, Gratten J, Wray NR, Lee SH, Ripke S, Neale BM, et al. Age at first birth in women is genetically associated with increased risk of schizophrenia. Scientific Reports [Internet]. 2018;8(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049684948&doi=10.1038%252fs41598-018-28160-z&partnerID=40&md5=2b236b5f8e538ded9b9a161e84820780

27.

Wolf G, Lifschytz T, Ben-Ari H, Tatarskyy P, Merzel TK, Lotan A, et al. Effect of chronic unpredictable stress on mice with developmental under-expression of the Ahi1 gene: Behavioral manifestations and neurobiological correlates. Translational Psychiatry [Internet]. 2018;8(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049411017&doi=10.1038%252fs41398-018-0171-1&partnerID=40&md5=a8968571d5ce43b042894c74edf70269

28.

Zai CC, Lee FH, Tiwari AK, Lu JY, De Luca V, Maes MS, et al. Investigation of the HSPG2Gene in tardive dyskinesia-new data and meta-analysis. Frontiers in Pharmacology [Internet]. 2018;9(SEP). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055250183&doi=10.3389%252ffphar.2018.00974&partnerID=40&md5=057edae8fb5bf5a9b4984ea9ccd32ab7

29.

LeBlanc M, Zuber V, Thompson WK, Andreassen OA, Frigessi A, Andreassen BK, et al. A correction for sample overlap in genome-wide association studies in a polygenic pleiotropy-informed framework. BMC Genomics [Internet]. 2018;19(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049066693&doi=10.1186%252fs12864-018-4859-7&partnerID=40&md5=0d7415e4e0996ec784342f02980211e4

30.

Ruderfer DM, Ripke S, McQuillin A, Boocock J, Stahl EA, Pavlides JMW, et al. Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes. Cell [Internet]. 2018;173(7):1705-1715.e16. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048172948&doi=10.1016%252fj.cell.2018.05.046&partnerID=40&md5=9c2fe8c1da738c06e8221069cb1ce568

31.

Ni G, Moser G, Ripke S, Neale BM, Corvin A, Walters JTR, et al. Estimation of Genetic Correlation via Linkage Disequilibrium Score Regression and Genomic Restricted Maximum Likelihood. American Journal of Human Genetics [Internet]. 2018;102(6):1185–94. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046126170&doi=10.1016%252fj.ajhg.2018.03.021&partnerID=40&md5=dfe0d1fbe544d9b2ebbbf5ace50d447b

32.

Lotan A, Lifschytz T, Wolf G, Keller S, Ben-Ari H, Tatarsky P, et al. Differential effects of chronic stress in young-adult and old female mice: Cognitive-behavioral manifestations and neurobiological correlates. Molecular Psychiatry [Internet]. 2018;23(6):1432–45. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049393829&doi=10.1038%252fmp.2017.237&partnerID=40&md5=17f7f9b74d7ed1fbd4f1f30c38e35400

33.

Lerer B. From freud to biology, from genes to medicines: A 40 year perspective. Israel Journal of Psychiatry [Internet]. 2018;55(3):65–71. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063270040&partnerID=40&md5=28b27a6e5de7e523f196d63cb4d8ca67

34.

Sarner-Levin K, Canetti L, Latzer Y, Bonne O, Lerer B, Bachar E. Anorexia nervosa, selflessness, and gender-role identity: A study of daughters and parents. Israel Journal of Psychiatry [Internet]. 2018;55(1):25–34. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049208878&partnerID=40&md5=b55d9124b64b3a7d6f401e86a9c59c5b

35.

Eitan R, Fontaine D, Benoît M, Giordana C, Darmon N, Israel Z, et al. One year double blind study of high vs low frequency subcallosal cingulate stimulation for depression. Journal of Psychiatric Research [Internet]. 2018;96:124–34. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85031508908&doi=10.1016%252fj.jpsychires.2017.09.026&partnerID=40&md5=972c53d026b472fdb7d233167693951e

36.

Wolf G, Lotan A, Lifschytz T, Ben-Ari H, Merzel TK, Tatarskyy P, et al. Differentially severe cognitive effects of compromised cerebral blood flow in aged mice: Association with myelin degradation and microglia activation. Frontiers in Aging Neuroscience [Internet]. 2017;9(JUN). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020940481&doi=10.3389%252ffnagi.2017.00191&partnerID=40&md5=5f99615d0757fa49491a7501429d25ae

37.

Lotan A, Lifschytz T, Mernick B, Lory O, Levi E, Ben-Shimol E, et al. Alterations in the expression of a neurodevelopmental gene exert long-lasting effects on cognitive-emotional phenotypes and functional brain networks: Translational evidence from the stress-resilient Ahi1 knockout mouse. Molecular Psychiatry [Internet]. 2017;22(6):884–99. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84961684947&doi=10.1038%252fmp.2016.29&partnerID=40&md5=81b1e4596d5e156fb0d7195e28ea03e9

38.

McLaughlin RL, Schijven D, Van Rheenen W, Van Eijk KR, O’Brien M, Kahn RS, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nature Communications [Internet]. 2017;8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85016060348&doi=10.1038%252fncomms14774&partnerID=40&md5=4af5b67e7eb3a7e59e9bb84cc99468b2

39.

Marshall CR, Howrigan DP, Merico D, Thiruvahindrapuram B, Wu W, Greer DS, et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nature Genetics [Internet]. 2017;49(1):27–35. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84997770295&doi=10.1038%252fng.3725&partnerID=40&md5=d655bef81f76387e7966caede994bd70

40.

Li M, Huang L, Grigoroiu-Serbanescu M, Bergen SE, Landén M, Hultman CM, et al. Convergent Lines of Evidence Support LRP8 as a Susceptibility Gene for Psychosis. Molecular Neurobiology [Internet]. 2016;53(10):6608–19. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84949490917&doi=10.1007%252fs12035-015-9559-6&partnerID=40&md5=3b5b87a83363c6f4e3db39958cb5af5b

41.

Johnson EC, Bjelland DW, Howrigan DP, Abdellaoui A, Breen G, Borglum A, et al. No Reliable Association between Runs of Homozygosity and Schizophrenia in a Well-Powered Replication Study. PLoS Genetics [Internet]. 2016;12(10). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994314495&doi=10.1371%252fjournal.pgen.1006343&partnerID=40&md5=c586411f40c56d8fe1f80b8bff63bf72

42.

Hagelkruys D, Böhm C, Motschnig R, Kertzman S, Sirota A, Lerer B, et al. Adapting a stand-alone computerized cognitive test battery for online use - A case-study in the context of users with special needs. Computers in Human Behavior [Internet]. 2016;63:757–68. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84975060910&doi=10.1016%252fj.chb.2016.05.069&partnerID=40&md5=80a0505f0ee8cefbcfdc9338c69fdd23

43.

Franke B, van Hulzen KJE, Arias-Vasquez A, Bralten J, Hoogman M, Klein M, et al. Genetic influences on schizophrenia and subcortical brain volumes: Large-scale proof of concept. Nature Neuroscience [Internet]. 2016;19(3):420–31. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84959158225&doi=10.1038%252fnn.4228&partnerID=40&md5=e4af587b3447d3c4dbbc1f9ec28c00ef

44.

Li X, Zhang W, Lencz T, Darvasi A, Alkelai A, Lerer B, et al. Common variants of IRF3 conferring risk of schizophrenia. Journal of Psychiatric Research [Internet]. 2015;64:67–73. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928209814&doi=10.1016%252fj.jpsychires.2015.03.008&partnerID=40&md5=a14c3adb4fcaae7d47509c2b24eefc4d

45.

Bulik-Sullivan B, Loh PR, Finucane HK, Ripke S, Yang J, Patterson N, et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nature Genetics [Internet]. 2015;47(3):291–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923946495&doi=10.1038%252fng.3211&partnerID=40&md5=64424cd59ea24519a34575a969d724ac

46.

Vilhjálmsson BJ, Yang J, Finucane HK, Gusev A, Lindström S, Ripke S, et al. Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores. American Journal of Human Genetics [Internet]. 2015;97(4):576–92. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84952665106&doi=10.1016%252fj.ajhg.2015.09.001&partnerID=40&md5=3ede1b9d7ae56c8a9dd1eea342e45bab

47.

Greenbaum L, Lerer B. Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson’s disease modifier genes. Frontiers in Neurology [Internet]. 2015;6(FEB). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926510214&doi=10.3389%252ffneur.2015.00027&partnerID=40&md5=3112676aab848eb60371278d2bb7a1de

48.

Lotan A, Lifschytz T, Slonimsky A, Broner EC, Greenbaum L, Abedat S, et al. Neural mechanisms underlying stress resilience in Ahi1 knockout mice: Relevance to neuropsychiatric disorders. Molecular Psychiatry [Internet]. 2014;19(2):243–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893637150&doi=10.1038%252fmp.2013.123&partnerID=40&md5=2b5e80ae9ca834cd99c50d234b01dc76

49.

Lotan A, Lifschytz T, Lory O, Goelman G, Lerer B. Amygdalar disconnectivity could underlie stress resilience in the Ahi1 knockout mouse: Conclusions from a resting-state functional MRI study. Molecular Psychiatry [Internet]. 2014;19(2):144. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84893067453&doi=10.1038%252fmp.2013.191&partnerID=40&md5=c6c0cb2a13e7f41b46c84c12db314bd8

50.

Gusev A, Lee SH, Trynka G, Finucane H, Vilhjálmsson BJ, Xu H, et al. Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. American Journal of Human Genetics [Internet]. 2014;95(5):535–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922273141&doi=10.1016%252fj.ajhg.2014.10.004&partnerID=40&md5=5ccf50ebbe5c486ad437513730bde4c9

51.

Luo XJ, Li M, Huang L, Steinberg S, Mattheisen M, Liang G, et al. Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene. Molecular Psychiatry [Internet]. 2014;19(7):774–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84908650212&doi=10.1038%252fmp.2013.103&partnerID=40&md5=9ef92619b521136d8522eb95307c5ecb

52.

Ripke S, Neale BM, Corvin A, Walters JTR, Farh KH, Holmans PA, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature [Internet]. 2014;511(7510):421–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904804929&doi=10.1038%252fnature13595&partnerID=40&md5=0ab32a0e306c327836768099ffa3c3d1

53.

Baldinger P, Lotan A, Frey R, Kasper S, Lerer B, Lanzenberger R. Neurotransmitters and electroconvulsive therapy. Journal of ECT [Internet]. 2014;30(2):116–21. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84901592664&doi=10.1097%252fYCT.0000000000000138&partnerID=40&md5=a2cd876846059e4a3a7e9edbd7a22355

54.

Greenbaum L, Goldwurm S, Zozulinsky P, Lifschytz T, Cohen OS, Yahalom G, et al. Do tardive dyskinesia and l-dopa induced dyskinesia share common genetic risk factors? An exploratory study. Journal of Molecular Neuroscience [Internet]. 2013;51(2):380–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84885172117&doi=10.1007%252fs12031-013-0020-x&partnerID=40&md5=3577996fab4e12417ced281a8f5fd9dd

55.

Gesundheit B, Rosenzweig JP, Naor D, Lerer B, Zachor DA, Procházka V, et al. Immunological and autoimmune considerations of Autism Spectrum Disorders. Journal of Autoimmunity [Internet]. 2013;44:1–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84881375626&doi=10.1016%252fj.jaut.2013.05.005&partnerID=40&md5=0f3458f0443e56402ad05df8663f0512

56.

Greenbaum L, Lorberboym M, Melamed E, Rigbi A, Barhum Y, Kohn Y, et al. Perspective: Identification of genetic variants associated with dopaminergic compensatory mechanisms in early Parkinson’s disease. Frontiers in Neuroscience [Internet]. 2013;(7 APR). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878888568&doi=10.3389%252ffnins.2013.00052&partnerID=40&md5=0816167a5e1d66b7198ea37591531798

57.

Teltsh O, Kanyas-Sarner K, Rigbi A, Greenbaum L, Lerer B, Kohn Y. Erratum: Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree (International Journal of Neuropsychopharmacology (2011) DOI:10.1017/S1461145711001374). International Journal of Neuropsychopharmacology [Internet]. 2013;16(5):1183. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878016921&doi=10.1017%252fS1461145712001162&partnerID=40&md5=652d5111855bc9b04a220c2028f9cb0c

58.

Greenbaum L, Rigbi A, Lipshtat N, Cilia R, Tesei S, Asselta R, et al. Association of nicotine dependence susceptibility gene, CHRNA5, with Parkinson’s disease age at onset: Gene and smoking status interaction. Parkinsonism and Related Disorders [Internet]. 2013;19(1):72–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871526790&doi=10.1016%252fj.parkreldis.2012.07.007&partnerID=40&md5=f1b8452c28666d6327aae895a1361b11

59.

Greenbaum L, Alkelai A, Zozulinsky P, Kohn Y, Lerer B. Support for association of HSPG2 with tardive dyskinesia in Caucasian populations. Pharmacogenomics Journal [Internet]. 2012;12(6):513–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84870056486&doi=10.1038%252ftpj.2011.32&partnerID=40&md5=58137c3e75b46023fd551d4c0052ebb6

60.

Lifschytz T, Broner EC, Zozulinsky P, Slonimsky A, Eitan R, Greenbaum L, et al. Relationship between Rgs2 gene expression level and anxiety and depression-like behaviour in a mutant mouse model: Serotonergic involvement. International Journal of Neuropsychopharmacology [Internet]. 2012;15(9):1307–18. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84871483557&doi=10.1017%252fS1461145711001453&partnerID=40&md5=f4bd5115e6143d063d85e7807adf5ed6

61.

Levinson DF, Shi J, Wang K, Oh S, Riley B, Pulver AE, et al. Genome-wide association study of multiplex schizophrenia pedigrees. American Journal of Psychiatry [Internet]. 2012;169(9):963–73. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865839935&doi=10.1176%252fappi.ajp.2012.11091423&partnerID=40&md5=624d712db47b7162f89c01b5bf652b29

62.

Pelov I, Teltsh O, Greenbaum L, Rigbi A, Kanyas-Sarner K, Lerer B, et al. Involvement of PTPN5, the gene encoding the striatal-enriched protein tyrosine phosphatase, in schizophrenia and cognition. Psychiatric Genetics [Internet]. 2012;22(4):168–76. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863456446&doi=10.1097%252fYPG.0b013e3283518586&partnerID=40&md5=937d905c13f0ae3090c59531a9635d10

63.

Alkelai A, Lupoli S, Greenbaum L, Kohn Y, Kanyas-Sarner K, Ben-Asher E, et al. Erratum: DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population (International Journal of Neuropsychopharmacology (2011) DOI: 10.1017/S1461145711000903). International Journal of Neuropsychopharmacology [Internet]. 2012;15(4):541. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862665357&doi=10.1017%252fS1461145711001519&partnerID=40&md5=d4818ed2997b38c05b7f52ff23c799a6

64.

Greenbaum L, Lifschytz T, Zozulinsky P, Broner EC, Slonimsky A, Kohn Y, et al. Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse model. European Neuropsychopharmacology [Internet]. 2012;22(5):379–86. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859213033&doi=10.1016%252fj.euroneuro.2011.09.006&partnerID=40&md5=15aeb47c258bfa1f9db0027a54ca8b6c

65.

Greenbaum L, Smith RC, Lorberboym M, Alkelai A, Zozulinsky P, Lifschytz T, et al. Erratum: Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients (Psychopharmacology DOI:10.1007/s00213- 011-2499-6). Psychopharmacology [Internet]. 2012;220(3):643. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84858451160&doi=10.1007%252fs00213-011-2547-2&partnerID=40&md5=c8151d3f7e38a102b1908a79bc8291e7

66.

Greenbaum L, Smith RC, Lorberboym M, Alkelai A, Zozulinsky P, Lifshytz T, et al. Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients. Psychopharmacology [Internet]. 2012;220(3):519–28. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84858441557&doi=10.1007%252fs00213-011-2499-6&partnerID=40&md5=5accd1976c686850d93be8d7242d004b

67.

Alkelai A, Greenbaum L, Lupoli S, Kohn Y, Sarner-Kanyas K, Ben-Asher E, et al. Association of the type 2 diabetes mellitus susceptibility gene, TCF7L2, with schizophrenia in an Arab-Israeli family sample. PLoS ONE [Internet]. 2012;7(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84855715016&doi=10.1371%252fjournal.pone.0029228&partnerID=40&md5=d0b7aa0958bfef42f0d059f58e145c89

68.

Stein DJ, Lerer B, Stahl S. Preface [Internet]. Essential Evidence-Based Psychopharmacology, Second Edition. 2012. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928422571&doi=10.1017%252fCBO9780511910395.001&partnerID=40&md5=ad88bc3d58b3414c6f4a7df734d1efc2

69.

Stein DJ, Lerer B, Stahl S. Essential evidence-based psychopharmacology, second edition [Internet]. Essential Evidence-Based Psychopharmacology, Second Edition. 2012. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928421941&doi=10.1017%252fCBO9780511910395&partnerID=40&md5=8aca1abe9f2c40c878067a12a6c80afa

70.

Lerer B, Belmaker RH. Conference scene in global personalized medicine: CINP Thematic Meeting on Pharmacogenomics and Personalised Medicine in Psychiatry, Jerusalem, Israel (April 21-23, 2013). Current Pharmacogenomics and Personalized Medicine [Internet]. 2012;10(4):264. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874907645&doi=10.2174%252f187569212803901738&partnerID=40&md5=37b03107989b1a084375c89138a8e0d6

71.

Alkelai A, Lupoli S, Greenbaum L, Kohn Y, Kanyas-Sarner K, Ben-Asher E, et al. DOCK4 and CEACAM21 as novel schizophrenia candidate genes in the Jewish population. International Journal of Neuropsychopharmacology [Internet]. 2012;15(4):459–69. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862648283&doi=10.1017%252fS1461145711000903&partnerID=40&md5=a2563b77a2f938b794789007e008f579

72.

Teltsh O, Kanyas-Sarner K, Rigbi A, Greenbaum L, Lerer B, Kohn Y. Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree. International Journal of Neuropsychopharmacology [Internet]. 2012;15(3):309–19. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84858794365&doi=10.1017%252fS1461145711001374&partnerID=40&md5=1bff9cd9ffebe5c3f67290371293ecfb

73.

Alkelai A, Lupoli S, Greenbaum L, Giegling I, Kohn Y, Sarner-Kanyas K, et al. Identification of new schizophrenia susceptibility loci in an ethnically homogeneous, family-based, Arab-Israeli sample. FASEB Journal [Internet]. 2011;25(11):4011–23. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-80355135154&doi=10.1096%252ffj.11-184937&partnerID=40&md5=b79bf109713c32df48095699b5fdd007

74.

Vardi N, Freedman N, Lester H, Gomori JM, Chisin R, Lerer B, et al. Hyperintensities on T2-weighted images in the basal ganglia of patients with major depression: Cerebral perfusion and clinical implications. Psychiatry Research - Neuroimaging [Internet]. 2011;192(2):125–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955473824&doi=10.1016%252fj.pscychresns.2010.11.010&partnerID=40&md5=6f4f3f8c457515abaa93941cda40c9a5

75.

Lifschytz T, Zozulinsky P, Eitan R, Landshut G, Ohayon S, Lerer B. Effect of triiodothyronine on antidepressant screening tests in mice and on presynaptic 5-HT 1A receptors: Mediation by thyroid hormone α receptors. Journal of Pharmacology and Experimental Therapeutics [Internet]. 2011;337(2):494–502. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79955015318&doi=10.1124%252fjpet.111.179564&partnerID=40&md5=9d6772950bbdb3e9dbd30ea3fed0efdf

76.

Greenbaum L, Levin R, Lerer E, Alkelai A, Kohn Y, Heresco-Levy U, et al. Association of Reelin (RELN) single nucleotide polymorphism rs7341475 with prepulse inhibition in the Jewish Israeli population. Biological Psychiatry [Internet]. 2011;69(5):e17–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79951674035&doi=10.1016%252fj.biopsych.2010.09.059&partnerID=40&md5=0b0f5024447b6f21e3ae56f9c9f5dd0f

77.

Rigbi A, Yakir A, Sarner-Kanyas K, Pollak Y, Lerer B. Why do young women smoke VI. A controlled study of nicotine effects on attention: Pharmacogenetic interactions. Pharmacogenomics Journal [Internet]. 2011;11(1):45–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79151477536&doi=10.1038%252ftpj.2010.15&partnerID=40&md5=8ea46f0800dc36ca67a3bf647056094e

78.

Isserles M, Rosenberg O, Dannon P, Levkovitz Y, Kotler M, Deutsch F, et al. Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome. Journal of Affective Disorders [Internet]. 2011;128(3):235–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-78751640778&doi=10.1016%252fj.jad.2010.06.038&partnerID=40&md5=afb27db625ff5648d9b63c1aabd74e1e

79.

Cooper-Kazaz R, Rigbi A, Lerer B. Targeting remission by 8 weeks: When should supplementation be considered in patients with major depression treated with a specific serotonin reuptake inhibitor? Comprehensive Psychiatry [Internet]. 2011;52(1):9–16. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-78651292672&doi=10.1016%252fj.comppsych.2010.04.007&partnerID=40&md5=c2d7b10afb58261d18c246957d964ff2

80.

Greenbaum L, Alkelai A, Rigbi A, Kohn Y, Lerer B. Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia. Movement Disorders [Internet]. 2010;25(16):2809–17. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650217739&doi=10.1002%252fmds.23377&partnerID=40&md5=6b93c74899dbc5f2c8320799395426f4

81.

Greenbaum L, Kanyas KS, Rigbi A, Alkelai A, Kohn Y, Lerer B. Why do young women smoke? VII COMT as a risk modifying gene for Nicotine dependence - Role of gene-gene interaction, personality, and environmental factors. Human Psychopharmacology [Internet]. 2010;25(7–8):536–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79951733308&doi=10.1002%252fhup.1149&partnerID=40&md5=c26b6c98128dc79bc9d2476f00761168

82.

Cooper R, Lerer B. [The use of thyroid hormones in the treatment of depression]. Harefuah [Internet]. 2010;149(8):529–34, 550, 549. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79953272016&partnerID=40&md5=f3072809030f267bbe987d4fc3ab0c33

83.

Torri F, Akelai A, Lupoli S, Sironi M, Amann-Zalcenstein D, Fumagalli M, et al. Fine mapping of AHI1 as a schizophrenia susceptibility gene: From association to evolutionary evidence. FASEB Journal [Internet]. 2010;24(8):3066–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77955822772&doi=10.1096%252ffj.09-152611&partnerID=40&md5=00cf6f710220c4045d9ec14d8831a18a

84.

Slonimsky A, Levy I, Kohn Y, Rigbi A, Ben-Asher E, Lancet D, et al. Lymphoblast and brain expression of AHI1 and the novel primate-specific gene, C6orf217, in schizophrenia and bipolar disorder. Schizophrenia Research [Internet]. 2010;120(1–3):159–66. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77954213029&doi=10.1016%252fj.schres.2010.03.041&partnerID=40&md5=8b4cb858f26e7acee0a5e25eccd8e158

85.

Eitan R, Landshut G, Lifschytz T, Einstein O, Ben-Hur T, Lerer B. The thyroid hormone, triiodothyronine, enhances fluoxetine-induced neurogenesis in rats: Possible role in antidepressant-augmenting properties. International Journal of Neuropsychopharmacology [Internet]. 2010;13(5):553–61. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953543845&doi=10.1017%252fS1461145709990769&partnerID=40&md5=da00844737ad93eae2849a75e92d0786

86.

Lifschytz T, Goltser-Dubner T, Landshut G, Lerer B. Effect of triiodothyronine on 5-HT1A and 5-HT1B receptor expression in rat forebrain and on latency to feed in the novelty suppressed feeding test. Progress in Neuro-Psychopharmacology and Biological Psychiatry [Internet]. 2010;34(4):632–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952674798&doi=10.1016%252fj.pnpbp.2010.02.029&partnerID=40&md5=fcad04900bd07e6eab7b4a1ae381f547

87.

Cooper-Kazaz R, Cohen A, Lerer B. Noradrenergic adverse effects due to combined treatment with reboxetine and triiodothyronine. Journal of Clinical Psychopharmacology [Internet]. 2010;30(2):211–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952222919&doi=10.1097%252fJCP.0b013e3181d273b3&partnerID=40&md5=6c50a444d37cb3847f8cdb42f4ead5d4

88.

Greenbaum L, Pelov I, Teltsh O, Lerer B, Kohn Y. No association between regulator of G-protein signaling 9 (RGS9) and schizophrenia in a Jewish population. Psychiatric Genetics [Internet]. 2010;20(1):47–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-75149126106&doi=10.1097%252fYPG.0b013e3283351234&partnerID=40&md5=97cac1493f2c37f7fa9e792d5a01d8da

89.

Ingason A, Giegling I, Cichon S, Hansen T, Rasmussen HB, Nielsen J, et al. A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with schizophrenia. Human Molecular Genetics [Internet]. 2010;19(7):1379–86. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952519163&doi=10.1093%252fhmg%252fddq009&partnerID=40&md5=164f88960d3c386608ae53f989bac736

90.

Alkelai A, Kohn Y, Olender T, Sarner-Kanyas K, Rigbi A, Hamdan A, et al. Evidence for an interaction of schizophrenia susceptibility loci on chromosome 6q23.3 and 10q24.33-q26.13 in Arab Israeli families. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics [Internet]. 2009;150(7):914–25. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349335972&doi=10.1002%252fajmg.b.30918&partnerID=40&md5=85bf996fd183c7302f853e84fd974a8e

91.

Greenbaum L, Rigbi A, Teltsh O, Lerer B. Role of genetic variants in the CHRNA5-CHRNA3-CHRNB4 cluster in nicotine dependence risk: Importance of gene-environment interplay. Molecular Psychiatry [Internet]. 2009;14(9):828–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-69249129065&doi=10.1038%252fmp.2009.25&partnerID=40&md5=110e443d0fe380e7521f2308c8e3df0a

92.

Alkelai A, Greenbaum L, Rigbi A, Kanyas K, Lerer B. Genome-wide association study of antipsychotic-induced parkinsonism severity among schizophrenia patients. Psychopharmacology [Internet]. 2009;206(3):491–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349574008&doi=10.1007%252fs00213-009-1627-z&partnerID=40&md5=2b43ee9f1719ba3cf60c8e7ad530298f

93.

Ng MYM, Levinson DF, Faraone SV, Suarez BK, Delisi LE, Arinami T, et al. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Molecular Psychiatry [Internet]. 2009;14(8):774–85. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-67651160485&doi=10.1038%252fmp.2008.135&partnerID=40&md5=c1c927f3010be70629371b11cb40473f

94.

Greenbaum L, Lerer B. Differential contribution of genetic variation in multiple brain nicotinic cholinergic receptors to nicotine dependence: Recent progress and emerging open questions. Molecular Psychiatry [Internet]. 2009;14(10):912–45. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-70349659834&doi=10.1038%252fmp.2009.59&partnerID=40&md5=2678c7350abbaa882b565c65cb1b0657

95.

Cooper-Kazaz R, van der Deure WM, Medici M, Visser TJ, Alkelai A, Glaser B, et al. Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronine. Journal of Affective Disorders [Internet]. 2009;116(1–2):113–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-67349143128&doi=10.1016%252fj.jad.2008.10.019&partnerID=40&md5=b58b19a567167d40b5c1824cfde7f162

96.

Rigbi A, Yakir A, Kanyas K, Pollak Y, Lerer B. Further support for a role of the His452Tyr variant in 5-HT2A receptor gene in memory functions in humans. International Journal of Neuropsychopharmacology [Internet]. 2009;12(5):723–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-69749089773&doi=10.1017%252fS1461145709000170&partnerID=40&md5=a0e03907ba07aec4b087d1f0b87852ad

97.

Greenbaum L, Smith RC, Rigbi A, Strous R, Teltsh O, Kanyas K, et al. Further evidence for association of the RGS2 gene with antipsychotic-induced parkinsonism: Protective role of a functional polymorphism in the 3′-untranslated region. Pharmacogenomics Journal [Internet]. 2009;9(2):103–10. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-63149084646&doi=10.1038%252ftpj.2008.6&partnerID=40&md5=7586303caa7e6af6a1cf3a2a7e07dc94

98.

Teltsh O, Kanyas K, Karni O, Levi A, Korner M, Hamdan A, et al. P.3.18 Mutation screening in a candidate region for schizophrenia on chromosome 20p13. European Neuropsychopharmacology [Internet]. 2009;19:S77. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85031279506&doi=10.1016%2fS0924-977X%2809%2970088-4&partnerID=40&md5=821df69fba906e97fcc0d073d5e24960

99.

Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: Leads for future research and new drug developments in depression. Metabolic Brain Disease [Internet]. 2009;24(1):27–53. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-57749179191&doi=10.1007%252fs11011-008-9118-1&partnerID=40&md5=d160da0afc449e35880148e50c784fb0

100.

Eitan R, Landshut G, Lerer B. Neurochemical effects of electrically induced seizures: Relevance to the antidepressant mechanism of electroconvulsive therapy [Internet]. Electroconvulsive and Neuromodulation Therapies. 2009. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84155176753&doi=10.1017%252fCBO9780511576393.004&partnerID=40&md5=7a7cbfad252ed39d95f1b447cba35dac

101.

Papakostas GI, Cooper-Kazaz R, Appelhof BC, Posternak MA, Johnson DP, Klibanski A, et al. Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: A quantitative synthesis of double-blind studies. International Clinical Psychopharmacology [Internet]. 2009;24(1):19–25. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-58349093751&doi=10.1097%252fYIC.0b013e328314dfaf&partnerID=40&md5=85de1d6779843a1ddae2835fae00a22a

102.

Thomas P, Srivastava V, Singh A, Mathur P, Nimgaonkar VL, Lerer B, et al. Correlates of response to Olanzapine in a North Indian Schizophrenia sample. Psychiatry Research [Internet]. 2008;161(3):275–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-56049094075&doi=10.1016%252fj.psychres.2007.09.010&partnerID=40&md5=0a18889e007b2c79f622cf06296971ea

103.

Lerer B. IJNP: A decade in perspective. International Journal of Neuropsychopharmacology [Internet]. 2008;11(8):1035–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-55549120255&doi=10.1017%252fS1461145708009632&partnerID=40&md5=8564d37459ae575c6dbded69695ff117

104.

Gesundheit B, Lerer B, Budowski E, Neuman T, Gomori JM, Or R. Sudden psychotic symptoms in a 28-year-old male with thymoma. Journal of Clinical Oncology [Internet]. 2008;26(26):4353–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-52049084352&doi=10.1200%252fJCO.2008.16.0879&partnerID=40&md5=dc23662c940f67f89efb3ff67d1e739d

105.

Kohn Y, Freedman N, Lester H, Krausz Y, Chisin R, Lerer B, et al. Cerebral perfusion after a 2-year remission in major depression. International Journal of Neuropsychopharmacology [Internet]. 2008;11(6):837–43. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-50849135599&doi=10.1017%252fS1461145708008936&partnerID=40&md5=6ada578b5eee9c65cf69a1975a569aa4

106.

Ludewick HP, Schwab SG, Albus M, Lerer B, Maier W, Trixler M, et al. No support for an association with TAAR6 and schizophrenia in a linked population of European ancestry. Psychiatric Genetics [Internet]. 2008;18(4):208–10. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-50349097153&doi=10.1097%252fYPG.0b013e3283050aba&partnerID=40&md5=75e1d3cc516f651cb0901a6f531b35c1

107.

Cooper-Kazaz R, Lerer B. Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors. International Journal of Neuropsychopharmacology [Internet]. 2008;11(5):685–99. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-46449102084&doi=10.1017%252fS1461145707008206&partnerID=40&md5=a61fe13f9a92180bf066f25b61a82032

108.

Canetti L, Kanyas K, Lerer B, Latzer Y, Bachar E. Anorexia nervosa and parental bonding: The contribution of parent-grandparent relationships to eating disorder psychopathology. Journal of Clinical Psychology [Internet]. 2008;64(6):703–16. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-46049100983&doi=10.1002%252fjclp.20482&partnerID=40&md5=be50fa14ec5f2582450f6e4ea5b26358

109.

Smith RC, Segman RH, Golcer-Dubner T, Pavlov V, Lerer B. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia. Pharmacogenomics Journal [Internet]. 2008;8(3):228–36. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-44049109281&doi=10.1038%252fsj.tpj.6500474&partnerID=40&md5=29577a11d80bcf31362d8d42d8aa95c4

110.

Bachar E, Kanyas K, Latzer Y, Canetti L, Bonne O, Lerer B. Depressive tendencies and lower levels of self-sacrifice in mothers, and selflessness in their anorexic daughters. European Eating Disorders Review [Internet]. 2008;16(3):184–90. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-44649146468&doi=10.1002%252ferv.840&partnerID=40&md5=51c55f212e98e0c97268c5e915ea8b40

111.

Teltsh O, Kanyas K, Karni O, Levi A, Korner M, Ben-Asher E, et al. Genome-wide linkage scan, fine mapping, and haplotype analysis in a large, inbred, arab israeli pedigree suggest a schizophrenia susceptibility locus on chromosome 20p13. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics [Internet]. 2008;147(2):209–15. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-40449142929&doi=10.1002%252fajmg.b.30591&partnerID=40&md5=85f5ab55072dd0e33f64c3dcf396f0d3

112.

Rigbi A, Kanyas K, Yakir A, Greenbaum L, Pollak Y, Ben-Asher E, et al. Why do young women smoke? V. Role of direct and interactive effects of nicotinic cholinergic receptor gene variation on neurocognitive function. Genes, Brain and Behavior [Internet]. 2008;7(2):164–72. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-40349116471&doi=10.1111%252fj.1601-183X.2007.00329.x&partnerID=40&md5=fc04502b274570f42a452bfd9eb5d5ec

113.

Schwab SG, Plummer C, Albus M, Borrmann-Hassenbach M, Lerer B, Trixler M, et al. DNA sequence variants in the metabotropic glutamate receptor 3 and risk to schizophrenia: An association study. Psychiatric Genetics [Internet]. 2008;18(1):25–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-38149035286&doi=10.1097%252fYPG.0b013e3282ef48d9&partnerID=40&md5=d199d51726d48b92a5850a68c5297152

114.

Srivastava V, Deshpande SN, Nimgaonkar VL, Lerer B, Thelma BK. Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: Role of metabolic pathway genes. Pharmacogenomics [Internet]. 2008;9(8):1055–68. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-50149118604&doi=10.2217%252f14622416.9.8.1055&partnerID=40&md5=9b8cbfb99029826347464355bc307e81

115.

Lerer B, Isserles M. From Meduna to ultrabrief: New directions for the oldest brain stimulation therapy. Brain Stimulation [Internet]. 2008;1(2):84–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-43749121448&doi=10.1016%252fj.brs.2008.03.005&partnerID=40&md5=5f593fe8d1038317518249f0e3329e04

116.

Pae CU, Yu HS, Amann D, Kim JJ, Lee CU, Lee SJ, et al. Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample. Journal of Psychiatric Research [Internet]. 2008;42(1):35–40. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-35248822612&doi=10.1016%252fj.jpsychires.2006.09.011&partnerID=40&md5=82e5f7568a5624b48ff85d53bd603a16

117.

Tiwari AK, Deshpande SN, Lerer B, Nimgaonkar VL, Thelma BK. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C > T polymorphism. Pharmacogenomics Journal [Internet]. 2007;7(5):305–11. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34748868401&doi=10.1038%252fsj.tpj.6500415&partnerID=40&md5=51194059d1c9c0efb7444cb61b5329a0

118.

Massat I, Lerer B, Souery D, Blackwood D, Muir W, Kaneva R, et al. HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter association study [3]. Molecular Psychiatry [Internet]. 2007;12(9):797–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548329722&doi=10.1038%252fsj.mp.4002018&partnerID=40&md5=3cbcc28033787c0ee0e583c287c9f892

119.

Kohn Y, Freedman N, Lester H, Krausz Y, Chisin R, Lerer B, et al. 99mTc-HMPAO SPECT study of cerebral perfusion after treatment with medication and electroconvulsive therapy in major depression. Journal of Nuclear Medicine [Internet]. 2007;48(8):1273–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34547817087&doi=10.2967%252fjnumed.106.039354&partnerID=40&md5=c6fd66a86bf03fb04593384d2bd7d981

120.

Greenbaum L, Strous RD, Kanyas K, Merbl Y, Horowitz A, Karni O, et al. Association of the RGS2 gene with extrapyramidal symptoms induced by treatment with antipsychotic medication. Pharmacogenetics and Genomics [Internet]. 2007;17(7):519–28. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34250213254&doi=10.1097%252fFPC.0b013e32800ffbb4&partnerID=40&md5=d07c7ddb56c0fb7802dd28d0f05d179f

121.

Segman RH, Kanyas K, Karni O, Lerer E, Goltser-Dubner T, Pavlov V, et al. Why do young women smoke? IV. Role of genetic variation in the dopamine transporter and lifetime traumatic experience. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics [Internet]. 2007;144(4):533–40. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34250888776&doi=10.1002%252fajmg.b.30507&partnerID=40&md5=e16326ac41b37c73645b002da10925fb

122.

Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, et al. Combined treatment with sertraline and liothyronine in major depression: A randomized, double-blind, placebo-controlled trial. Archives of General Psychiatry [Internet]. 2007;64(6):679–88. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34249934373&doi=10.1001%252farchpsyc.64.6.679&partnerID=40&md5=2922c7ce4dd96982cc950cb31a6f470a

123.

Strous RD, Greenbaum L, Kanyas K, Merbl Y, Horowitz A, Karni O, et al. Association of the dopamine receptor interacting protein gene, NEF3, with early response to antipsychotic medication. International Journal of Neuropsychopharmacology [Internet]. 2007;10(3):321–33. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34247860699&doi=10.1017%252fS1461145706006651&partnerID=40&md5=fa4f29694f6c81433bd10d11eb764a52

124.

Thelma BK, Tiwari AK, Deshpande SN, Lerer B, Nimgaonkar VL. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: Role of oxidative stress pathway genes. Schizophrenia Research [Internet]. 2007;92(1–3):278–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34247107021&doi=10.1016%252fj.schres.2006.12.019&partnerID=40&md5=a5cdbef38da793f2d220da5a0b1f9577

125.

Morar B, Schwab SG, Albus M, Maier W, Lerer B, Wildenauer DB. Evaluation of association of SNPs in the TNF alpha gene region with schizophrenia. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics [Internet]. 2007;144(3):318–24. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34247326401&doi=10.1002%252fajmg.b.30451&partnerID=40&md5=3a6c36a607ff66fce6996bb24ad8aecb

126.

Yakir A, Rigbi A, Kanyas K, Pollak Y, Kahana G, Karni O, et al. Why do young women smoke? III. Attention and impulsivity as neurocognitive predisposing factors. European Neuropsychopharmacology [Internet]. 2007;17(5):339–51. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33847188178&doi=10.1016%252fj.euroneuro.2006.09.004&partnerID=40&md5=a7af3da8e21398dd360021bc073d41d7

127.

Amann-Zalcenstein D, Avidan N, Kanyas K, Ebstein RP, Kohn Y, Hamdan A, et al. Erratum: AHI1, a pivotal neurodevelopment gene, and C6orf217 are associated with susceptibility to schizophrenia (European Journal of Human Genetics (2006) vol. 14 (1111-1119) 10.1038/sj.ejhg.5201675). European Journal of Human Genetics [Internet]. 2007;15(3):387. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33847225268&doi=10.1038%252fsj.ejhg.5201794&partnerID=40&md5=240070843aa452752595f8d42f2d7f1b

128.

Lerer B. IJNP Editorial Board: Meeting new challenges. International Journal of Neuropsychopharmacology [Internet]. 2007;10(1):1–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846329075&doi=10.1017%252fS1461145706007498&partnerID=40&md5=e965c95ec3c01560d630e700cb2ebc98

129.

Krausz Y, Freedman N, Lester H, Barkai G, Levin T, Bocher M, et al. Brain SPECT study of common ground between hypothyroidism and depression. International Journal of Neuropsychopharmacology [Internet]. 2007;10(1):99–106. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846286081&doi=10.1017%252fS1461145706006481&partnerID=40&md5=efde5e2f58bd4aeb52d7ac50c6b495db

130.

Schwab SG, Knapp M, Sklar P, Eckstein GN, Sewekow C, Borrmann-Hassenbach M, et al. Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIα gene (PIP5K2A) with schizophrenia. Molecular Psychiatry [Internet]. 2006;11(9):837–46. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33748068453&doi=10.1038%252fsj.mp.4001864&partnerID=40&md5=4984b18f35389e51a8772f56bb3c0dce

131.

Lerer E, Kanyas K, Karni O, Ebstein RP, Lerer B. Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes. Molecular Psychiatry [Internet]. 2006;11(8):771–81. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33746500116&doi=10.1038%252fsj.mp.4001855&partnerID=40&md5=13206ced11038d42367f1aaf5f154c7d

132.

Eitan R, Lerer B. Nonpharmacological, somatic treatments of depression: Electroconvulsive therapy and novel brain stimulation modalities. Dialogues in Clinical Neuroscience [Internet]. 2006;8(2):241–58. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33746370695&partnerID=40&md5=93564fabb4d1f8c0ad7d67372395d7e6

133.

Lerer B, Segman RH. Pharmacogenetics of antipsychotic therapy: Pivotal research issues and the prospects for clinical implementation. Dialogues in Clinical Neuroscience [Internet]. 2006;8(1):85–94. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646152737&partnerID=40&md5=30e107c6e54a1cb27d65dea7c6991db6

134.

Greenbaum L, Kanyas K, Karni O, Merbl Y, Olender T, Horowitz A, et al. Localization of SNPs in the CHRNB2 gene. Molecular Psychiatry [Internet]. 2006;11(3):223. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644629051&doi=10.1038%252fsj.mp.4001810&partnerID=40&md5=98304759c61e3f31024c76d270088698

135.

Cheng R, Juo SH, Loth JE, Nee J, Iossifov I, Blumenthal R, et al. Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Molecular Psychiatry [Internet]. 2006;11(3):252–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644622470&doi=10.1038%252fsj.mp.4001778&partnerID=40&md5=1cd043d4719c55603f2c28e95d9c2411

136.

Greenbaum L, Kanyas K, Karni O, Merbl Y, Olender T, Horowitz A, et al. Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes. Molecular Psychiatry [Internet]. 2006;11(3):312–22. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644614050&doi=10.1038%252fsj.mp.4001774&partnerID=40&md5=195d5ce189a0aebec1dee1ce08315940

137.

Lerer B. Recent strategies for potentiation and facilitation of antidepressant treatment: Introduction. Current Drug Targets [Internet]. 2006;7(2):137. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644858604&doi=10.2174%252f138945006775515400&partnerID=40&md5=f8d38ff482bcc1c21c9df17c6fad1626

138.

Lifschytz T, Segman R, Shalom G, Lerer B, Gur E, Golzer T, et al. Basic mechanisms of augmentation of antidepressant effects with thyroid hormone. Current Drug Targets [Internet]. 2006;7(2):203–10. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33644850947&doi=10.2174%252f138945006775515482&partnerID=40&md5=baefae29ded2c363a8aea37e87ffafb6

139.

Amann D, Avidan N, Kanyas K, Kohn Y, Hamdan A, Ben-Asher E, et al. The trace amine receptor 4 gene is not associated with schizophrenia in a sample linked to chromosome 6q23 [3]. Molecular Psychiatry [Internet]. 2006;11(2):119–21. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-31544474870&doi=10.1038%252fsj.mp.4001752&partnerID=40&md5=fadb4889c5060b1e86e79f2787d569fc

140.

Lifschytz T, Shalom G, Lerer B, Newman ME. Sex-dependent effects of fluoxetine and triiodothyronine in the forced swim test in rats. European Neuropsychopharmacology [Internet]. 2006;16(2):115–21. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-31344445562&doi=10.1016%252fj.euroneuro.2005.07.003&partnerID=40&md5=9da7d5680abeb79a2f5e6011b566529a

141.

Amann-Zalcenstein D, Avidan N, Kanyas K, Ebstein RP, Kohn Y, Hamdan A, et al. AHI1, a pivotal neurodevelopmental gene, and C6orf217 are associated with susceptibility to schizophrenia. European Journal of Human Genetics [Internet]. 2006;14(10):1111–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749061673&doi=10.1038%252fsj.ejhg.5201675&partnerID=40&md5=4a41e75ae8756f32d8bebd1371bad925

142.

Srivastava V, Varma PG, Prasad S, Semwal P, Nimgaonkar VL, Lerer B, et al. Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms. Pharmacogenetics and Genomics [Internet]. 2006;16(2):111–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-31344437482&doi=10.1097%252f01.fpc.0000184957.98150.0f&partnerID=40&md5=041ba60e40a37f77d9923cf6aae94d7d

143.

Kohn Y, Lerer B. Excitement and confusion on chromosome 6q: The challenges of neuropsychiatric genetics in microcosm. Molecular Psychiatry [Internet]. 2005;10(12):1062–73. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-32844458681&doi=10.1038%252fsj.mp.4001738&partnerID=40&md5=8b0a88eb6033dfd4fe987d74971ee735

144.

Schwab SG, Hoefgen B, Hanses C, Hassenbach MB, Albus M, Lerer B, et al. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of european sib-pair families. Biological Psychiatry [Internet]. 2005;58(6):446–50. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-25844437076&doi=10.1016%252fj.biopsych.2005.05.005&partnerID=40&md5=2562ca73e5f4d8d1f9d6d8e8be11f174

145.

Deshpande SN, Varma PG, Semwal P, Rao AR, Bhatia T, Nimgaonkar VL, et al. II. Serotonin receptor gene polymorphisms and their association with tardive dyskinesia among schizophrenia patients from North India. Psychiatric Genetics [Internet]. 2005;15(3):157–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-24144503437&doi=10.1097%252f00041444-200509000-00002&partnerID=40&md5=a496a57cf1fbaa959c2ffd82f4a01035

146.

Lerer B, Segman RH, Tan EC, Basile VS, Cavallaro R, Aschauer HN, et al. Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype. International Journal of Neuropsychopharmacology [Internet]. 2005;8(3):411–25. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-22344436588&doi=10.1017%252fS1461145705005389&partnerID=40&md5=7705da748d9bf5e6955d38cf0c3e39da

147.

Levi A, Kohn Y, Kanyas K, Amann D, Pae CU, Hamdan A, et al. Fine mapping of a schizophrenia susceptibility locus at chromosome 6q23: Increased evidence for linkage and reduced linkage interval. European Journal of Human Genetics [Internet]. 2005;13(6):763–71. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-20544477167&doi=10.1038%252fsj.ejhg.5201406&partnerID=40&md5=50937934bc1206cb752726985bf97d60

148.

Tiwari AK, Deshpande SN, Rao AR, Bhatia T, Lerer B, Nimgaonkar VL, et al. Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: III. Lack of association of CYP3A4 and CYP2D6 gene polymorphisms. Schizophrenia Research [Internet]. 2005;75(1):21–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-16844384063&doi=10.1016%252fj.schres.2004.12.011&partnerID=40&md5=194a3af563267e31b022f57ae0e67632

149.

Tiwari AK, Deshpande SN, Rao AR, Bhatia T, Mukit SR, Shriharsh V, et al. Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism. Pharmacogenomics Journal [Internet]. 2005;5(1):60–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-13544259943&doi=10.1038%252fsj.tpj.6500282&partnerID=40&md5=12270f003fc3da62e2b75ea53a58875d

150.

Lifschytz T, Gur E, Lerer B, Newman ME. Erratum: Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: Regional differences (Journal of Neuroscience Methods (2004) 140 (133-139) PII: S0165-0270(04)00290-0 and DOI: 10.1016/j.jneumeth.2004.03.028). Journal of Neuroscience Methods [Internet]. 2005;141(2):335. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-12344277809&doi=10.1016%252fj.jneumeth.2004.12.008&partnerID=40&md5=9742a52c6d8e6443b7ed78691797b3ed

151.

Ozdemir V, Lerer B. Pharmacogenomics and the promise of personalized medicine [Internet]. Pharmacogenomics, Second Edition. 2005. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84984779772&partnerID=40&md5=4997888569f5528bcdd7be5374a8189d

152.

McQueen MB, Devlin B, Faraone SV, Nimgaonkar VL, Sklar P, Smoller JW, et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. American Journal of Human Genetics [Internet]. 2005;77(4):582–95. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-25444466232&doi=10.1086%252f491603&partnerID=40&md5=e01a377784b8434cc4d85d6348ede529

153.

Weiser M, Kanyas K, Malaspina D, Harvey PD, Glick I, Goetz D, et al. Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-L. Comprehensive Psychiatry [Internet]. 2005;46(1):38–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-10444221822&doi=10.1016%252fj.comppsych.2004.07.016&partnerID=40&md5=e3dccf4d35ba49400813100977e56283

154.

Lifschytz T, Gur E, Lerer B, Newman ME. Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: Regional differences. Journal of Neuroscience Methods [Internet]. 2004;140(1-2 SPEC. ISS.):133–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-10344237049&doi=10.1016%252fj.jneumeth.2004.03.028&partnerID=40&md5=463d32af6f367ce98cdfef8bb98bce8c

155.

Park N, Juo SH, Cheng R, Liu J, Loth JE, Lilliston B, et al. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schipzoprenia. Molecular Psychiatry [Internet]. 2004;9(12):1091–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-19944428702&doi=10.1038%252fsj.mp.4001541&partnerID=40&md5=94017b212a0701178a4c1af47f1ff426

156.

Gur E, Lifschytz T, Van De Kar LD, Lerer B, Newman ME. Effects of triiodothyronine on 5-HT1A and 5-HT1B autoreceptor activity, and postsynaptic 5-HT1A receptor activity, in rat hypothalamus: Lack of interaction with imipramine. Psychoneuroendocrinology [Internet]. 2004;29(9):1172–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-3042690048&doi=10.1016%252fj.psyneuen.2004.01.011&partnerID=40&md5=7838b778678b8e0bcf6c4c800278737d

157.

Gur E, Lerer B, Van De Kar LD, Newman ME. Chronic rTMS induces subsensitivity of post-synaptic 5-HT1A receptors in rat hypothalamus. International Journal of Neuropsychopharmacology [Internet]. 2004;7(3):335–40. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-4444328089&doi=10.1017%252fS1461145703003985&partnerID=40&md5=10ba1bf16018b87fe129aaf0fbc852bc

158.

Bah J, Quach H, Ebstein RP, Segman RH, Melke J, Jamain S, et al. Maternal transmission disequilibrium of the glutamate receptor GRIK2 in schizophrenia. NeuroReport [Internet]. 2004;15(12):1987–91. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-4444291477&doi=10.1097%252f00001756-200408260-00031&partnerID=40&md5=216a68b994607b25d1d13536987919f7

159.

Kohn Y, Danilovich E, Filon D, Oppenheim A, Karni O, Kanyas K, et al. Linkage disequlibrium in the DTNBP1 (dysbindin) gene region and on chromosome 1p36 among psychotic patients from a genetic isolate in Israel: Findings from identity by descent haplotype sharing analysis. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2004;128 B(1):65–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-3042722158&partnerID=40&md5=c6f01179a8b1aea79bc2bc260bfe74da

160.

Mendlewicz J, Massat I, Souery D, Del-Favero J, Oruč L, Nöthen MM, et al. Serotonin transporter 5HTTLPR polymorphism and affective disorders: No evidence of association in a large European multicentre study. European Journal of Human Genetics [Internet]. 2004;12(5):377–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-2442696545&doi=10.1038%252fsj.ejhg.5201149&partnerID=40&md5=d0a6a7f30ab1bcdf13647965263b8f7e

161.

Blairy S, Linotte S, Souery D, Papadimitriou GN, Dikeos D, Lerer B, et al. Social adjustment and self-esteem of bipolar patients: A multicentric study. Journal of Affective Disorders [Internet]. 2004;79(1–3):97–103. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-12144291510&doi=10.1016%2fS0165-0327%2802%2900347-6&partnerID=40&md5=7d666abe81c725c411e10aad388bee2f

162.

Siegfried Z, Kanyas K, Latzer Y, Karni O, Bloch M, Lerer B, et al. Association Study of Cannabinoid Receptor Gene (CNR1) Alleles and Anorexia Nervosa: Differences between Restricting and Bingeing/Purging Subtypes. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2004;125 B(1):126–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0942301430&doi=10.1002%252fajmg.b.20089&partnerID=40&md5=5f6ae594a8efabc672722eaab59de6bb

163.

Kanyas K, Karni O, Hamdan A, Turetsky N, Kaadan M, Lerer B. Illness Recognition and Disruptiveness in Psychotic Illness. Comprehensive Psychiatry [Internet]. 2004;45(2):109–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-1542723664&doi=10.1016%252fj.comppsych.2003.12.001&partnerID=40&md5=314df1fff9424b1fb5007b9f7c3d8004

164.

Schwab SG, Mondabon S, Knapp M, Albus M, Hallmayer J, Borrmann-Hassenbach M, et al. Association of tumor necrosis factor alpha gene -G308A polymorphism with schizophrenia. Schizophrenia Research [Internet]. 2003;65(1):19–25. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-10744219906&doi=10.1016%2fS0920-9964%2802%2900534-0&partnerID=40&md5=23d82298f17c65f53f93b8028bd277c5

165.

Bonne O, Gilboa A, Louzoun Y, Kempf-Sherf O, Katz M, Fishman Y, et al. Cerebral blood flow in chronic symptomatic mild traumatic brain injury. Psychiatry Research - Neuroimaging [Internet]. 2003;124(3):141–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-10744232321&doi=10.1016%2fS0925-4927%2803%2900109-4&partnerID=40&md5=7d79af71aff5526f693231e48b6613de

166.

Segman RH, Goltser T, Heresco-Levy U, Finkel B, Shalem R, Schlafman M, et al. Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia. Pharmacogenomics Journal [Internet]. 2003;3(5):277–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-10744222019&doi=10.1038%252fsj.tpj.6500194&partnerID=40&md5=51eed8927bf6a50fa2beed6f22c51185

167.

Lerer B. Evidence-based psychopharmacology series. International Journal of Neuropsychopharmacology [Internet]. 2003;6(3):301. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0348198441&doi=10.1017%252fS1461145703003596&partnerID=40&md5=38d8520c1cd6c8ec22424ceb595d16de

168.

Lerer B, Segman RH, Hamdan A, Kanyas K, Karni O, Kohn Y, et al. Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24. Molecular Psychiatry [Internet]. 2003;8(5):488–98. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-10744232691&doi=10.1038%252fsj.mp.4001322&partnerID=40&md5=ef850dc66d13867010471e49ae6f8e6a

169.

Liu J, Juo SH, Dewan A, Grunn A, Tong X, Brito M, et al. Evidence for a putative bipolar disorder locus on 2p13-16 and other potential loci on 4q31, 7q34, 8q13, 9q31, 10q21-24, 13q32, 14q21 and 17q11-12. Molecular Psychiatry [Internet]. 2003;8(3):333–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037938810&doi=10.1038%252fsj.mp.4001254&partnerID=40&md5=45253f77860189cebc6ad27d98f6ddfd

170.

Agid O, Lerer B. Algorithm-based treatment of major depression in an outpatient clinic: Clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation. International Journal of Neuropsychopharmacology [Internet]. 2003;6(1):41–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037345048&doi=10.1017%252fS146114570200322X&partnerID=40&md5=00371b183bd848089cb4e83c04118d97

171.

Lichtigfeld FJ, Gillman MA, Lerer B, Macciardi F. Another marker for different types of depression [3] (multiple letters). International Journal of Neuropsychopharmacology [Internet]. 2003;6(1):91–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037345002&doi=10.1017%252fS1461145703003286&partnerID=40&md5=5925b029c48ae94485de12b698e801b5

172.

Bonne O, Louzoun Y, Aharon I, Krausz Y, Karger H, Lerer B, et al. Cerebral blood flow in depressed patients: A methodological comparison of statistical parametric mapping and region of interest analyses. Psychiatry Research - Neuroimaging [Internet]. 2003;122(1):49–57. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-12244286754&doi=10.1016%2fS0925-4927%2802%2900103-8&partnerID=40&md5=37facd880a5b92912f8f10d46e6b4674

173.

Lerer B, Macciardi F. Reply to Lichtigfeld and Gillman. International Journal of Neuropsychopharmacology [Internet]. 2003;6(1):93. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85022610597&doi=10.1017%252fS1461145703003298&partnerID=40&md5=002778130e60da553920f8e6a9834dda

174.

Kohn Y, Lerer B. Methodological Advances in Psychiatric Genetics [Internet]. Handbook of Medical Psychiatry. 2003. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646216596&doi=10.3109%252f9780203912485-7&partnerID=40&md5=60669fb19ede787ebdf52f4f287f841e

175.

Rigbi A, Shalev-Mevorach L, Taller A, Taller Y, Lerer B. Relationship of clinical and demographic characteristics of schizophrenia patients to rehabilitation status. Israel Journal of Psychiatry and Related Sciences [Internet]. 2003;40(4):258–67. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-1642277787&partnerID=40&md5=25e3e54b0d6f9f885f97d51e2acf42f3

176.

Agid R, Levin T, Gomori JM, Lerer B, Bonne O. T2-weighted image hyperintensities in major depression: Focus on the basal ganglia. International Journal of Neuropsychopharmacology [Internet]. 2003;6(3):215–24. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0141927311&doi=10.1017%252fs146114570300347x&partnerID=40&md5=3c449fea506c3b689331a893d46cbad9

177.

Dremencov E, Gur E, Lerer B, Newman ME. Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus. Progress in Neuro-Psychopharmacology and Biological Psychiatry [Internet]. 2003;27(5):729–39. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0041630988&doi=10.1016%2fS0278-5846%2803%2900123-4&partnerID=40&md5=e9b9c52eaaf8199edc8f27eb4172b953

178.

Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. American Journal of Human Genetics [Internet]. 2003;72(1):185–90. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037222276&doi=10.1086%252f345463&partnerID=40&md5=11ed3880e02b7ffa7a93fa52ca6026c3

179.

Gur E, Lifschytz T, Lerer B, Newman ME. Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT1 autoreceptor activity in rat cortex. European Journal of Pharmacology [Internet]. 2002;457(1):37–43. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037073601&doi=10.1016%2fS0014-2999%2802%2902642-0&partnerID=40&md5=83ffa6e99e2a79a14085325d3760c188

180.

Gur E, Dremencov E, Garcia F, Van de Kar LD, Lerer B, Newman ME. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT1A and 5-HT1B receptor activity in rat hippocampus and hypothalamus. Brain Research [Internet]. 2002;952(1):52–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037064272&doi=10.1016%2fS0006-8993%2802%2903193-1&partnerID=40&md5=41783b0bb25adc1ea4d8bb7b9193e459

181.

Dremencov E, Gur E, Lerer B, Newman ME. Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hypothalamus. Progress in Neuro-Psychopharmacology and Biological Psychiatry [Internet]. 2002;26(6):1029–34. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036774363&doi=10.1016%2fS0278-5846%2802%2900227-0&partnerID=40&md5=1da4be05ee45b4c9651ba0c97909bef9

182.

Lerer B, Macciardi F. Pharmacogenetics of antidepressant and mood-stabilizing drugs: A review of candidate-gene studies and future research directions. International Journal of Neuropsychopharmacology [Internet]. 2002;5(3):255–75. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036734874&doi=10.1017%252fS1461145702002936&partnerID=40&md5=4a4555df16d9e42723a5fe7e5ef03b44

183.

Cichon S, Schumacher J, Müller DJ, Hürter M, Windemuth C, Strauch K, et al. Erratum: A genome screen for genes predisposing to bipolar affecting disorder detects a new susceptibility locus on 8q (Human Molecular Genetics (2001) vol. 10 (2933-2944)). Human Molecular Genetics [Internet]. 2002;11(14):1685. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-18444397462&partnerID=40&md5=beeb724ca6770eb09de1ca2521ebaf51

184.

Lerer B, Segman RH, Fangerau H, Daly AK, Basile VS, Cavallaro R, et al. Pharmacogenetics of tardive dyskinesia: Combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology [Internet]. 2002;27(1):105–19. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036283004&doi=10.1016%2fS0893-133X%2802%2900293-2&partnerID=40&md5=bb2d73cbf246560cf3bed912a92bc22e

185.

Levinson DF, Holmans PA, Laurent C, Riley B, Pulver AE, Gejman PV, et al. No major schizophrenia locus detected on chromosome 1q in a large multicenter sample. Science [Internet]. 2002;296(5568):739–41. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-18344389404&doi=10.1126%252fscience.1069914&partnerID=40&md5=184c747642225b63135df7c6c94bb9a0

186.

Segman RH, Shapira Y, Modai I, Hamdan A, Zislin J, Heresco-Levy U, et al. Angiotensin converting enzyme gene insertion/deletion polymorphism: Case-control association studies in schizophrenia, major affective disorder, and tardive dyskinesia and a family-based association study in schizophrenia. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2002;114(3):310–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037041338&doi=10.1002%252fajmg.10255&partnerID=40&md5=399abdbd12406adbd2c70bcadb1213e9

187.

Schwab SG, Hallmayer J, Freimann J, Lerer B, Albus M, Borrmann-Hassenbach M, et al. Investigation of linkage and association/linkage disequilibrium of HLA A-, DQA1-, DQB 1-, AND DRB1-alleles in 69 sib-pair- and 89 trio-families with schizophrenia. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2002;114(3):315–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0012284588&doi=10.1002%252fajmg.10307&partnerID=40&md5=b7675549192a37304abbfa8c62d31952

188.

Massat I, Souery D, Del-Favero J, Van Gestel S, Serretti A, Macciardi F, et al. Positive association of dopamine D2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association study of affective disorders. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2002;114(2):177–85. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-18244407076&doi=10.1002%252fajmg.10118&partnerID=40&md5=9f6932d9b37bc1cf1dda09694c18a9eb

189.

Segman RH, Heresco-Levy U, Yakir A, Goltser T, Strous R, Greenberg DA, et al. Interactive effect of cytochrome P450 17α-hydroxylase and dopamine D3 receptor gene polymorphisms on abnormal involuntary movements in chronic schizophrenia. Biological Psychiatry [Internet]. 2002;51(3):261–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036468993&doi=10.1016%2fS0006-3223%2801%2901302-6&partnerID=40&md5=fc92ee7a671e1b86fda3324f1012053e

190.

Gur E, Dremencov E, Van De Kar LD, Lerer B, Newman ME. Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus. European Journal of Pharmacology [Internet]. 2002;436(1–2):57–65. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036468373&doi=10.1016%2fS0014-2999%2801%2901578-3&partnerID=40&md5=5b1597947eb2163cb47995adf3d6cb18

191.

Kohn Y, Lerer B. Genetics of Schizophrenia: A review of linkage findings. Israel Journal of Psychiatry and Related Sciences [Internet]. 2002;39(4):240–51. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-3042838979&partnerID=40&md5=d15cebd96844260bcc4146bb7a471511

192.

Segman RH, Lerer B. Age and the relationship of dopamine D3, serotonin 2C and serotonin 2A receptor genes to abnormal involuntary movements in chronic schizophrenia [2]. Molecular Psychiatry [Internet]. 2002;7(2):137–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036181204&doi=10.1038%252fsj.mp.4000960&partnerID=40&md5=8ac93ca76b82dca9205bb603b5197f84

193.

Cichon S, Schumacher J, Müller DJ, Hürter M, Windemuth C, Strauch K, et al. A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. Human Molecular Genetics [Internet]. 2001;10(25):2933–44. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-18244366107&doi=10.1093%252fhmg%252f10.25.2933&partnerID=40&md5=d4ab364d42a8ee5686d16369ef495f49

194.

Schumacher J, Cichon S, Richter C, Aboujamra R, Albus M, Borrmann-Hassenbach M, et al. Fine-mapping of chromosomal region 8q24 in bipolar affective disorder. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2001;105(7):610. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749110074&partnerID=40&md5=435d732895551221fc35da0f3a97f197

195.

Schwab SG, Sklar P, Hallmayer J, Albus M, Rietschel M, Lerer B, et al. Association of SNPs with schizophrenia on chromosome 10p, a region with previously detected linkage. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2001;105(7):562. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0142202282&partnerID=40&md5=65eab294e9f4e509e44160fb3b1a4027

196.

Lerer B, Shapira B. Time-dependent sensitization and ECT [1]. Molecular Psychiatry [Internet]. 2001;6(5):500. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-17944379347&doi=10.1038%252fsj.mp.4000917&partnerID=40&md5=f8d6bd15944d6b57adb65ac0ce55476a

197.

Lerer B, Macciardi F, Segman RH, Adolfsson R, Blackwood D, Blairy S, et al. Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder. Molecular Psychiatry [Internet]. 2001;6(5):579–85. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-17944371747&doi=10.1038%252fsj.mp.4000883&partnerID=40&md5=a87e609f16b81c5fa7a3f109341791d0

198.

Sklar P, Schwab SG, Williams NM, Daly M, Schaffner S, Maier W, et al. Association analysis of NOTCH4 loci in schizophrenia using family and population-based controls. Nature Genetics [Internet]. 2001;28(2):126–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034975491&doi=10.1038%252f88836&partnerID=40&md5=88a746f5efb376af7d278561faaa0587

199.

Cichon S, Schmidt-Wolf G, Schumacher J, Müller DJ, Hürter M, Schulze TG, et al. A possible susceptibility locus for bipolar affective disorder in chromosomal region 10q25-q26. Molecular Psychiatry [Internet]. 2001;6(3):342–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-17744389964&doi=10.1038%252fsj.mp.4000864&partnerID=40&md5=1b226b869bc34d1b39184cad60b7c51b

200.

Segman RH, Heresco-Levy U, Finkel B, Goltser T, Shalem R, Schlafman M, et al. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia. Molecular Psychiatry [Internet]. 2001;6(2):225–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-17744392199&doi=10.1038%252fsj.mp.4000842&partnerID=40&md5=b1f10c87cd3e2efbc3b51f1b0c38741f

201.

Liu J, Juo SH, Terwilliger JD, Grunn A, Tong X, Brito M, et al. A follow-up linkage study supports evidence for a bipolar affective disorder locus on chromosome 21q22. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2001;105(2):189–94. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035825987&doi=10.1002%252fajmg.1195&partnerID=40&md5=6c8ef81402098dd3b32c6705895552c5

202.

Nimgaonkar VL, Faraone SV, Lerer B, Mallet J, Sherrington R, Maier W. Impact of overlapping recruitment on psychiatric genetic studies. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2001;105(2):139–40. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035825961&doi=10.1002%252fajmg.1191&partnerID=40&md5=829faa853ce2bc79451cf51127df420b

203.

Souery D, Van Gestel S, Massat I, Blairy S, Adolfsson R, Blackwood D, et al. Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: A Multicenter Association Study. Biological Psychiatry [Internet]. 2001;49(5):405–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035281091&doi=10.1016%2fS0006-3223%2800%2901043-X&partnerID=40&md5=409c70c147596a5a38e64863affe4501

204.

Gur E, Dremencov E, Lerer B, Newman ME. Functional effects of corticosterone on 5-HT1A and 5-HT1B receptor activity in rat brain: In vivo microdialysis studies. European Journal of Pharmacology [Internet]. 2001;411(1–2):115–22. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035183120&doi=10.1016%2fS0014-2999%2800%2900911-0&partnerID=40&md5=5076624e295398d7c1f23d88fd77c1a9

205.

Kohn Y, Zislin J, Agid O, Hanin B, Troudart T, Shapira B, et al. Increased prevalence of negative life events in subtypes of major depressive disorder. Comprehensive Psychiatry [Internet]. 2001;42(1):57–63. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035148320&doi=10.1053%252fcomp.2001.19753&partnerID=40&md5=09de2e2252040d7c43c7230b76bf1184

206.

Agid O, Shalev AY, Lerer B. Triiodothyronine augmentation of selective serotonin reuptake inhibitors in posttraumatic stress disorder. Journal of Clinical Psychiatry [Internet]. 2001;62(3):169–73. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035057268&doi=10.4088%252fJCP.v62n0306&partnerID=40&md5=0b15bd20430e52f9dba9b210d23e61b3

207.

Parasol N, Cohen N, Zemishlany Z, Lerer B, Kosower NS. Duffy antigen/receptor for chemokines (DARC): Genotypes in Ashkenazi and non-Ashkenazi Jews in Israel. Human Biology [Internet]. 2001;73(2):307–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034929768&doi=10.1353%252fhub.2001.0024&partnerID=40&md5=ec8420f06fbf78353a24bd1839544da0

208.

Newman ME, Gur E, Dremencov E, Garcia F, Lerer B, Van De Kar LD. Chronic clomipramine alters presynaptic 5-HT(1B) and postsynaptic 5-HT(1A) receptor sensitivity in rat hypothalamus and hippocampus, respectively. Neuropharmacology [Internet]. 2000;39(12):2309–17. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033880456&doi=10.1016%2fS0028-3908%2800%2900077-0&partnerID=40&md5=241df8a6cf7a927eb5b757ff56cddf95

209.

Gur E, Lerer B, Dremencov E, Newman ME. Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain. NeuroReport [Internet]. 2000;11(13):2925–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034637798&doi=10.1097%252f00001756-200009110-00019&partnerID=40&md5=7bd827952821123cdf47d447de781c9c

210.

Segman RH, Levy UH, Finkel B, Greenberg D, Yakir A, Shlaffman M, et al. 5-HT2A receptor polymorphism and susceptibility to tardive dyskinesia in patients with chronic schizophrenia. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2000;96(4):526. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749114006&partnerID=40&md5=6a918a345c5bb5baa043b76417bb1b3d

211.

Segman RH, Levy U, Finkel B, Greenberg D, Lerner A, Yakir A, et al. Additive contribution of DRD3gly and HT2CRser alleles to susceptibility to tardive dyskinesia in patients with chronic schizophrenia. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2000;96(4):529–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749106563&partnerID=40&md5=56049b1694d4dbab52403d14c84086ce

212.

Cichon S, Schumacher J, Muller DJ, Hürter M, Albus M, Borrmann-Hassenbach M, et al. Systematic search for susceptibility genes in bipolar affective disorder. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2000;96(4):467–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749106131&partnerID=40&md5=08b708be6701d1ca1b9e06ac1e38f41a

213.

Eckstein GN, Schwab SG, Hallmayer J, Albus M, Lerer B, Maier W, et al. A genome-wide survey for transmission disequilibrium in schizophrenia. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2000;96(4):552–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749091178&partnerID=40&md5=8e4d58718b680e7ec3e54da12d599737

214.

Liu J, Juo SH, Terwilliger JD, Grunn A, Tong X, Brito M, et al. Further analysis of chromosome 21q22 augments prior evidence for linkage to bipolar affective disorder. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2000;96(4):483. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749090348&partnerID=40&md5=760b7204539410b654ff8d8c368cd78e

215.

Schumacher J, Cichon S, Albus M, Borrmann-Hassenbach M, Franzek E, Fritze J, et al. No evidence for an X-chromosomal locus for bipolar affective disorder in 64 German and 4 Israeli families. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2000;96(4):548. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749089931&partnerID=40&md5=89c9ccaf07674ab217af111246beb224

216.

Kanyas K, Segman RH, Agid O, Lerer B. The molecular genetics of cigarette smoking: Demographic and environmental complexities. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2000;96(4):505. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749087736&partnerID=40&md5=4b91a15abbf0db63b309d4eac4f3b79c

217.

Karni O, Yakir A, Kanyas K, Turetsky N, Lerer B. Age at onset in sibling pairs with schizophrenia and schizoaffective disorder. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2000;96(4):505. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749084366&partnerID=40&md5=c40eb47fbf9f18a1a4f700a04eae9c2c

218.

Lerer B, Mendlewicz J. Vaeiability of 5-HT2C receptor CYS23SER polymorphism in European populations and vulnerability to affective disorder. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2000;96(4):484. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0012775305&partnerID=40&md5=0e38b809d784961dfe7774f46295ef4d

219.

Schwab SG, Eckstein GN, Gabel S, Hallmayer J, Lerer B, Albus M, et al. Susceptibility locus for schizophrenia on 10p: Searching for a candidate. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 2000;96(4):461. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0008896937&partnerID=40&md5=0dd0001ac5501c320029faf784f438e6

220.

Shapira B, Newman ME, Gelfin Y, Lerer B. Blunted temperature and cortisol responses to ipsapirone in major depression: Lack of enhancement by electroconvulsive therapy. Psychoneuroendocrinology [Internet]. 2000;25(5):421–38. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034097799&doi=10.1016%2fS0306-4530%2899%2900067-0&partnerID=40&md5=535a062361abd56a328a2cb42af6535a

221.

Newman ME, Agid O, Gur E, Lerer B. Pharmacological mechanisms of T3 augmentation of antidepressant action. International Journal of Neuropsychopharmacology [Internet]. 2000;3(2):187–91. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033916754&doi=10.1017%252fS1461145700001875&partnerID=40&md5=a228a9b7ead8521d8107200c04ee9433

222.

Shapira B, Tubi N, Lerer B. Balancing speed of response to ECT in major depression and adverse cognitive effects: Role of treatment schedule. Journal of ECT [Internet]. 2000;16(2):97–109. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034200343&doi=10.1097%252f00124509-200006000-00002&partnerID=40&md5=ad9fab2d284761f6f544b10e708be51a

223.

Agid O, Kohn Y, Lerer B. Environmental stress and psychiatric illness. Biomedicine and Pharmacotherapy [Internet]. 2000;54(3):135–41. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034177824&doi=10.1016%2fS0753-3322%2800%2989046-0&partnerID=40&md5=013e65da4ec5a89310ec91a1abc00f0d

224.

Dremencov E, Gur E, Lerer B, Newman ME. Subchronic fluoxetine administration to rats: Effects on 5-HT autoreceptor activity as measured by in vivo microdialysis. European Neuropsychopharmacology [Internet]. 2000;10(4):229–36. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034130377&doi=10.1016%2fS0924-977X%2800%2900078-X&partnerID=40&md5=bea79a8d463796aa659737c48fd42c3b

225.

Frisch A, Michaelovsky E, Rockah R, Amir I, Hermesh H, Laor N, et al. Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. European Neuropsychopharmacology [Internet]. 2000;10(3):205–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033995464&doi=10.1016%2fS0924-977X%2800%2900071-7&partnerID=40&md5=936d10576e18d329320a7f00267506e3

226.

Hranilovic D, Schwab SG, Jernej B, Knapp M, Lerer B, Albus M, et al. Serotonin transporter gene and schizophrenia: Evidence for association/linkage disequilibrium in families with affected siblings. Molecular Psychiatry [Internet]. 2000;5(1):91–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033966436&doi=10.1038%252fsj.mp.4000599&partnerID=40&md5=9b280d03580ffbfbcff0eb8416492595

227.

Levinson DF, Holmans P, Straub RE, Owen MJ, Wildenauer DB, Gejman PV, et al. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: Schizophrenia linkage collaborative group III. American Journal of Human Genetics [Internet]. 2000;67(3):652–63. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033842462&doi=10.1086%252f303041&partnerID=40&md5=dc03c91533fb8b713e8a350b4347c7ed

228.

Canetti L, Bachar E, Bonne O, Agid O, Lerer B, De-Nour AK, et al. The impact of parental death versus separation from parents on the mental health of Israeli adolescents. Comprehensive Psychiatry [Internet]. 2000;41(5):360–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033811994&doi=10.1053%252fcomp.2000.9002&partnerID=40&md5=86492a3617413de10960738c7850038f

229.

Segman RH, Heresco-Levy U, Finkel B, Inbar R, Neeman T, Schlafman M, et al. Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: Additive contribution of 5-HT2C(ser) and DRD3(gly) alleles to susceptibility. Psychopharmacology [Internet]. 2000;152(4):408–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033667902&doi=10.1007%252fs002130000521&partnerID=40&md5=7e08378806f5a0cbfeb4dff87d9f855d

230.

Schwab SG, Hallmayer J, Albus M, Lerer B, Eckstein GN, Borrmann M, et al. A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: Support for loci on chromosome 10p and 6. Molecular Psychiatry [Internet]. 2000;5(6):638–49. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033647377&doi=10.1038%252fsj.mp.4000791&partnerID=40&md5=514e47d67b9dcaf19c1404fd199e5dd1

231.

Shapira B, Lerer B. Speed of response to bilateral ECT: An examination of possible predictors in two controlled trials. Journal of ECT [Internet]. 1999;15(3):202–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033190892&partnerID=40&md5=6bc49e4eec420c889494269438bdf3f3

232.

Souery D, Lipp O, Rivelli SK, Massat I, Serretti A, Cavallini C, et al. Tyrosine hydroxylase polymorphism and phenotypic heterogeneity in bipolar affective disorder: A multicenter association study. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1999;88(5):527–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033569889&doi=10.1002%2f%28SICI%291096-8628%2819991015%2988%3a5%3c527%3a%3aAID-AJMG17%3e3.0.CO%3b2-4&partnerID=40&md5=6c6b787cef6c47875c4b1370a311d257

233.

Newman ME, Li Q, Gelfin Y, Van de Kar LD, Lerer B. Low doses of ipsapirone increase growth hormone but not oxytocin secretion in normal male and female subjects. Psychopharmacology [Internet]. 1999;145(1):99–104. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032777845&doi=10.1007%252fs002130051037&partnerID=40&md5=811b3849df54530346b6706f16e3e2eb

234.

Lerer B. The neurobiology of ECT: The road ahead. Journal of ECT [Internet]. 1999;15(1):1–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032981809&partnerID=40&md5=5820d94342d068758d6d88d9c6695b0d

235.

Lerer B, Shapira B, Bloch M, Hanin B, Trudart T, Alexander JR, et al. Possible precipitants of psychiatric hospitalization in patients with major depression: Results from the Jerusalem Collaborative Depression Project. Depression and Anxiety [Internet]. 1999;9(4):156–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033047825&doi=10.1002%2f%28SICI%291520-6394%281999%299%3a4%3c156%3a%3aAID-DA2%3e3.0.CO%3b2-E&partnerID=40&md5=70deec1b4f452ce7e3dce0a2b62afffd

236.

Lerer B, Gelfin Y, Shapira B. Neuroendocrine evidence for age-related decline in central serotonergic function. Neuropsychopharmacology [Internet]. 1999;21(2):321–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033010886&doi=10.1016%2fS0893-133X%2898%2900125-0&partnerID=40&md5=8e300bae74c457b2e6da3ec462537922

237.

Lerer B, Gelfin Y, Gorfine M, Allolio B, Lesch KP, Newman ME. 5-HT(1A) Receptor function in normal subjects on clinical doses of fluoxetine: Blunted temperature and hormone responses to ipsapirone challenge. Neuropsychopharmacology [Internet]. 1999;20(6):628–39. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033137334&doi=10.1016%2fS0893-133X%2898%2900106-7&partnerID=40&md5=3938e1c0478672435763ffe84aed6d5a

238.

Rietschel M, Kennedy JL, Macciardi F, Meltzer HY, Breier A, DeLisi LE, et al. Application of pharmacogenetics to psychotic disorders: The first consensus conference. Date and Place of Meeting: 12 July 1998, Marriott Hotel, 500 Argyle Street, Glasgow. Schizophrenia Research [Internet]. 1999;37(2):191–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033602828&doi=10.1016%2fS0920-9964%2898%2900153-4&partnerID=40&md5=a20f0ef05a79c675200dff9896ce7d2c

239.

Gur E, Dremencov E, Lerer B, Newman ME. Venlafaxine: Acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo. European Journal of Pharmacology [Internet]. 1999;372(1):17–24. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032894207&doi=10.1016%2fS0014-2999%2899%2900164-8&partnerID=40&md5=0492ec1f7668f80a28b030b51639f06f

240.

Bonne O, Krausz Y, Aharon Y, Gelfin Y, Chisin R, Lerer B. Clinical doses of fluoxetine and cerebral blood flow in healthy volunteers. Psychopharmacology [Internet]. 1999;143(1):24–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032947545&doi=10.1007%252fs002130050915&partnerID=40&md5=ac48a7ce48361563afa7d8d152b7d953

241.

Bachar E, Lerer B, Shapira B. Increment in reminiscing after ECT: Possible connections to neuropsychologic changes [2]. Journal of ECT [Internet]. 1999;15(2):165–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033407167&doi=10.1097%252f00124509-199906000-00010&partnerID=40&md5=2f783242b7a52f484dccf0c39693cb33

242.

Aita VM, Liu J, Knowles JA, Terwilliger JD, Baltazar R, Grunn A, et al. A comprehensive linkage analysis of chromosome 21q22 supports prior evidence for a putative bipolar affective disorder locus. American Journal of Human Genetics [Internet]. 1999;64(1):210–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033361017&doi=10.1086%252f302185&partnerID=40&md5=5779e2ac48695ab5562ec7a6e17bde6e

243.

Segman R, Neeman T, Heresco-Levy U, Finkel B, Karagichev L, Schlafman M, et al. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia. Molecular Psychiatry [Internet]. 1999;4(3):247–53. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033046439&doi=10.1038%252fsj.mp.4000511&partnerID=40&md5=2068d826b018d5de3a8f719b49c93f22

244.

Wildenauer DB, Schwab SG, Maier W, Lerer B. Searching for genes in schizophrenia. Acta Neuropsychiatrica [Internet]. 1999;11(2):50–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033039381&doi=10.1017%252fS0924270800036140&partnerID=40&md5=e7ed3fc26c96d929aeca7719b1f515d4

245.

Wittekindt O, Schwab SG, Burgert E, Knapp M, Albus M, Lerer B, et al. Association between hSKCa3 and schizophrenia not confirmed by transmission disequilibrium test in 193 offspring/parents trios. Molecular Psychiatry [Internet]. 1999;4(3):267–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033009853&doi=10.1038%252fsj.mp.4000495&partnerID=40&md5=640c03c8b2db19dcdbe753d576d6e3c1

246.

Agid O, Lerer B. Risperidone augmentation of paroxetine in a case of severe, treatment- refractory obsessive-compulsive disorder without comorbid psychopathology [3]. Journal of Clinical Psychiatry [Internet]. 1999;60(1):55–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032959596&doi=10.4088%252fJCP.v60n0112d&partnerID=40&md5=104773829421e0955a9f1ababb1161c9

247.

Shapira B, Zislin J, Gelfin Y, Osher Y, Gorfine M, Souery D, et al. Social adjustment and self-esteem in remitted patients with unipolar and bipolar affective disorder: A case-control study. Comprehensive Psychiatry [Internet]. 1999;40(1):24–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032950989&doi=10.1016%2fS0010-440X%2899%2990072-X&partnerID=40&md5=3f0bd20e1fa09b8c7331c312c8d2c32e

248.

Agid O, Shapira B, Zislin J, Ritsner M, Hanin B, Murad H, et al. Environment and vulnerability to major psychiatric illness: A case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Molecular Psychiatry [Internet]. 1999;4(2):163–72. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032910319&doi=10.1038%252fsj.mp.4000473&partnerID=40&md5=640ff6c0a3fa59352c21ee31f6ac2cbd

249.

Gur E, Lerer B, Newman ME. Chronic clomipramine and triiodothyronine increase serotonin levels in rat frontal cortex in vivo: Relationship to serotonin autoreceptor activity. Journal of Pharmacology and Experimental Therapeutics [Internet]. 1999;288(1):81–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032909487&partnerID=40&md5=d44d53caad65304ac917cca8128db293

250.

Morag M, Morag A, Reichenberg A, Lerer B, Yirmiya R. Psychological variables as predictors of rubella antibody titers and fatigue - A prospective, double blind study. Journal of Psychiatric Research [Internet]. 1999;33(5):389–95. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032774317&doi=10.1016%2fS0022-3956%2899%2900010-2&partnerID=40&md5=97ebe8b0a17b09cd1c12d8cbce1dc3bc

251.

Segman RH, Neeman T, Heresco-Levy U, Finkel B, Karagacev L, Schlafman M, et al. Genetic factors in tardive dyskinesia: Possible role of the dopamine transporter. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1998;81(6):477. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33749099369&partnerID=40&md5=cba1811a87ffe3826ffdf097d4dd6403

252.

Wildenauer DB, Knapp M, Albus M, Lerer B, Borrmann M, Segman R, et al. Association/linkage disequilibrium of G-Olfα in 59 families with schizophrenic index patients in the presence of linkage. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1998;81(6):524. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0345624584&partnerID=40&md5=ddd9f720cbc38dcc96f408881de09d16

253.

Liu J, Aita VM, Knowles JA, Terwilliger JD, Baltazar R, Grunn A, et al. A genome-wide scan for bipolar affective disorder. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1998;81(6):462. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0345192547&partnerID=40&md5=8d27fa6f0340dbbf2c9798e69d9dd8b9

254.

Segman RH, Shapira Y, Kanyas K, Hirschmann S, Heresco-Levy U, Kami O, et al. Angiotensin converting enzyme polymorphism in schizophrenia and major affective disorder: Population and family-based association studies. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1998;81(6):522–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038257016&partnerID=40&md5=eac49af1e66e921493c6ef0097f5d2d2

255.

Wildenauer DB, Schwab SG, Hallmayer J, Lerer B, Albus M, Borrman M, et al. Genome scan for autosomal genes conferring risk to schizophrenia in a German/ Israeli sample. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1998;81(6):454. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0008910968&partnerID=40&md5=072862d580c2219c5763c1763a83fa18

256.

Aita VM, Liu J, Terwilliger JD, Baltazar R, Grunn A, Loth JE, et al. A follow-up linkage analysis of chromosome 21 continues to provide evidence for a putative bipolar affective disorder locus. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1998;81(6):476. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0006438695&partnerID=40&md5=07544e2aa273185df46c41b6eb102fc3

257.

Hallmayer J, Schwab SG, Albus M, Lerer B, Zill P, Hanses C, et al. A potential susceptibility locus for schizophrenia on 22q12,13: Re-evaluation in 72 families. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1998;81(6):529. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0004885812&partnerID=40&md5=afa5beddd06ef5e1a50174c5c76ce765

258.

Freymann J, Schwab SG, Knapp M, Albus M, Lerer B, Hallmayer J, et al. Association studies of HLA genes in families with linkage to chromosome 6p. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1998;81(6):517. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0004558913&partnerID=40&md5=16440862f72b3c98dee440c6ecfd5307

259.

Schwab SG, Hallmayer J, Albus M, Lerer B, Hanses C, Kanyas K, et al. A potential susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1998;81(6):528–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0000422514&partnerID=40&md5=c0d8221417fe892668bd24446b50bc8d

260.

Newman ME, Gur E, Shapira B, Lerer B. Neurochemical mechanisms of action of ECS: Evidence from in vivo studies. Journal of ECT [Internet]. 1998;14(3):153–71. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031714151&partnerID=40&md5=0ca911cce1ef7d11c9009e8ed6f77a81

261.

Lerer B. The neurobiology of ECT: The road taken. Journal of ECT [Internet]. 1998;14(3):149–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031667756&partnerID=40&md5=4df93d96d38a7fc61e32c6893de846f2

262.

Krausz Y, Bonne O, Gorfine M, Karger H, Lerer B, Chisin R. Age-related changes in brain perfusion of normal subjects detected by 99mTc-HMPAO SPECT. Neuroradiology [Internet]. 1998;40(7):428–34. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031852914&doi=10.1007%252fs002340050617&partnerID=40&md5=d0f92af3a84b91ddf311ed2ddf6892bd

263.

Vallada HP, Collier DA, Curtis D, Sham PC, Kunugi H, Zhao J, et al. A transmission disequilibrium and linkage analysis of D22S278 marker alleles in 574 families: Further support for a susceptibility locus for schizophrenia at 22q12. Schizophrenia Research [Internet]. 1998;32(2):115–21. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032572612&doi=10.1016%2fS0920-9964%2898%2900048-6&partnerID=40&md5=cc7e8422f697b6e1a0333dfdb32d71c0

264.

Schwab SG, Hallmayer J, Albus M, Lerer B, Hanses C, Kanyas K, et al. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with Schizophrenia by nonparametric linkage analysis. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1998;81(4):302–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-17744421277&doi=10.1002%2f%28SICI%291096-8628%2819980710%2981%3a4%3c302%3a%3aAID-AJMG5%3e3.0.CO%3b2-V&partnerID=40&md5=1f7a699810d38032cef431838ff2a61f

265.

Morag M, Yirmiya R, Lerer B, Morag A. Influence of socioeconomic status on behavioral, emotional and cognitive effects of rubella vaccination: A prospective, double blind study. Psychoneuroendocrinology [Internet]. 1998;23(4):337–51. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031817114&doi=10.1016%2fS0306-4530%2898%2900012-2&partnerID=40&md5=30869443fd526d7b5c15867a8726b0ec

266.

Gelfin Y, Gorfine M, Lerer B. Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers. American Journal of Psychiatry [Internet]. 1998;155(2):290–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031908546&partnerID=40&md5=1e66ab5652f4233a2ffd94cdd582eb18

267.

Lerer B, Frazer A, Stahl S, Farde L, Lesch P. The International Journal of Neuropsychopharmacology. International Journal of Neuropsychopharmacology [Internet]. 1998;1(1):1–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-55549093990&doi=10.1017%252fS1461145798009018&partnerID=40&md5=e72ab1673804aa15f506e27efaddadfe

268.

Knowles JA, Rao PA, Cox-Matise T, Loth JE, De Jesus GM, Levine L, et al. No evidence for significant linkage between bipolar affective disorder and chromosome 18 pericentromeric markers in a large series of multiplex extended pedigrees. American Journal of Human Genetics [Internet]. 1998;62(4):916–24. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-17344368986&doi=10.1086%252f301785&partnerID=40&md5=8f21b0ae597fff5db1db914184bcab47

269.

Schwab SG, Hallmayer J, Lerer B, Albus M, Borrmann M, Hönig S, et al. Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. American Journal of Human Genetics [Internet]. 1998;63(4):1139–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032231638&doi=10.1086%252f302046&partnerID=40&md5=aec46bca8250511b5c44160ba851529f

270.

Shapira B, Tubi N, Drexler H, Lidsky D, Calev A, Lerer B. Cost and benefit in the choice of ECT schedule: Twice versus three times weekly ECT. British Journal of Psychiatry [Internet]. 1998;172(JAN.):44–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031952025&doi=10.1192%252fbjp.172.1.44&partnerID=40&md5=be0b4f609cf9b13ddac420e74a149389

271.

Souery D, Lipp O, Serretti A, Mahieu B, Rivelli SK, Cavallini C, et al. European Collaborative Project on Affective Disorders: Interactions between genetic and psychosocial vulnerability factors. Psychiatric Genetics [Internet]. 1998;8(4):197–205. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0005592992&doi=10.1097%252f00041444-199808040-00001&partnerID=40&md5=57c478721a9e3a7f66051cf617f81114

272.

Newman ME, Shapira B, Lerer B. Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: A critical review. International Journal of Neuropsychopharmacology [Internet]. 1998;1(1):49–69. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0003001681&doi=10.1017%252fS1461145798001072&partnerID=40&md5=fad192d6f7928dc1390ae330252e7a53

273.

Amar A, Segman RH, Shtrussberg S, Sherman L, Safirman C, Lerer B, et al. An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201. International Journal of Neuropsychopharmacology [Internet]. 1998;1(1):41–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0002084753&doi=10.1017%252fS1461145798001023&partnerID=40&md5=f383332293edeeed58d56df62631ce0b

274.

Gur E, Berman E, Lerer B, Newman ME. In vivo cyclic AMP responses in rat brain are not modified by chronic electroconvulsive shock. European Neuropsychopharmacology [Internet]. 1997;7(3):189–93. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030871698&doi=10.1016%2fS0924-977X%2897%2900399-4&partnerID=40&md5=3ffd28b746ab274dad834e2029b2f782

275.

Dann J, DeLisi LE, Devoto M, Laval S, Nancarrow DJ, Shields G, et al. A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. Psychiatry Research [Internet]. 1997;70(3):131–43. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030755699&doi=10.1016%2fS0165-1781%2897%2903138-7&partnerID=40&md5=8e2352c446c479fbf04c314111dfccb0

276.

Bloch M, Schwartzman Y, Bonne O, Lerer B. Concurrent treatment of nonresistant major depression with desipramine and lithium: A double-blind, placebo-controlled study. Journal of Clinical Psychopharmacology [Internet]. 1997;17(1):44–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031025698&doi=10.1097%252f00004714-199702000-00008&partnerID=40&md5=7f7ae0a0969cb7f251d56cf3f376646d

277.

Kohn Y, Ebstein RP, Heresco-Levy U, Shapira B, Nemanov L, Gritsenko I, et al. Dopamine D4 receptor gene polymorphisms: Relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects. European Neuropsychopharmacology [Internet]. 1997;7(1):39–43. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030940989&doi=10.1016%2fS0924-977X%2896%2900380-X&partnerID=40&md5=ba6b5fbfe95cef989af00f742930f858

278.

Kotler M, Cohen H, Segman R, Gritsenko I, Nemanov L, Lerer B, et al. Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Molecular Psychiatry [Internet]. 1997;2(3):251–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-8244242533&doi=10.1038%252fsj.mp.4000248&partnerID=40&md5=e127c30124ff46b9bfce634578141226

279.

Schwab SG, Eckstein GN, Hallmayer J, Lerer B, Albus M, Borrmann M, et al. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Molecular Psychiatry [Internet]. 1997;2(2):156–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-8244226000&doi=10.1038%252fsj.mp.4000263&partnerID=40&md5=ae00aa375c5e70f665b94153518ea18a

280.

Ebstein RP, Macciardi F, Heresco-Levi U, Serretti A, Blaine D, Verga M, et al. Evidence for an association between the dopamine d3 receptor gene DRD3 and schizophrenia. Human Heredity [Internet]. 1997;47(1):6–16. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-17644435549&doi=10.1159%252f000154382&partnerID=40&md5=14f4b751ae333574491bac5c8aa9bf89

281.

Lerer B, Segman RH. Correspondence regarding German psychiatric genetics and Ernst Rüdin. American journal of medical genetics [Internet]. 1997;74(4):459–63. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031586172&doi=10.1002%2f%28sici%291096-8628%2819970725%2974%3a4%3c459%3a%3aaid-ajmg24%3e3.0.co%3b2-g&partnerID=40&md5=8edf3c0a598a8696d715949dd512b7bb

282.

Heresco-Levy U, Greenberg D, Lerer B, Javitt DC, Brown WA. Serum Neuroleptic Levels during Reduced Dose Fluphenazine Decanoate Maintenance Therapy. Israel Journal of Psychiatry and Related Sciences [Internet]. 1997;34(4):281–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031305653&partnerID=40&md5=d19a91f85d7f3a31bd16cff07e3390a6

283.

Bleich A, Koslowsky M, Dolev A, Lerer B. Post-traumatic stress disorder and depression: An analysis of comorbidity. British Journal of Psychiatry [Internet]. 1997;170(MAY):479–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030920164&doi=10.1192%252fbjp.170.5.479&partnerID=40&md5=f8bfddd5b11c095f2051a12208abb7e6

284.

Segman RH, Ebstein RP, Heresco-Levy U, Gorfine M, Avnon M, Gur E, et al. Schizophrenia, chronic hospitalization and the 5-HT(2C) receptor gene. Psychiatric Genetics [Internet]. 1997;7(2):75–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030821011&doi=10.1097%252f00041444-199722000-00003&partnerID=40&md5=66ae4ad72041a456843d20aa1dbf816a

285.

Gur E, Lerer B, Newman ME. Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: An in vivo microdialysis study. Journal of Neural Transmission [Internet]. 1997;104(8–9):795–804. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030668520&doi=10.1007%252fBF01285548&partnerID=40&md5=9f95ced75732ca993795ca7368689774

286.

Schreiber S, Lerer B. “Failure to thrive” in elderly depressed patients: A new concept or a different name for an old problem? Israel Journal of Psychiatry and Related Sciences [Internet]. 1997;34(2):108–14. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030633907&partnerID=40&md5=5dc415285a9df1f10bc10fe2bc19b91f

287.

Bonne O, Krausz Y, Gorfine M, Karger H, Gelfin Y, Shapira B, et al. Cerebral hypoperfusion in medication resistant, depressed patients assessed by Tc99m HMPAO SPECT. Journal of Affective Disorders [Internet]. 1996;41(3):163–71. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-18244426740&doi=10.1016%2fS0165-0327%2896%2900058-4&partnerID=40&md5=461ea873c488173e7a27b67b6d6704b7

288.

Petrides G, Fink M, Shapira B, Lerer B. Choosing a dosing strategy for electrical stimulation in ECT [3]. Journal of Clinical Psychiatry [Internet]. 1996;57(10):487–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029829825&partnerID=40&md5=27ea5f64672e9920a3bb4831eb3b3e06

289.

Bonne O, Krausz Y, Shapira B, Bocher M, Karger H, Gorfine M, et al. Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. Journal of Nuclear Medicine [Internet]. 1996;37(7):1075–80. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029743081&partnerID=40&md5=de927e5656305f5d1f2f4beaad00edfa

290.

Rifkin A, Selzer JA, Lerer B, Shapira B. ECT sessions: How many a week? [16]. American Journal of Psychiatry [Internet]. 1996;153(4):585–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029884991&partnerID=40&md5=3dc2cdbcfdd4305f4cc53f29b9faba95

291.

Lerer B, Gillon D, Lichtenberg P, Gorfine M, Gelfin Y, Shapira B. Interrelationship of age, depression, and central serotonergic function: Evidence from fenfluramine challenge studies. International Psychogeriatrics [Internet]. 1996;8(1):83–102. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029990720&doi=10.1017%252fS1041610296002499&partnerID=40&md5=657e58a5fead869a2f6e9f13e93a876a

292.

Wildenauer DB, Hallmayer J, Schwab SG, Albus M, Eckstein GN, Zill P, et al. Searching for susceptibility genes in schizophrenia by genetic linkage analysis. Cold Spring Harbor Symposia on Quantitative Biology [Internet]. 1996;61:845–50. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-12644293808&doi=10.1101%252fsqb.1996.061.01.083&partnerID=40&md5=a4dcf176ae2fc847d3d19e71e1e4f5ec

293.

Maier W, Minges J, Eckstein N, Brodski C, Albus M, Lerer B, et al. Genetic relationship between dopamine transporter gene and schizophrenia: Linkage and association. Schizophrenia Research [Internet]. 1996;20(1–2):175–80. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030152382&doi=10.1016%2f0920-9964%2895%2900083-6&partnerID=40&md5=b7ca951ebf3f6dcc2ca6de09b5e0e475

294.

Shapira B, Lidsky D, Gorfine M, Lerer B. Electroconvulsive therapy and resistant depression: Clinical implications of seizure threshold. Journal of Clinical Psychiatry [Internet]. 1996;57(1):32–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030045974&partnerID=40&md5=fc7862ed85e4787dd1ab61a1b01a9ead

295.

Gur E, Lerer B, Newman ME. Acute or chronic lithium does not affect agonist-stimulated inositol trisphosphate formation in rat brain in vivo. NeuroReport [Internet]. 1996;7(2):393–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029916799&doi=10.1097%252f00001756-199601310-00004&partnerID=40&md5=6a5c7ad2aa9068c88a3fa2673c90c531

296.

Krausz Y, Bonne O, Marciano R, Yaffe S, Lerer B, Chisin R. Brain SPECT imaging of neuropsychiatric disorders. European Journal of Radiology [Internet]. 1996;21(3):183–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029872129&doi=10.1016%2f0720-048X%2895%2900725-6&partnerID=40&md5=567ab3a2226e918b6a823a46124ef47e

297.

Wildenauer DB, Schwab SG, Albus M, Hallmayer J, Lerer B, Maier W, et al. Additional Support for Schizophrenia Linkage on Chromosomes 6 and 8: A Multicenter Study. American Journal of Medical Genetics [Internet]. 1996;67(6):580–94. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029845435&doi=10.1002%2f%28SICI%291096-8628%2819961122%2967%3a6%3c580%3a%3aAID-AJMG11%3e3.0.CO%3b2-P&partnerID=40&md5=29d3ab35230fcaa0f53c6241faf23299

298.

Schwab SG, Lerer B, Albus M, Maier W, Hallmayer J, Fimmers R, et al. Potential linkage for schizophrenia on chromosome 22q12-q13: A replication study. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1995;60(5):436–43. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028802764&doi=10.1002%252fajmg.1320600515&partnerID=40&md5=977a2b3053de59ac9db139d3df703eb3

299.

Gelfin Y, Lerer B, Lesch KP, Gorfine M, Allolio B. Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects. Psychopharmacology [Internet]. 1995;120(3):356–64. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029146357&doi=10.1007%252fBF02311184&partnerID=40&md5=a2500fef5a0dc8f80c18c5e539363ad0

300.

Segman RH, Gorfine M, Lerer B, Shapira B. Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy. Psychopharmacology [Internet]. 1995;119(4):440–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029066032&doi=10.1007%252fBF02245860&partnerID=40&md5=c694ffdb91489bd894b1623c09195b58

301.

Kohn Y, Newman ME, Lerer B, Orr SP, Pitman RK. Absence of reduced platelet adenylate cyclase activity in Vietnam veterans with PTSD. Biological Psychiatry [Internet]. 1995;37(3):205–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028804591&doi=10.1016%2f0006-3223%2894%2900213-M&partnerID=40&md5=78c57d8ac91e84dc1f569e8114e9d39e

302.

Heresco-Levy U, Greenberg D, Lerer B, Dasberg H, Brown WA. Two-year trial of maintenance neuroleptic dose reduction in schizophrenic out-patients: predictors of relapse. The Israel journal of psychiatry and related sciences [Internet]. 1995;32(4):268–75. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029450340&partnerID=40&md5=3664a272d83a85c35c15002d6732a161

303.

Lerer B. Biological psychiatry in Israel: approaching the challenge of maturity. Israel Journal of Psychiatry and Related Sciences [Internet]. 1995;32(1):1–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029176393&partnerID=40&md5=c0d97f9d618e7cefd0633d3c7b1be1fc

304.

Shapira B, Gorfine M, Lerer B. A prospective study of lithium continuation therapy in depressed patients who have responded to electroconvulsive therapy. Convulsive Therapy [Internet]. 1995;11(2):80–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029070701&partnerID=40&md5=dd6bc10955d4aa7bf6cb314f24bdf3c4

305.

Devanand DP, Shapira B, Petty F, Kramer G, Fitzsimons L, Lerer B, et al. Effects of electroconvulsive therapy on plasma GABA. Convulsive Therapy [Internet]. 1995;11(1):3–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028968664&partnerID=40&md5=6ab1b11011831b0a38790b0066683a99

306.

Alexander JR, Benjamin J, Lerer B, Baron M, Belmaker RH. Frequency of positive family history in bipolar patients in a catchment-area population. Progress in Neuropsychopharmacology and Biological Psychiatry [Internet]. 1995;19(3):367–73. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028924191&doi=10.1016%2f0278-5846%2895%2900018-Q&partnerID=40&md5=6bc46327e38dd29874f1744feb349c9c

307.

Mulcrone J, Whatley SA, Marchbanks R, Wildenauer D, Altmark D, Daoud H, et al. Genetic linkage analysis of schizophrenia using chromosome 11q13-24 markers in Israeli pedigrees. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1995;60(2):103–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028920398&doi=10.1002%252fajmg.1320600204&partnerID=40&md5=e3539b38ed294d069515077237f07178

308.

Lerer B, Shapira B, Calev A, Tubi N, Drexler H, Kindler S, et al. Antidepressant and cognitive effects of twice-versus three-times-weekly ECT. American Journal of Psychiatry [Internet]. 1995;152(4):564–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028908641&doi=10.1176%252fajp.152.4.564&partnerID=40&md5=c651c0616ec3b93a78a03e97d18c7717

309.

Kosower NS, Gerad L, Goldstein M, Parasol N, Zipser Y, Ragolsky M, et al. Constitutive heterochromatin of chromosome 1 and Duffy blood group alleles in schizophrenia. American Journal of Medical Genetics - Neuropsychiatric Genetics [Internet]. 1995;60(2):133–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028903128&doi=10.1002%252fajmg.1320600209&partnerID=40&md5=16186f2c199e67bdf2a1b34f7991c199

310.

Schwab SG, Albus M, Hallmayer J, Hönig S, Borrmann M, Lichtermann D, et al. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib–pair linkage analysis. Nature Genetics [Internet]. 1995;11(3):325–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028862998&doi=10.1038%252fng1195-325&partnerID=40&md5=29f839e5ec70cbe7f7bdbb1d0cebc4f6

311.

Shapira B, Newman M, Lerer B. Serotonergic mechanisms in depression: Clinical insights and biological correlates. Israel Journal of Medical Sciences [Internet]. 1994;30(2):162–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028369266&partnerID=40&md5=30fa336507964c3789d5025de07052f9

312.

Bloch M, Schwartzmann Y, Bonne O, Lerer B. Does concurrent lithium administration potentiate the antidepressant effect of desipramine? European Neuropsychopharmacology [Internet]. 1994;4(3):299–300. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-43949160495&doi=10.1016%2f0924-977X%2894%2990110-4&partnerID=40&md5=284b1779b52221c6fc4b4a15fa2b2494

313.

Segman R, Newman ME, Lerer B. Serotonin stimulation of GTP binding in rat hippocampal membranes and the action of antidepressant drugs. European Neuropsychopharmacology [Internet]. 1994;4(3):318. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-43949159801&doi=10.1016%2f0924-977X%2894%2990133-3&partnerID=40&md5=4a89244d7d0a3f6208b6f501a1327387

314.

Heresco-Levy U, Lerer B, Greenberg D, Javitt DC, Brown WA. Serum levels of fluphenazine in schizophrenic outpatients maintained on two reduced doses of fluphenazine decanoate. European Neuropsychopharmacology [Internet]. 1994;4(3):385–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-43949158317&doi=10.1016%2f0924-977X%2894%2990214-3&partnerID=40&md5=bed5ef0b3bc91047da9b502610dafbce

315.

Bonne OB, Krausz Y, Kempf O, Tubi N, Gorfine M, Bocher H, et al. Cerebral blood flow in symptomatic closed cranial injury patients. European Neuropsychopharmacology [Internet]. 1994;4(3):442. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-43949158058&doi=10.1016%2f0924-977X%2894%2990282-8&partnerID=40&md5=997aa31a0a1e249effef4bdb32d35838

316.

Gur E, Rogel-Fuchs Y, Newman ME, Lerer B. Effects of antidepressants on cyclic AMP responses in the living rat. European Neuropsychopharmacology [Internet]. 1994;4(3):317–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-43949157706&doi=10.1016%2f0924-977X%2894%2990132-5&partnerID=40&md5=8cbff0c16b05a1c97ec731c53aad56a2

317.

Gelfin G, Lesch KP, Lerer B. Effect of normal aging on 5-HT1A receptor mediated temperature and hormone responses. European Neuropsychopharmacology [Internet]. 1994;4(3):406–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-43949156420&doi=10.1016%2f0924-977X%2894%2990239-9&partnerID=40&md5=10258c73ec1761f2bfd6c563502486a7

318.

Shapira B, Gorfine M, Lidsky D, Lerer B. Seizure threshold and the treatment of major depression by electroconvulsive therapy. European Neuropsychopharmacology [Internet]. 1994;4(3):300–1. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-43949156398&doi=10.1016%2f0924-977X%2894%2990111-2&partnerID=40&md5=654c419162b9481b701fc634866d5c88

319.

Lerer B, Shapira B. How resistant is resistant depression? Focus on electroconvulsive therapy. European Neuropsychopharmacology [Internet]. 1994;4(3):211–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0043229307&doi=10.1016%2f0924-977X%2894%2990044-2&partnerID=40&md5=ae39213f959dcba3619a8fc1f29384be

320.

Bleich A, Dolev A, Koslowski M, Vozner Y, Lerer B. Psychiatric morbidity following psychic trauma of combat origin. Harefuah [Internet]. 1994;126(9):493–6, 562. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028437847&partnerID=40&md5=d4610d067df8af7468525da5c153409d

321.

Weizmann R, Gur E, Laor N, Reiss A, Muller U, Yoresh A, et al. Platelet adenylate cyclase activity in israeli victims of iraqi Scud missile attacks with post-traumatic stress disorder. Psychopharmacology [Internet]. 1994;114(3):509–12. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028318810&doi=10.1007%252fBF02249343&partnerID=40&md5=bb1a892390c2fcd7babd06b2195b03b9

322.

Baron M, Endicott J, Lerer B, Loth JE, Alexander JR, Simon R, et al. A pedigree series for mapping disease genes in bipolar affective disorder: Sampling, assessment, and analytic considerations. Psychiatric Genetics [Internet]. 1994;4(1):43–55. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028210116&doi=10.1097%252f00041444-199421000-00007&partnerID=40&md5=d36922582c15f381ff7519405ebc45f4

323.

Baron M, Straub RE, Lehner T, Endicott J, Ott J, Gilliam TC, et al. Bipolar disorder and linkage to Xq28. Nature Genetics [Internet]. 1994;7(4):461. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028087877&doi=10.1038%252fng0894-461a&partnerID=40&md5=6d78089ceaebe9769d9a33d618839e93

324.

Straub RE, Lehner T, Luo Y, Loth JE, Shao W, Sharpe L, et al. A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3. Nature Genetics [Internet]. 1994;8(3):291–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027987228&doi=10.1038%252fng1194-291&partnerID=40&md5=e1c8c87e6cab5c5999882076ed8de562

325.

Bloch M, Lerer B. Temporal changes in depression during the 20th century: is the world heading toward an era of depression? Harefuah [Internet]. 1993;125(11):412–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027748053&partnerID=40&md5=9c25e642fbdc4c25f716a676bbbfe17c

326.

Shapira B, Cohen J, Newman ME, Lerer B. Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patients. Biological Psychiatry [Internet]. 1993;33(7):531–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027173021&doi=10.1016%2f0006-3223%2893%2990008-2&partnerID=40&md5=6dd3dbefc8e96403818a4f34d9f1ecd9

327.

Baron M, Freimer NF, Risch N, Lerer B, Alexander JR, Straub RE, et al. Diminished support for linkage between manic depressive illness and X–chromosome markers in three Israeli pedigrees. Nature Genetics [Internet]. 1993;3(1):49–55. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027509066&doi=10.1038%252fng0193-49&partnerID=40&md5=9dab02ca4a594dc3c3392313501f3726

328.

Zervas IM, Calev A, Jandorf L, Schwartz J, Gaudino E, Tubi N, et al. Age-dependent effects of electroconvulsive therapy on memory. Convulsive Therapy [Internet]. 1993;9(1):39–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027479840&partnerID=40&md5=731da467b1693ee425544193ed4207d2

329.

Heresco-Levy U, Greenberg D, Lerer B, Dasberg H, Brown WA. Trial of maintenance neuroleptic dose reduction in schizophrenic outpatients: Two-year outcome. Journal of Clinical Psychiatry [Internet]. 1993;54(2):59–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027406152&partnerID=40&md5=861aec5599d79002be3caa54797d31ff

330.

Silver H, David D, Kaplan M, Hadjez J, Tubi N, Darnel A, et al. Factor analysis of schizophrenic symptoms and comparison of different rating scales. Schizophrenia Research [Internet]. 1993;10(1):67–75. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027327460&doi=10.1016%2f0920-9964%2893%2990078-W&partnerID=40&md5=934bc1352d07dce8ed44064e2ba86df6

331.

Tubi N, Calev A, Nigal D, Shapira B, Fink M, Pass HL, et al. Subjective symptoms in depression and during the course of electroconvulsive therapy. Neuropsychiatry, Neuropsychology and Behavioral Neurology [Internet]. 1993;6(3):187–92. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027323962&partnerID=40&md5=90f5299ffbb5c44aba57be01d6af0a15

332.

Newman ME, Lerer B, Shapira B. 5-HT-1A receptor-mediated effects of antidepressants. Progress in Neuropsychopharmacology and Biological Psychiatry [Internet]. 1993;17(1):1–19. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027193582&doi=10.1016%2f0278-5846%2893%2990031-M&partnerID=40&md5=977c32fc98e699a60cdf41bd85ae2b38

333.

Bloch M, Admon D, Bonne O, Lerer B. Electroconvulsive therapy in a depressed heart transplant patient. Convulsive Therapy [Internet]. 1992;8(4):290–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027104412&partnerID=40&md5=9a0c6c73ce9ed366b92ba32611b18414

334.

Newman ME, Lerer B, Lichtenberg P, Shapira B. Platelet adenylate cyclase activity in depression and after clomipramine and lithium treatment: relation to serotonergic function. Psychopharmacology [Internet]. 1992;109(1–2):231–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026467007&doi=10.1007%252fBF02245505&partnerID=40&md5=7ee2d614e60cbc21bc64ee74dae36442

335.

Shapira B, Yagmur MJ, Gropp C, Newman M, Lerer B. Effect of clomipramine and lithium on fenlfuramine-induced hormone release in major depression. Biological Psychiatry [Internet]. 1992;31(10):975–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026670939&doi=10.1016%2f0006-3223%2892%2990091-D&partnerID=40&md5=47e65abb24f1f9e8a945b465e772f3d6

336.

Lichtenberg P, Shapira B, Blacker M, Gropp C, Calev A, Lerer B. Effect of fenfluramine on mood: A double-blind placebo-controlled trial. Biological Psychiatry [Internet]. 1992;31(4):351–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026520483&doi=10.1016%2f0006-3223%2892%2990228-R&partnerID=40&md5=31eafcdbbe61690b805677ac3e1b992a

337.

Moscovich DG, Shapira B, Lerer B, Belmaker RH. Rapid lithiumization in acute manic patients. Human Psychopharmacology: Clinical and Experimental [Internet]. 1992;7(5):343–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027077497&doi=10.1002%252fhup.470070508&partnerID=40&md5=89dc2e3375dc02568eeb5c3ba01cd6c5

338.

Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, et al. Hormone responses to fenfluramine and placebo challenge in endogenous depression. Psychiatry Research [Internet]. 1992;43(2):137–46. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026782424&doi=10.1016%2f0165-1781%2892%2990128-P&partnerID=40&md5=90f67fccbabff1bf8c02be0942d3bc8b

339.

Bonne O, Krausz Y, Lerer B. SPECT imaging in psychiatry. A review. General Hospital Psychiatry [Internet]. 1992;14(5):296–306. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026658203&doi=10.1016%2f0163-8343%2892%2990063-G&partnerID=40&md5=4baf9e16b7c06596c5cce7c69d707125

340.

Newman ME, Shapira B, Lerer B. Regulation of 5-hydroxytryptamine(1A) receptor function in rat hippocampus by short- and long-term administration of 5-hydroxytryptamine(1A) agonists and antidepressants. Journal of Pharmacology and Experimental Therapeutics [Internet]. 1992;260(1):16–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026610296&partnerID=40&md5=55668ced44c5c1e47eb63a3cf6766688

341.

Shapira B, Lerer B, Kindler S, Lichtenberg P, Gropp C, Cooper T, et al. Enhanced serotonergic responsivity following electroconvulsive therapy in patients with major depression. British Journal of Psychiatry [Internet]. 1992;160(FEB.):223–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026573136&doi=10.1192%252fbjp.160.2.223&partnerID=40&md5=3afaf9fc02a6778bd3e9a1cafe957679

342.

Alexander JR, Lerer B, Baron M. Ethical issues in genetic linkage studies of psychiatric disorders. British Journal of Psychiatry [Internet]. 1992;160(JAN.):98–102. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026513980&doi=10.1192%252fbjp.160.1.98&partnerID=40&md5=481d59c3d4b9e2d1f5bb813c4fb9d858

343.

Shapira B, Newman M, Lerer B. Serotonergic mechanisms of ECT: neuroendocrine evidence. Clinical neuropharmacology [Internet]. 1992;15 Suppl 1 Pt A:673A-674A. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026497153&doi=10.1097%252f00002826-199201001-00348&partnerID=40&md5=e437d8ea46db9670b6ead9cc4e3f026b

344.

Silver H, Blacker M, Weller MPI, Lerer B. Treatment of chronic schizophrenia with cyproheptadine: A double-blind placebo-controlled study. Biological Psychiatry [Internet]. 1991;30(5):523–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026072350&doi=10.1016%2f0006-3223%2891%2990317-F&partnerID=40&md5=794f32e2d42805c291b14b8a0bcdff79

345.

Newman ME, Ben-Zeev A, Lerer B. Chloroamphetamine did not prevent the effects of chronic antidepressants on 5-hydroxytryptamine inhibition of forskolin-stimulated adenylate cyclase in rat hippocampus. European Journal of Pharmacology: Molecular Pharmacology [Internet]. 1991;207(3):209–13. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025738183&doi=10.1016%2f0922-4106%2891%2990032-D&partnerID=40&md5=adb6a92271258f46cbfd85a8c186e530

346.

Bennett ER, Yedgar S, Lerer B, Ebstein RP. Phospholipase A2 activity in Epstein-Barr virus-transformed lymphoblast cells from schizophrenic patients. Biological Psychiatry [Internet]. 1991;29(11):1058–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025922138&doi=10.1016%2f0006-3223%2891%2990247-J&partnerID=40&md5=1ae703327334f485174f049f5f2dd09f

347.

Lesch KP, Lerer B. The 5-HT receptor - G-protein - effector system complex in depression I. Effect of glucocorticoids. Journal of Neural Transmission [Internet]. 1991;84(1–2):3–18. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025903725&doi=10.1007%252fBF01249105&partnerID=40&md5=4f4e2315811f74e19692a9c110a37895

348.

Shapira B, Calev A, Lerer B. Optimal use of electroconvulsive therapy: Choosing a treatment schedule. Psychiatric Clinics of North America [Internet]. 1991;14(4):935–46. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026321185&doi=10.1016%2fs0193-953x%2818%2930277-6&partnerID=40&md5=d2ac70160728e2f02c2fd1c655e1bb86

349.

Calev A, Phil D, Kochav-lev E, Tubi N, Nigal D, Chazan S, et al. Change in attitude toward electroconvulsive therapy: Effects of treatment, time since treatment, and severity of depression. Convulsive Therapy [Internet]. 1991;7(3):184–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026045325&partnerID=40&md5=b07cf90c6a243f7a7a55718dd0584216

350.

Calev A, Nigal D, Shapira B, Tubi N, Chazan S, Ben-Yehuda Y, et al. Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions. Journal of Nervous and Mental Disease [Internet]. 1991;179(9):526–33. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026042331&doi=10.1097%252f00005053-199109000-00002&partnerID=40&md5=1a40ef30ed1fb9b28e7b293d2cbd332e

351.

Newman ME, Shapira B, Lerer B. Effects of lithium and desimipramine on second messenger responses in rat hippocampus: relation to G protein effects. Neuropharmacology [Internet]. 1991;30(12):1297–301. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026008619&doi=10.1016%2f0028-3908%2891%2990026-8&partnerID=40&md5=e453981876427a9f41e341a6aa9de6df

352.

Bachar E, Kindler S, Schefler G, Lerer B. Reminiscing as a technique in the group psychotherapy of depression: A comparative study. British Journal of Clinical Psychology [Internet]. 1991;30(4):375–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026001636&doi=10.1111%252fj.2044-8260.1991.tb00960.x&partnerID=40&md5=8fd101f9deecfaee88e61270313ea8fa

353.

Calev A, Nigal D, Kugelmass S, Weller MPI, Lerer B. Performance of long‐stay schizophrenics after drug withdrawal on matched immediate and delayed recall tasks. British Journal of Clinical Psychology [Internet]. 1991;30(3):241–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025893333&doi=10.1111%252fj.2044-8260.1991.tb00942.x&partnerID=40&md5=01bab790d00d74ac01332bfec598449a

354.

Calev A, Drexler H, Tubi N, Nigal D, Shapira B, Kugelmass S, et al. Atropine and cognitive performance after electroconvulsive therapy. Convulsive Therapy [Internet]. 1991;7(2):92–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025874305&partnerID=40&md5=894f4297c6d3edb1e536e839619e2dec

355.

Kindler S, Shapira B, Hadjez J, Abramowitz M, Brom D, Lerer B. Factors influencing response to bilateral electroconvulsive therapy in major depression. Convulsive Therapy [Internet]. 1991;7(4):245–54. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025840292&partnerID=40&md5=3b6662f5809ae7fc53e15f68412f33c1

356.

Calev A, Cohen R, Tubi N, Nigal D, Shapira B, Kugelmass S, et al. Disorientation and bilateral moderately suprathreshold titrated ECT. Convulsive Therapy [Internet]. 1991;7(2):99–110. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025834997&partnerID=40&md5=7ea369f4d755ffd52c8067abc0c69f97

357.

Calev A, Edelist S, Kugelmass S, Lerer B. Performance of long-stay schizophrenics on matched verbal and visuospatial recall tasks. Psychological Medicine [Internet]. 1991;21(3):655–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025834021&doi=10.1017%252fS0033291700022297&partnerID=40&md5=f861d0a3946addb0b1dfe6c2755ac0b2

358.

Solomon Z, Bleich A, Koslowsky M, Kron S, Lerer B, Waysman M. Post-traumatic stress disorder: Issues of co-morbidity. Journal of Psychiatric Research [Internet]. 1991;25(3):89–94. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025787203&doi=10.1016%2f0022-3956%2891%2990002-R&partnerID=40&md5=0527eab6c5e2575c8d3a4d302f0eec82

359.

Belmaker RH, Lerer B, Newman M, Fuchs I. Lack of effect of lithium, propranolol or haloperidol on basal plasma cyclic AMP levels. Lithium [Internet]. 1991;2(2):115–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025760293&partnerID=40&md5=ae2935c398b854ae0be4b98dc6858233

360.

Nigal D, Calev A, Kugelmass S, Lerer B. Effect of four-week neuroleptic and anticholinergic drug withdrawal on memory function in chronic long-hospitalized schizophrenics. Annals of Clinical Psychiatry [Internet]. 1991;3(2):141–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025739681&doi=10.3109%252f10401239109147983&partnerID=40&md5=7414c7222244b1a8ed93065c6b27afbf

361.

Lerer B, Bleich A, Bennett ER, Ebstein RP, Balkin J. Platelet adenylate cyclase and phospholipase C activity in posttraumatic stress disorder. Biological Psychiatry [Internet]. 1990;27(7):735–40. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025278546&doi=10.1016%2f0006-3223%2890%2990588-S&partnerID=40&md5=fbf170b284c4da9898bb83f9d45af4bd

362.

Newman ME, Drummer D, Lerer B. Single and combined effects of desimipramine and lithium on serotonergic receptor number and second messenger function in rat brain. Journal of Pharmacology and Experimental Therapeutics [Internet]. 1990;252(2):826–31. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025355884&partnerID=40&md5=bbb89e2bebc8392c6594bb336334ff46

363.

Braun P, Greenberg D, Dasberg H, Lerer B. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. Journal of Clinical Psychiatry [Internet]. 1990;51(6):236–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025352832&partnerID=40&md5=eeef4a4a4de97440c6935bfd92d10f97

364.

Bachar E, Dasberg H, Shapira B, Lerer B. Reminiscing in depressed, ageing patients: Effect of ECT and antidepressants. International Journal of Geriatric Psychiatry [Internet]. 1990;5(4):251–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025063561&doi=10.1002%252fgps.930050408&partnerID=40&md5=4605e08c634989887439e5c31b9a43dd

365.

Bachar E, Calev A, Shapira B, Lerer B. Memories in depression: Pleasant or unpleasant? British Journal of Psychiatry [Internet]. 1990;157(OCT.):623–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024990766&doi=10.1192%252fbjp.157.4.623b&partnerID=40&md5=e83c31f89ae18d3d5e3db06b7160abef

366.

Ebstein RP, Bennett ER, Hadjez J, Silver H, Yedgar S, Lerer B. Cyclic AMP second messenger signal generation in EBV-transformed lymphoblastoid cells from schizophrenic patients. Journal of Psychiatric Research [Internet]. 1990;24(2):121–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024990230&doi=10.1016%2f0022-3956%2890%2990052-R&partnerID=40&md5=e4437096dd18f2529966b7d986a73a77

367.

Gil T, Calev A, Greenberg D, Kugelmass S, Lerer B. Cognitive functioning in Post-Traumatic Stress Disorder. Journal of Traumatic Stress [Internet]. 1990;3(1):29–45. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0002145968&doi=10.1007%252fBF00975134&partnerID=40&md5=17af1c1d1a2071e4f176f346b3fc0520

368.

Lerer B, Shapira B. ECT: Twice or thrice a week: Reply. Convulsive Therapy [Internet]. 1989;5(4):364–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024852018&partnerID=40&md5=595b3a78690307e0994b5210bc9dd102

369.

Heresco-Levy U, Greenberg D, Wittman L, Dasberg H, Lerer B. Prescribing patterns of neuroactive drugs in 98 schizophrenic patients. Israel Journal of Psychiatry and Related Sciences [Internet]. 1989;26(3):157–63. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024828247&partnerID=40&md5=45ad7fdf10bf46afce351134b53d586a

370.

Newman ME, Lerer B. Post-receptor-mediated increases in adenylate cyclase activity after chronic antidepressant treatment: relationship to receptor desensitization. European Journal of Pharmacology [Internet]. 1989;162(2):345–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024521996&doi=10.1016%2f0014-2999%2889%2990298-7&partnerID=40&md5=c96a1c9c831ebe98727164c38e3f3065

371.

Silver H, Blacker M, Weller MPI, Lerer B. Treatment of chronic schizophrenia with cyproheptadine. Biological Psychiatry [Internet]. 1989;25(4):502–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024521624&doi=10.1016%2f0006-3223%2889%2990206-0&partnerID=40&md5=d103b990de3bd7b72c569bc25f5f131c

372.

Roth D, Hamburger-Bar R, Lerer B. Peripheral versus central manifestations in the toxic interaction of lithium and pilocarpine. Biological Psychiatry [Internet]. 1989;25(2):153–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024492011&doi=10.1016%2f0006-3223%2889%2990159-5&partnerID=40&md5=c3ad7b4cd1da94e6b5760602326763cd

373.

Itzchaky S, Lerer B, Ebstein RP. Uptake of 3H-spiperone by lymphocytes in schizophrenia. Journal of Psychiatric Research [Internet]. 1989;23(3–4):221–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024855190&doi=10.1016%2f0022-3956%2889%2990027-7&partnerID=40&md5=a7d0488f121d2adf989bd6cf8bd13747

374.

Calev A, Ben-Tzvi E, Shapira B, Drexler H, Carasso R, Lerer B. Distinct memory impairments following electroconvulsive therapy and imipramine. Psychological Medicine [Internet]. 1989;19(1):111–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024605018&doi=10.1017%252fS0033291700011077&partnerID=40&md5=8e61ffd31371331c8533351db78703c9

375.

Shapira B, Reiss A, Kaiser N, Kindler S, Lerer B. Effect of imipramine treatment on the prolactin response to fenfluramine and placebo challenge in depressed patients. Journal of Affective Disorders [Internet]. 1989;16(1):1–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024534949&doi=10.1016%2f0165-0327%2889%2990047-5&partnerID=40&md5=27d861cc485a126072c5e95368e8d587

376.

Newman ME, Lerer B. Modulation of second messenger function in rat brain by in vivo alteration of receptor sensitivity: Relevance to the mechanism of action of electroconvulisve therapy and antidepressants. Progress in Neuropsychopharmacology and Biological Psychiatry [Internet]. 1989;13(1–2):1–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024512297&doi=10.1016%2f0278-5846%2889%2990002-X&partnerID=40&md5=961e73f9c6c84a65175b826b3f137e09

377.

Newman ME, Lerer B. Effects of chronic electroconvulsive shock on D1 and D2 dopamine receptor-mediated activity of adenylate cyclase in homogenates of striatum and limbic forebrain of rat. Neuropharmacology [Internet]. 1989;28(8):787–90. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024394965&doi=10.1016%2f0028-3908%2889%2990168-8&partnerID=40&md5=ea4862e9ad24d1ebe961625dc1df1119

378.

Lichtenberg P, Lerer B. Implications of clinical spectrum for mechanisms of action: ECT and antidepressants reconsidered. Convulsive Therapy [Internet]. 1989;5(3):216–26. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024380383&partnerID=40&md5=e481adbf2b881e70fe999ab017f0be7d

379.

Newman ME, Lerer B. Effects of lithium and desipramine administration on agonist-stimulated inositol phosphate accumulation in rat cerebral cortex. Biochemical Pharmacology [Internet]. 1988;37(10):1991–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023926205&doi=10.1016%2f0006-2952%2888%2990546-1&partnerID=40&md5=59d0e63717cf3d57f248d57d19d18c49

380.

Newman ME, Lerer B. Chronic electroconvulsive shock and desimipramine reduce the degree of inhibition by 5-HT and carbachol of forskolin-stimulated adenylate cyclase in rat hippocampal membranes. European Journal of Pharmacology [Internet]. 1988;148(2):257–60. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023829881&doi=10.1016%2f0014-2999%2888%2990571-7&partnerID=40&md5=dae1b45ae22c40180028e002073ecfa9

381.

Lerer B, Ran A, Blacker M, Silver H, Weller MPI, Drummer D, et al. Neuroendocrine responses in chronic schizophrenia. Evidence for serotonergic dysfunction. Schizophrenia Research [Internet]. 1988;1(6):405–10. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024245153&doi=10.1016%2f0920-9964%2888%2990022-9&partnerID=40&md5=57d066c74e2bce1c2016154bd801623a

382.

Shapira B, Kindler S, Lerer B. Failure to convulse with ECT. The British journal of psychiatry : the journal of mental science [Internet]. 1988;153:413–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0024085969&doi=10.1192%252fbjp.153.3.413b&partnerID=40&md5=5bb2a983066b10e056fab16b48b2cd87

383.

Ebstein RP, Lerer B, Bennett ER, Shapira B, Kindler S, Shemesh Z, et al. Lithium modulation of second messenger signal amplification in man: Inhibition of phosphatidylinositol- specific phospholipase C and adenylate cyclase activity. Psychiatry Research [Internet]. 1988;24(1):45–52. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023948931&doi=10.1016%2f0165-1781%2888%2990138-2&partnerID=40&md5=8335a39fe7260bdc7e31c35070749a08

384.

Ebstein RP, Lerer B, Shapira B, Shemesh Z, Moscovich DG, Kindler S. Cyclic AMP second-messenger signal amplification in depression. British Journal of Psychiatry [Internet]. 1988;152(MAY):665–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023907890&doi=10.1192%252fbjp.152.5.665&partnerID=40&md5=33aca7d573414b4b47304a65ec2ce08d

385.

Shestatzky M, Greenberg D, Lerer B. A controlled trial of phenelzine in posttraumatic stress disorder. Psychiatry Research [Internet]. 1988;24(2):149–55. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023895894&doi=10.1016%2f0165-1781%2888%2990057-1&partnerID=40&md5=80f41257480847ef7bf465412a000017

386.

Shapira B, Kindler S, Lerer B. Medication outcome in ECT-resistant depression. Convulsive Therapy [Internet]. 1988;4(3):192–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023778676&partnerID=40&md5=b37f36d7dd18a187613c5192f8534a3e

387.

Lichtenberg P, Navon R, Wertman E, Dasberg H, Lerer B. Post-partum psychosis in adult GM2 gangliosidosis: A case report. British Journal of Psychiatry [Internet]. 1988;153(SEP.):387–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023735444&doi=10.1192%252fbjp.153.3.387&partnerID=40&md5=85e03d73e44e05d47edeaa5d1e077c9c

388.

Chazan S, Calev A, Gil T, Tubi N, Amiri Z, Lerer B. A study of the discriminating power of the Wechsler Memory Scale using schizophrenic and normal subjects in Israel. Israel Journal of Psychiatry and Related Sciences [Internet]. 1987;24(3):179–90. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023625325&partnerID=40&md5=550037263057221264b0d8be860eb3db

389.

Lerer B, Moore N, Meyendorff E, Cho SR, Gershon S. Carbamazepine versus lithium in mania: A double-blind study. Journal of Clinical Psychiatry [Internet]. 1987;48(3):89–93. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023117368&partnerID=40&md5=852efc1a9272f4fc0c15d75e04d98698

390.

Ebstein RP, Bennett ER, Stessman J, Lerer B. Isoelectric focusing of human platelet phospholipase C: Evidence for multimolecular forms. Life Sciences [Internet]. 1987;40(2):161–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023231666&doi=10.1016%2f0024-3205%2887%2990355-9&partnerID=40&md5=0de89a9a1d72ee60c91f941d1f1393eb

391.

Lerer B, Bleich A, Kotler M, Garb R, Hertzberg M, Levin B. Posttraumatic Stress Disorder in Israeli Combat Veterans: Effect of Phenelzine Treatment. Archives of General Psychiatry [Internet]. 1987;44(11):976–81. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023513719&doi=10.1001%252farchpsyc.1987.01800230056010&partnerID=40&md5=752e92c784e27a9befdf86bdaaadd150

392.

Garb R, Bleich A, Lerer B. Bereavement in combat. The Psychiatric clinics of North America [Internet]. 1987;10(3):421–36. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023414474&doi=10.1016%2fs0193-953x%2818%2930552-5&partnerID=40&md5=79691df05e168ad9c5afa30cf9fb74b6

393.

Newman ME, Miskin I, Lerer B. Effects of Single and Repeated Electroconvulsive Shock Administration on Inositol Phosphate Accumulation in Rat Brain Slices. Journal of Neurochemistry [Internet]. 1987;49(1):19–23. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023252051&doi=10.1111%252fj.1471-4159.1987.tb03387.x&partnerID=40&md5=6def15214b7a99bdf26b90f76df4008b

394.

Hamburger-Bar R, Kindler S, Bertish T, Lerer B. Conditioned avoidance acquisition and extinction following repeated electroconvulsive shock: Strain effect and response to vasopressin. Biological Psychiatry [Internet]. 1987;22(5):593–602. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023243337&doi=10.1016%2f0006-3223%2887%2990187-9&partnerID=40&md5=5ecda05dcb40e81e87223465eb3ea240

395.

Lerer B, Ebstein RP, Shestatsky M, Shemesh Z, Greenberg D. Cyclic AMP signal transduction in posttraumatic stress disorder. American Journal of Psychiatry [Internet]. 1987;144(10):1324–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023232251&doi=10.1176%252fajp.144.10.1324&partnerID=40&md5=f181fe1b299bb5c4c92b66c956428538

396.

Newman ME, Lipot M, Lerer B. Differential effects of chronic administration of desipramine on the cyclic AMP response in cortical slices and membranes in the rat. Neuropharmacology [Internet]. 1987;26(8):1127–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023222115&doi=10.1016%2f0028-3908%2887%2990258-9&partnerID=40&md5=ce55dd45cf2ad5a4bc908416020d46c7

397.

Shapira B, Lerer B, Gilboa D, Drexler H, Kugelmass S, Calev A. Facilitation of ECT by caffeine pretreatment. American Journal of Psychiatry [Internet]. 1987;144(9):1199–202. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023205334&doi=10.1176%252fajp.144.9.1199&partnerID=40&md5=deee0bfca7eb709a06cf63e89c23b743

398.

Ebstein RP, Moscovich D, Zeevi S, Amiri Z, Lerer B. Effect of lithium in vitro and after chronic treatment on human platelet adenylate cyclase activity: Postreceptor modification of second messenger signal amplification. Psychiatry Research [Internet]. 1987;21(3):221–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023197793&doi=10.1016%2f0165-1781%2887%2990026-6&partnerID=40&md5=e5488b3d14694c969c80f86bce82e416

399.

Calev A, Korin Y, Kugelmass S, Lerer B. Performance of chronic schizophrenics on matched word and design recall tasks. Biological Psychiatry [Internet]. 1987;22(6):699–709. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023182650&doi=10.1016%2f0006-3223%2887%2990201-0&partnerID=40&md5=3463b46d28297e6a62b4da427ea90509

400.

Calev A, Berlin H, Lerer B. Remote and recent memory in long-hospitalized chronic schizophrenics. Biological Psychiatry [Internet]. 1987;22(1):79–85. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0023073279&doi=10.1016%2f0006-3223%2887%2990133-8&partnerID=40&md5=da092228461aacdf3d6e71bb89f677ff

401.

Ebstein RP, Lerer B, Bennett ER, Dayek DB, Newman ME, Shapira B, et al. Second messenger function in lymphocytes and platelets: a comparison of peripheral and central mechanisms. Clinical Neuropharmacology [Internet]. 1986;9 Suppl 4:350–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-17044441913&partnerID=40&md5=a789cf788d3d3d62a88435a530e548f1

402.

Lerer B, Shapira B, Drexler H, Calev A, Newman ME. Pharmacological manipulation of ECT-induced seizure duration. Clinical Neuropharmacology [Internet]. 1986;9 Suppl 4:453–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022839082&partnerID=40&md5=9473ab4d4479ccbbde2b5ed27895a127

403.

Calev A, Korin Y, Shapira B, Kugelmass S, Lerer B. Verbal and non verbal recall by depressed and euthymic affective patients. Psychological Medicine [Internet]. 1986;16(4):789–94. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022998583&doi=10.1017%252fS0033291700011806&partnerID=40&md5=3e3c7ba3ca19a2518a9acf6c959ae455

404.

Shapira B, Lerer B. Clinical response rate to ECT. Psychiatry Research [Internet]. 1986;17(3):247–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022691423&doi=10.1016%2f0165-1781%2886%2990053-3&partnerID=40&md5=84894d949d98770e9a4207e1251c76dd

405.

Newman ME, Solomon H, Lerer B. Electroconvulsive Shock and Cyclic AMP Signal Transduction: Effects Distal to the Receptor. Journal of Neurochemistry [Internet]. 1986;46(6):1667–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022642433&doi=10.1111%252fj.1471-4159.1986.tb08482.x&partnerID=40&md5=fe01ceaab244c302bd159a84950137ca

406.

Lerer B, Stanley M, Keegan M, Altman H. Proactive and retroactive effects of repeated electroconvulsive shock on passive avoidance retention in rats. Physiology and Behavior [Internet]. 1986;36(3):471–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022639808&doi=10.1016%2f0031-9384%2886%2990317-3&partnerID=40&md5=b4f5aa2241d818135755834d636af091

407.

LERER B, SHAPIRA B. Neurochemical Mechanisms of Mood Stabilization: Focus on Electroconvulsive Therapy. Annals of the New York Academy of Sciences [Internet]. 1986;462(1):366–75. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022558654&doi=10.1111%252fj.1749-6632.1986.tb51271.x&partnerID=40&md5=e88afb7da71386c313286cd6a7465b73

408.

LERER B, STANLEY M, ALTMAN H, KEEGAN M. An Animal Model of Electroconvulsive‐Therapy‐Induced Amnesia: Possible Neurochemical Correlates. Annals of the New York Academy of Sciences [Internet]. 1986;462(1):91–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022558632&doi=10.1111%252fj.1749-6632.1986.tb51243.x&partnerID=40&md5=4df5a386ff0b47f9ec7bc4be0b8dce26

409.

Bleich A, Siegel B, Garb R, Lerer B. Post-traumatic stress disorder following combat exposure: Clinical features and psychopharmacological treatment. British Journal of Psychiatry [Internet]. 1986;149(SEPT.):365–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022446834&doi=10.1192%252fbjp.149.3.365&partnerID=40&md5=d6d38bc809152d46713472f21eff3b66

410.

Lerer B, Warner J, Friedman E, Vincent G, Gamzu E. Cortical cholinergic impairment and behavioral deficits produced by kainic acid lesions of rat magnocellular basal forebrain. Behavioral Neuroscience [Internet]. 1985;99(4):661–77. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022256188&doi=10.1037%252f0735-7044.99.4.661&partnerID=40&md5=3f2760a09bf78b4cba27fb53e67e7b8d

411.

Lerer B, Moore N, Meyendorff E, Cho SR, Gershon S. Carbamazepine and lithium: Different profiles in affective disorder? Psychopharmacology Bulletin [Internet]. 1985;21(1):18–22. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021813543&partnerID=40&md5=0cf7c4d83e8c7709d8f27d0bd557852b

412.

Lerer B, Stanley M. Effect of chronic lithium on cholinergically mediated responses and [3H]QNB binding in rat brain. Brain Research [Internet]. 1985;344(2):211–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021971238&doi=10.1016%2f0006-8993%2885%2990797-8&partnerID=40&md5=68201f3b99066e34cb8d6c7cb9685ad4

413.

Meyendorff E, Lerer B, Moore NC, Bow J, Gershon S. Methylphenidate infusion in euthymic bipolars: Effect of carbamazepine pretreatment. Psychiatry Research [Internet]. 1985;16(4):303–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022366228&doi=10.1016%2f0165-1781%2885%2990121-0&partnerID=40&md5=728b228d308b9f2f7dc877a6fd67152e

414.

Lerer B. Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium. Biological Psychiatry [Internet]. 1985;20(1):20–40. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022230259&doi=10.1016%2f0006-3223%2885%2990132-5&partnerID=40&md5=e3056633b5820d1d35219967e6a9e087

415.

Lerer B, Stanley M. Doe lithium stabilize muscarinic receptors? Biological Psychiatry [Internet]. 1985;20(11):1247–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0022150765&doi=10.1016%2f0006-3223%2885%2990185-4&partnerID=40&md5=2cb67ec0d52facbf7401de6c34a2b448

416.

Moore NC, Lerer B, Meyendorff E, Gershon S. Three cases of carbamazepine toxicity. American Journal of Psychiatry [Internet]. 1985;142(8):974–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021968345&doi=10.1176%252fajp.142.8.974&partnerID=40&md5=d3d9f3651ac01c87ae1f2882dedfa24c

417.

Stanley M, Lerer B. Electroconvulsive shock and brain cholinergic function: Role of striatal muscarinic receptors. Convulsive Therapy [Internet]. 1985;1(3):158–66. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021927984&partnerID=40&md5=e56627d2bc7e2675f994bd5b2026c554

418.

Lerer B. Alternative therapies for bipolar disorder. Journal of Clinical Psychiatry [Internet]. 1985;46(8):309–16. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021864452&partnerID=40&md5=8976b6d8188b436e656f02f59bcfa89a

419.

Lerer B, Stanley M, McIntyre I, Altman H. Electroconvulsive shock and brain muscarinic receptors: Relationship to anterograde amnesia. Life Sciences [Internet]. 1984;35(26):2659–64. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021688459&doi=10.1016%2f0024-3205%2884%2990035-3&partnerID=40&md5=84ba2da63f484e6cc4d002b4c3269bc5

420.

Lerer B. ECT and tardive dyskinesia. Journal of Clinical Psychiatry [Internet]. 1984;45(4):188. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021418996&partnerID=40&md5=acb6785eb61c4f56f4b372932cd88b4c

421.

Klein E, Lerer B, Newman M, Belmaker RH, Bhargava HN. Effect of cyclo(Leu-Gly) on reserpine-induced hypomotility and increases in cortical β-adrenergic receptors. Psychopharmacology [Internet]. 1984;83(1):76–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021343727&doi=10.1007%252fBF00427426&partnerID=40&md5=9ef8e14aaf22f7ece88b68c7ee1dc95f

422.

Lerer B, Stanley M. ECT-induced memory impairment – a cholinergic mechanism? Behavioral and Brain Sciences [Internet]. 1984;7(1):29–30. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84974126928&doi=10.1017%252fS0140525X00025978&partnerID=40&md5=62716724533a6c1e3eaabb41310eb151

423.

Klein E, Bental E, Lerer B, Belmaker RH. Carbamazepine and Haloperidol v Placebo and Haloperidol in Excited Psychoses: A Controlled Study. Archives of General Psychiatry [Internet]. 1984;41(2):165–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021368753&doi=10.1001%252farchpsyc.1984.01790130061009&partnerID=40&md5=440dbac1088f4e537a11ef01153fceda

424.

Lerer B. Electroconvulsive shock and neurotransmitter receptors: Implications for mechanism of action and adverse effects of electroconvulsive therapy. Biological Psychiatry [Internet]. 1984;19(3):361–83. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021270191&partnerID=40&md5=c1499d90142665b1294a36e9de3a4869

425.

Lerer B, Globus M, Brik E, Hamburger R, Belmaker RH. Effect of treatment and withdrawal from chronic lithium in rats on stimulant-induced responses. Neuropsychobiology [Internet]. 1984;11(1):28–32. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021248023&doi=10.1159%252f000118046&partnerID=40&md5=0745c519e4e018401783546511df562f

426.

Lerer B, Altman H, Stanley M. Enhancement of memory by a cholinesterase inhibitor associated with muscarinic receptor down-regulation. Pharmacology Biochemistry and Behavior [Internet]. 1984;21(3):467–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021151886&doi=10.1016%2fS0091-3057%2884%2980112-4&partnerID=40&md5=3775bf918c2004045bb25c1d330b9eef

427.

Ebstein RP, Lerer B, Shlaufman M, Belmaker RH. The effect of repeated electroconvulsive shock treatment and chronic lithium feeding on the release of norepinephrine from rat cortical vesicular preparations. Cellular and Molecular Neurobiology [Internet]. 1983;3(3):191–201. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020962713&doi=10.1007%252fBF00710946&partnerID=40&md5=6c353f323c40f1de7013508382d6ec60

428.

Lerer B, Stanley M, Demetriou S, Gershon S. Effect of Electroconvulsive Shock on Muscarinic Cholinergic Receptors in Rat Cerebral Cortex and Hippocampus. Journal of Neurochemistry [Internet]. 1983;41(6):1680–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0021076876&doi=10.1111%252fj.1471-4159.1983.tb00880.x&partnerID=40&md5=deacdc24f1843946dd300376da7ee982

429.

Lerer B, Zabow T, Egnal N, Belmaker RH. Effect of vasopressin on memory following electroconvulsive therapy. Biological Psychiatry [Internet]. 1983;18(7):821–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020611784&partnerID=40&md5=cc22f7de44edbb1dcc793146912e2d2d

430.

Belmaker RH, Lerer B, Klein E, Michael N, Klein E, Earl D. Clinical implications of research on the mechanism of action of lithium. Progress in Neuropsychopharmacology and Biological Psychiatry [Internet]. 1983;7(2–3):287–96. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020546542&doi=10.1016%2f0278-5846%2883%2990118-5&partnerID=40&md5=94208b98a87afd49b79a75ccc97c6b41

431.

Lerer B, Sitaram N. Clinical strategies for evaluating ect mechanisms - pharmacological, biochemical and psychophysiological approaches. Progress in Neuropsychopharmacology and Biological Psychiatry [Internet]. 1983;7(2–3):309–33. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020520782&doi=10.1016%2f0278-5846%2883%2990120-3&partnerID=40&md5=f8761c56bf57f1e25a661a8264e393f7

432.

Birmaher B, Lerer B, Belmaker RH. Lithium does not prevent ECS-induced decreases in β-adrenergic receptors. Psychopharmacology [Internet]. 1982;78(2):190–1. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020470575&doi=10.1007%252fBF00432261&partnerID=40&md5=5f53a7b818a0eb12c377c5acb7d362be

433.

Lerer B, Jabotinsky-Rubin K, Bannet J, Ebstein RP, Belmaker RH. Electroconvulsive shock prevents dopamine receptor supersensitivity. European Journal of Pharmacology [Internet]. 1982;80(1):131–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020072635&doi=10.1016%2f0014-2999%2882%2990188-1&partnerID=40&md5=a09a26f3c30eff9481e6335b06ebbdd7

434.

Globus M, Bannet J, Lerer B, Belmaker RH. The effect of chronic bromocriptine and l-Dopa on spiperone binding and apomorphine-induced stereotypy. Psychopharmacology [Internet]. 1982;78(1):81–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019994057&doi=10.1007%252fBF00470594&partnerID=40&md5=ab0dbc2a67bf33fb81ec84035222b8fa

435.

Zohar J, Lerer B, Ebstein RP, Belmaker RH. Lithium does not prevent agonist-induced subsensitivity of human adenylate cyclase. Biological Psychiatry [Internet]. 1982;17(3):343–50. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020083275&partnerID=40&md5=7378d47911f54838ba6ea1e864cedf8c

436.

Lerer B, Belmaker RH. Receptors and the mechanism of action of ECT. Biological Psychiatry [Internet]. 1982;17(4):497–511. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020047379&partnerID=40&md5=94d166e4d0e297f3da7cec92515f9a3c

437.

Belmaker RH, Lerer B, Zohar J. Salbutamol treatment of depression. Advances in biochemical psychopharmacology [Internet]. 1982;32:181–93. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0020010043&partnerID=40&md5=c8a6e08f9216e251e8a390056d8fdee5

438.

Belmaker RH, Lerer B, Bannet J, Birmaher B. The effect of electroconvulsive shock at a clinically equivalent schedule on rat cortical β‐adrenoceptors. Journal of Pharmacy and Pharmacology [Internet]. 1982;34(4):275–275. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019950425&doi=10.1111%252fj.2042-7158.1982.tb04246.x&partnerID=40&md5=2bdd2f81d2baa0330adce88c5c5e17ec

439.

Lerer B, Ebstein RP, Belmaker RH. Subsensitivity of human β-adrenergic adenylate cyclase after salbutamol treatment of depression. Psychopharmacology [Internet]. 1981;75(2):169–72. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019782129&doi=10.1007%252fBF00432181&partnerID=40&md5=d30c27c9680e92d95a73122c45726b0b

440.

Belmaker RH, Lerer B, Ebstein RP. Noradrenaline, dopamine and mood. Advances in the Biosciences [Internet]. 1981;31(C):17–29. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-49149138622&doi=10.1016%252fb978-0-08-026382-3.50007-4&partnerID=40&md5=18379f7c5f3fdf73af35f6864a30107b

441.

Lerer B, Jacobowitz J. Treatment of essential hyperhidrosis by psychotherapy. Psychosomatics [Internet]. 1981;22(6):536–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019861153&doi=10.1016%2fS0033-3182%2881%2973500-X&partnerID=40&md5=d799527eec16ad2ea94c17353d9ee8fd

442.

Goldman Z, Ebstein RP, Lerer B, Zohar J, Hermoni M, Belmaker RH. Haloperidol blood levels during dosage reduction in chronic schizophrenic patients. Neuropsychobiology [Internet]. 1981;7(6):281–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019843431&doi=10.1159%252f000117861&partnerID=40&md5=b0d5e39a19e1ac29e2c15120f10d666f

443.

Globus M, Lerer B, Hamburger R, Belmaker RH. Chronic electroconvulsive shock and chronic haloperidol administration are not additive in effects on dopamine receptors. Neuropharmacology [Internet]. 1981;20(11):1125–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019810387&doi=10.1016%2f0028-3908%2881%2990107-6&partnerID=40&md5=86547a5c696b6fcc051501ee12a27c02

444.

Hertz DG, Lerer B. The “rape family”: family reactions to the rape victim. International Journal of Family Psychiatry [Internet]. 1981;2(3–4):301–15. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019736891&partnerID=40&md5=b7bf766384d17498e0f5430cbce62154

445.

Bannet J, Lerer B, Ebstein RP, Ben-David M, Belmaker RH. Lack of effect of beta-2 adrenergic stimulation on human prolactin. Psychoneuroendocrinology [Internet]. 1981;6(2):177–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019457476&doi=10.1016%2f0306-4530%2881%2990010-X&partnerID=40&md5=78303ee7beef33f3600360cdb064ffd8

446.

Lerer B, Birmacher B, Ebstein RP, Belmaker RH. 48-Hour depressive cycling induced by antidepressant. British Journal of Psychiatry [Internet]. 1980;137(2):183–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019313115&doi=10.1192%252fbjp.137.2.183&partnerID=40&md5=15486ed8f8f268f9f0670ce1dc6aabdd

447.

Lerer B, Ebstein RP, Felix A, Belmaker RH. Lithium amelioration ofreserpine-induced hypoactivity in rats. International Pharmacopsychiatry [Internet]. 1980;15(6):338–43. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019231063&doi=10.1159%252f000468460&partnerID=40&md5=9712063d244b6b2348617bb87cb6a493

448.

HERMONI M, LERER B, EBSTEIN RP, BELMAKER RH. Chronic lithium prevents reserpine‐induced supersensitivity of adenylate cyclase. Journal of Pharmacy and Pharmacology [Internet]. 1980;32(1):510–1. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019229037&doi=10.1111%252fj.2042-7158.1980.tb12982.x&partnerID=40&md5=cc8ff093e230f339e233388c510487d0

449.

Lerer B, Jacobowitz J, Wahba A. Personality features in essential hyperhidrosis. International Journal of Psychiatry in Medicine [Internet]. 1980;10(1):59–67. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0019190881&doi=10.2190%252f866g-qqa9-q9ae-15nb&partnerID=40&md5=e5b48ab7e9d68fb6c5be172388f7b383

450.

Lerer B. Odyssey into the unknown. A resident’s views on psychotherapy and supervision. Israel Annals of Psychiatry and Related Disciplines [Internet]. 1979;17(1):74–80. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0018390330&partnerID=40&md5=be2ecd6e06517c3ddbcc7678dcf1a121

451.

Segal M, Edelstein EL, Lerer B. Interaction between delta-6-tetrahydrocannabinol (delta-6-THC) and lithium at the blood brain barrier in rats. Experientia [Internet]. 1978;34(5):629. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0018146622&doi=10.1007%252fBF01937002&partnerID=40&md5=e9dc4eebd90bdd69b0350db4ab328d3f

452.

Lerer B. Hyperhidrosis: A review of its psychological aspects. Psychosomatics [Internet]. 1977;18(5):28–31. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0017606634&doi=10.1016%2fS0033-3182%2877%2971043-6&partnerID=40&md5=dc2db041c70d36aa6ca7cfa4d75b71be

453.

Lerer B, Avni J, Wiesel D. Bad tidings and the hospitalized patient. Mental Health and Society [Internet]. 1976;3(3–4):205–11. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0017206172&partnerID=40&md5=e27c9656f1f6fe378db536067ddd50d2

454.

Lerer B, Avni J. Suicide in a general hospital psychiatric department. Psychiatria Clinica [Internet]. 1976;9(2):106–11. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0017212763&partnerID=40&md5=30621a5cdab02a38588c4cc607e7789c